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i 
Abstract 
 Chapter 1 introduces the field of supramolecular chemistry and reviews 
examples of supramolecular architectures. Applications of these assemblies are 
outlined with a focus on DNA recognition.  
In chapter 2 the synthesis and characterisation of an array of 
palladium(II) and platinum(II) tetra-stranded, dinuclear complexes is described. 
The synthesis of two palladium(II) triangles and a palladium(II) pyramid are also 
presented. 
Chapter 3 investigates the biological activities of four of the               
tetra-stranded palladium(II) complexes described in chapter 2. The results show 
that while all of them bind to DNA, only two show good cytotoxic activities in an 
MTT assay. Toxicological studies were conducted on the two active cylinders 
and excitingly, the preliminary results indicate that they are not genotoxic or 
mutagenic. 
 In chapter 4 the interaction of two novel single-stranded palladium(II) and 
platinum(II) complexes with B-DNA is probed by circular and linear dichroism 
and gel electrophoresis. The study confirms that the complexes bind to DNA, 
causing it to kink and bend.  
  Chapter 5 presents the synthesis and crystallographic characterisation 
of four new silver(I) supramolecular polymers. 
 In chapter 6 a new pyridylazo ligand system is described and the 
coordination chemistry of this ligand with silver(I), copper(I) and palladium(II) 
investigated. 
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Chapter 1 
1.1 Overview 
Since the discovery of the leading anti-cancer drug cis-platin, metal complexes 
that bind to DNA have attracted a great deal of attention. In the Hannon group, 
research has been focused on non-covalent DNA recognition by             
metallo-supramolecular complexes. The supramolecular methodology has 
allowed the construction of large synthetic agents that have been shown to bind             
non-covalently to DNA and cause remarkable and unprecedented effects on its 
structure. Advances in this field have shown that the supramolecular approach 
is a valuable tool for the design of new DNA recognition agents. In this 
introduction, the principles of supramolecular chemistry will be discussed and 
some examples of the types of architectures formed will be presented.  
 
1.2 Supramolecular Chemistry 
Molecular chemists have developed a large collection of reliable procedures for 
preparing complex molecules and materials from atoms connected by covalent 
bonds.1 Beyond the molecule, supramolecular chemistry has been described by 
one of its pioneers, Jean-Marie Lehn, as the ‘chemistry of molecular assemblies 
and of the intermolecular bond’.2 In broader terms it is the self-assembly of 
small molecular subunits into larger arrays via non-covalent, intermolecular 
interactions. The simple self-assembly process rules out the need for 
complicated, multi-step organic synthesis and is the key driving force in the 
formation of supramolecular structures. The interactions involved in the        
self-assembly process include metal ion coordination, aromatic π-π stacking, 
solvent effects, hydrogen bonding and host-guest interactions, each one varying 
in its binding strength. The controlled utilisation of one or more of these 
 2 
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interactions has enabled the design and synthesis of a multitude of 
supramolecular architectures.3  
 
1.3 Metallo-Supramolecular Architectures 
The successful synthesis of supramolecular assemblies is reliant on the careful 
selection of the starting materials and the reaction conditions, thus permitting 
self-assembly to occur in a controlled manner. Metallo-supramolecular 
chemistry is a term used to describe metal-mediated self-assembly. In this field, 
the emphasis lies in the careful design of the organic ligands and the 
appropriate selection of the metal ions.4 The metal ions are used as templates 
in the organisation of the molecular building blocks and are thus chosen for their 
coordination numbers and stereochemical preferences. The ligands are 
designed with the appropriate features required for the formation of the 
synthetic target i.e. with the appropriate use of spacer groups and the correct 
number and spatial arrangement of the donor sites. Metal-directed                
self-assembly plays a key role in supramolecular chemistry and has led to the 
development of an array of highly sophisticated architectures including boxes,5 
helicates,6 triangles7 and grids.8 Some examples of these are discussed in more 
detail in the following sections. 
 
1.4 Supramolecular Helicates 
First introduced by Jean-Marie Lehn in 1987, the term helicate is used to 
describe supramolecular structures in which ‘one or more covalent organic 
strands are wrapped about and coordinated to a series of metal ions defining 
the helical axis’.9 Helicates are formed by self-assembly, therefore the subunits 
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must be pre-designed so that they are complementary in the formation of the 
helical structure. The metal ions are chosen for their coordination number and 
geometry preferences which should be closely matched to the properties of the 
ligand. The ligands are designed with two or more binding sites that are capable 
of coordinating to the chosen metal ion(s). The spacer group between the 
binding sites should be flexible enough to allow the ligand to wrap about the 
helical axis, but also rigid enough to prevent multiple binding sites of that ligand 
from coordinating to the same metal centre.   
Helicates can be classified as homotopic or heterotopic. If the 
coordinated ligand strands contain similar binding sites along their length, they 
will form homotopic helicates. If the ligand strands possess dissimilar binding 
sites, the resulting helicates will be heterotopic. As shown in Scheme 1.1, 
heterotopic helicates exist in two isomeric forms.10 
 
 
Scheme.1.1. A schematic representation of homotopic and heterotopic helicates 
(Taken from reference 10). 
 
A number of helical structures have been reported. The majority of these 
structures contain either one, two, three or four ligand strands. Some interesting 
examples of supramolecular helicates are discussed in the following section. 
 4 
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1.4.1 Single-Stranded Helicates 
Single-stranded helicates can be formed by employing a metal ion which is too 
small to fit the cavity of a multi-dentate ligand. A small twist is induced in the 
ligand to minimise the steric interactions between the two ends of the strand.  
In 1988 Constable et al. reported the formation of a single-stranded 
helicate from the reaction of silver(I) acetate with 2,2’:6’,2”:6”,2”’:6”’,2””-
quinquepyridine (La). Constable found that the silver(I) ion was too small for the 
gap between the pyridine rings. Therefore, when the five nitrogen donors bind 
to the metal ion the ligand is forced to wrap around it with a slight helical twist 
(Figure 1.1). 11 
 
 
 
 
  (La) 
 
 
 
Ag(I) 
 
 
 
Figure 1.1. Constable’s single-stranded helicate.11 
 
More recently, Zhang and co-workers have used a tetra-dentate ligand system 
(Lb) to generate a single-stranded copper(II) helicate. The metal centre is     
five-coordinate with the fifth position being occupied by a water molecule. Once 
again the ligand cavity is too large for the copper(II) centre resulting in the 
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formation of a helical structure (Figure 1.2). Zhang has also shown that a 
silver(I) double-stranded helicate can also be formed using this ligand.12  
 
 
 
 
 
Figure 1.2. Zhang’s (a) Ligand Lb and (b) single-stranded copper(II) helicate.12 
 (b)   (a) 
 
1.4.2 Double-Stranded Helicates 
An abundant literature reports the formation of double-stranded helicates. 
Ligand Lc is one of the first ligands pre-designed to encourage the formation of 
a double helicate by virtue of steric interactions between the four methyl groups 
(Figure 1.3 (a)).13  
 
 
 
 
      (a)                     (b) 
  
Figure 1.3. (a) Ligand Lc and (b) Ligand Ld. 
 
As anticipated, the reaction of Lc with copper(I) results in the formation of a 
double-stranded [Cu2L2]2+ helicate. Interestingly, Constable et al. later 
discovered that the reaction of copper(I) with the less sterically hindered ligand 
Ld (Figure 1.3 (b)) also resulted in the formation of a double helicate.14 This 
result shows that the tetrahedral coordination geometry of the metal centre was 
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enough to induce helicate formation. However, the Cu···Cu separation is larger 
in the methylated complex than in the nonmethylated one, indicating that the 
methyl groups do play an important role in controlling the pitch of the helical 
structure.  
Most double-stranded helicates are formed from ligands consisting of 
bidentate binding sites and metal ions preferring four-coordinate geometry. 
However, a small number have also been prepared from ligands with terdentate 
binding sites and six-coordinate metal centres. One of the simplest examples 
involves the reaction of the poly-pyridyl ligand La with six-coordinate metal 
centres such as iron(II), nickel(II) and ruthenium(II) resulting in the formation of 
double-stranded helicates (Figure 1.4).15 This is a prime example of how the 
self-assembly process can be controlled by the selection of the subunits. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Constable’s double-stranded nickel(II) helicate.15 
  
Double helical architectures have also been synthesised using macrocyclic 
ligands. One of the first examples was provided by Fenton et al. who 
coordinated the Schiff base macrocycle Le to cobalt(II), nickel(II) and zinc(II). 
The X-ray crystal structure of the zinc(II) complex of Le is shown in            
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Figure 1.5 (b).16 The large macrocyclic ring is compressed so that the metal 
ions, which occupy a distorted octahedral environment, can be accommodated. 
    (a)             (b) 
  
 
 
 
 
 
 
Figure 1.5. (a) Ligand Le and (b) X-ray crystal structure of Fenton’s 
 zinc(II) helicate.16 
 
1.4.3 Triple-Stranded Helicates 
A multitude of triple-stranded helicates have been reported using three, six or 
nine-coordinate metal ions. The first structurally characterised triple helicate 
was reported by Williams et al. in 1991.17 Williams incorporated a rigid spacer 
into the ligand (Lf) preventing it from acting as a tetra-dentate chelator. 
Therefore, the reaction of the ligand with six-coordinate cobalt(II) resulted in the 
formation of the triple-stranded helicate shown in Figure1.6.   
 
 
 
 
 
 
 
 
Figure 1.6. (a) Ligand Lf and (b) William’s triple-stranded helicate.17 
(a)                  (b) 
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The ligand has also been shown to form double-stranded helicates in the 
presence of four-coordinate metal centres such as copper(I).18 
More recently, Hannon and co-workers have investigated the use of 
imine-based ligands such as Lg in the formation of an array of different 
helicates.19 Figure 1.7 shows the formation of a triple-stranded helicate on 
coordination of Lg to iron(II).20  
2
FeCl2
NH2NH2
N
N
N
N
N
O
 
 
 
 
 
 
(Lg) 
 
Figure 1.7. Hannon’s triple-stranded helicate.20 
 
The helicate formation is induced by the six-coordinate metal centres and the 
pre-designed structure of the ligand. The central methylene group incorporates 
flexibility into the ligand and the spacer groups sterically prevent the two 
bidentate binding sites from coordinating to the same metal ion. The ligand also 
has the advantages of being very inexpensive and easy to prepare. 
 During the last two decades hundreds of helicates have been reported, 
however, only a few heteronuclear metallo-helicates have been described. 
Piguet and co-workers have described the synthesis of heteronuclear helicates 
using ligand Lh. This heterotopic ligand consists of bi-dentate and tri-dentate 
binding sites separated by a rigid spacer unit. Therefore, the self-assembly of 
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Lh with ruthenium(II) and europium(III) metal ions results in the formation of the 
heteronuclear helicate shown in Figure 1.8.21 
 
 
 
 
 
 
 
 
 
Figure 1.8. (a) Ligand Lh and (b) Piguet’s heteronuclear helicate.21 
    (a)                      (b) 
 
1.4.4 Quadruply-Stranded Helicates 
In 1998 Steel et al. were the first group to report the formation of a 
coordinatively saturated, quadruply-stranded helicate (Figure 1.9). This was 
achieved by employing a combination of four Li ligands and two square planar 
palladium(II) metal centres in a self-assembly process.22 
 
(Li) 
 
 
 
 
 
 
Figure 1.9. Steel’s quadruply-stranded helicate.22 
 
The X-ray crystal structure of the helicate revealed that a hexaflurophosphate 
ion is encapsulated within the central cavity. This is the first example in which a 
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polyatomic anion has been encapsulated within any helicate. Therefore the 
structure could prove useful in the potential use of helicates in host-guest 
recognition processes. 
 
1.4.5 Applications of Helicates 
Although the last two decades have seen the emergence of hundreds of 
beautiful helicates, much of this research has been aimed at enhancing our 
knowledge of the self-assembly processes and not on the potential applications 
of the end products. However, now that our understanding of this field has 
become more advanced a number of potential applications have slowly begun 
to emerge. 
 Many helicates are able to act as hosts in the binding and recognition of 
anionic guests: Rice and co-workers23 have observed the binding of a nitrate 
anion by a cobalt(II) triple-stranded helicate and Janiak et al.24 have reported 
anion binding within clefts formed by mononuclear [FeL3]2+ helicates. In 2006 
Kruger et al. reported three triple-stranded helicates that have been specially 
designed to act as anion receptors. The helicates were formed from the ligands 
shown in Figure 1.10.25 
 
(Lj) 
 
 
 
 
 
 
Figure 1.10. Kruger’s helicating ligands. 
 
 
 
 
 
(Lk) 
 
 
 
 
 
(Ll) 
 
(Lj) 
 
 
 
 
(Lk) 
 
 
 
 
(Ll) 
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1H NMR titration experiments of the helicates with Bu4NCl showed that they are 
capable of binding chloride anions within their intra-helical cavities in a 
host:guest ratio of 1:2. A molecular model for the proposed mode of binding is 
shown for one of the helicates in Figure 1.11. 
 
 
 
 
 
 
 
 
Figure 1.11. Molecular model of the triple helical [Fe2L3]4+ complex showing  
the proposed mode of binding of two chloride ions (shown  
in space filling mode) within the intrahelical cavity.25 
 
Another important application of supramolecular helicates lies in the 
pharmaceutical industry. Most important anti-cancer drugs involve molecules 
that interact directly with DNA. Lehn, Hannon, Sletten and Moreno have 
described supramolecular helicates which are capable of binding to and 
modifying the structure of DNA.26 The DNA binding of helicates will be 
discussed in more detail in section 1.7. 
 
1.5 Prismatic Supramolecular Architectures 
1.5.1 Trigonal prismatic cages 
Silver(I) ions are known to display a flexible coordination geometry varying from 
two-coordinate to six-coordinate. In 2001, Su and co-workers reported the 
synthesis of a trigonal prismatic cage from silver(I) ions and ligand Lm. The     
X-ray crystal structure shows that the two silver(I) centres occupy a trigonal 
planar geometry and are coordinated by three imino nitrogen atoms         
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(Figure 1.12). The central cavity of the cage is accommodated by a distorted 
triflate anion.27 
 
 
  (Lm) 
 Ag(I)  
 
 
 
 
 
 
 
 
Figure 1.12. Su’s trigonal prismatic cage.27 
 
In 2005, Du et al. reported a trigonal cage formed by the reaction of tetrahedral 
copper(I) ions with ligand Ln (Figure 1.13). 28  
 
 
 
Figure 1.13. Ligand Ln. 
 
In this case one of the metal coordination sites is occupied by an acetronitrile 
solvent molecule and the other three are coordinated to the nitrogenous ligands. 
The X-ray crystal structure reveals that each prismatic cage hosts a water 
molecule inside the central cavity (Figure 1.14).  
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Figure 1.14. Du’s copper(I) trigonal prismatic cage.28 
 
1.5.2 Tetragonal prismatic cages 
Metallo-supramolecular chemistry facilitates the formation of elaborate 
architectures that would be difficult, if not impossible to achieve using classical 
organic chemistry. In 1998, Atwood et al. were the first group to report the 
formation of a M2L4 cage, achieved by employing four bidentate ligands (Lo) 
bound to two octahedral copper(II) ions (Figure 1.15).29  
 
(Lo) 
 
2 Cu(NO3)2 
4 H2O 
 
 
 
 
 
 
Figure 1.15. Atwood’s tetragonal prismatic cage.29 
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This is an example of a tetragonal prismatic cage in which the axial positions 
are blocked by the use of water molecules. Similar examples incorporating 
cobalt(II) and zinc(II) have also been reported.30  
Another tetragonal prismatic architecture was constructed by Su and        
co-workers using the previously described ligand Lm with copper(I) (Figure 
1.16).27 In this case each copper(I) metal centre adopts a square planar 
coordination environment and makes short contacts to an encapsulated 
perchlorate anion. A nickel(II) analogue of this complex has also been 
reported.31 
 
 
 
 
 
 
 
Figure 1.16. Su’s copper(I) tetragonal prismatic cage.27 
 
More recently, Su et al. have also presented the formation of another tetragonal 
cage using the bis-monodentate ligand Lp and copper(II) ions instead of 
copper(I) (Figure 1.17).32 The six-coordinate metal centres bind four different 
pyridyl nitrogen atoms in the equatorial positions enabling the prismatic 
structure to be formed. The axial positions are occupied by anions. 
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Cu(II) 
  (Lp) 
 
 
 
 
 
 
 
Figure 1.17. Su’s copper(II) tetragonal prismatic cage  
(axial anions are not shown).32 
 
Other examples utilizing square-planar metal ions also exist. Fujita and          
co-workers have prepared a rigid, bis-pyridyl ligand (Lq) which reacts with 
palladium(II) in a 1:2 ratio to yield a tetragonal prismatic cage. The X-ray crystal 
structure of the cage confirmed that a nitrate anion is encapsulated within the 
central cavity (Figure 1.18).33 
 
  
 
Pd(II) 
 (Lq) 
 
 
Figure 1.18. Fujita’s tetragonal prismatic cage.33 
 
Puddephatt et al. have also reported the formation of functional palladium(II) 
tetragonal prismatic cages from ligands Lr and Ls (Figure 1.19).34 
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(Lr) R = H 
(Ls)  R = t-Bu 
 
 
 
 
 
Figure 1.19. Ligands Lr and Ls. 
 
The complexes exhibit interesting host-guest chemistry and have been shown 
to encapsulate cations, anions and water molecules (Figure 1.20). 
 
 
 
 
   
 
 
 
 
Figure 1.20. Puddephatt’s tetragonal prismatic cages.34 
 
1.6 Cyclic supramolecular architectures 
1.6.1 Supramolecular Squares 
A square is defined as having four distinct sides of equal length, four angles of 
90º and a cavity running through the centre. Supramolecular squares are 
formed by self-assembly. In this section the use of metal ions that prefer a 
square planar coordination geometry, to access 90º and 180º angles, is 
discussed. The ligands used are also pre-selected to be complimentary in the 
formation of the square architecture.  
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In 1990, Fujita and co-workers reported the synthesis of a supramolecular 
square from (ethylenediamine)palladium(II) nitrate and 4,4’-bipyridine (Lt). The 
leaving groups of (ethylenediamine)palladium(II) nitrate are cis to each other 
and coordinate to the rigid and highly directional ligand units resulting in the 
formation of the square shown in Figure 1.21.35  
 
Figure 1.21. Fujita’s square. 
 
The central cavity within the square is π-electron deficient and has been shown 
to bind electron rich benzene derivatives, such as 1,4-dimethoxybenzene and 
1,3,5-trimethoxybenzene, through hydrophobic and π-π stacking interactions.4 
When the reaction was repeated with longer analogues of 4,4’-bipyridine, such 
as bis(4-pyridyl)acetylene, a second minor product was formed in addition to the 
square. On the 1H NMR spectrum of the minor product, the pyridyl protons are 
equivalent suggesting the formation of a highly symmetrical, macrocyclic 
product. It was proposed that the use of a more flexible ligand had allowed the 
formation of a molecular triangle that is in equilibrium with the more stable 
square architecture. Supramolecular triangles will be discussed in more detail in 
section 1.6.2.  
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A number of other techniques have been used to synthesise supramolecular 
squares. Figure 1.22 illustrates one such example reported by Lehn et al. In this 
instance the metal ions are blocked in a trans fashion and coordinated to     
right-angled ligands (Lu) which form the corners of the square.36 
 
 
 
 
 
 
 
 
 
 
M= 2H or Zn 
Figure 1.22. Lehn’s supramolecular square structure. 
 
More recently, Maverick et al. assembled supramolecular squares by the 
reaction of bis(β-diketone) ligands (Lv) with copper(II) ions. As with Lehn’s 
square, the organic ligands form the corners of the square and the metal ions 
are located in the centre of the sides (Figure 1.23). Maverick’s squares are able 
to function as hosts to guest molecules such as 4,4’-bipyridine and fullerenes.37 
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Figure 1.23. Maverick’s supramolecular squares.37 
R= CH3 or 
CH2CH3 
 
 
 
1.6.2 Supramolecular Triangles 
The equilibrium between a square and a triangle has already been discussed in 
the previous section. These structures involved relatively rigid ligands 
coordinating to square planar palladium(II). 
 Lippert et al. have reported the synthesis of a supramolecular triangle 
from [(en)Pd(2,2’-bpz-N1,N1’)]2+ and trans-(NH3)2Pt(II). The palladium(II) ions 
form the three vertices of the triangle and the platinum(II) ions are located in the 
sides. The X-ray crystal structure reveals that the triangle encapsulates a 
perchlorate anion which is held in place by hydrogen bonding interactions 
(Figure 1.24).38 
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N
N
Pd
N
N
NN 
 
 
 
 
 
  
Figure 1.24. Lippert’s supramolecular triangle.38 
 
Hannon’s ligand Lw is an analogue of the previously described ligand Lg 
(Figure 1.25). Lg reacts with tetrahedral metal ions to give a solution equilibrium 
of two dimeric isomers; a helicate and a box. Lw was designed with the goal of 
sterically disfavouring the formation of the box structure. While the methyl 
groups do indeed achieve this they also cause other dramatic effects too.39 
  
 
 (Lg) 
 
 
 
 
 
(Lw) 
 
 
 
Figure 1.25. Hannon’s ligands Lg and Lw. 
 
The reaction of Lw with copper(I) ions formed a triangular helicate in which the 
ligand strands wrap over and under the plane formed by the three metal centres 
(Figure 1.26). 
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Figure 1.26. (a) Top view and (b) side view of the molecular structure of the 
[Cu3(Lw)3]3+ ion. Each ligand is shown in a different colour  
to emphasise the helical nature of the triangle.39 
 
These helical triangles have been shown to pack together to form tetrameric 
ball-shaped aggregates. 
In 2007, Mukherjee and co-workers reported the self-assembly of a 
heterometallic triangle from the reaction of 1,1'-Bis(diphenylphosphino) 
ferrocene-palladium(II)ditriflate with sodium nicotinate (Figure 1.27).40 
 
 
 
 
 
 
 
Figure 1.27. Mukherjee’s supramolecular triangle. 
(Phenyl rings have been omitted for clarity). 40 
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The bowing of the ligands along the sides of the triangle allow the O-Pd-N 
angles to approach close to their preferred 90º, minimising the angle strain at 
the metal centre. 
 
The previous section focused on the principles of supramolecular chemistry and 
highlights the success of recent advances in this area. Our interest in this field 
stems from the potential for supramolecular complexes to be used as DNA 
recognition agents. Before introducing the modes of DNA recognition, the 
structure of DNA itself will be discussed.   
 
1.7 Deoxyribonucleic Acid (DNA) 
1.7.1 DNA Background 
DNA is the nucleic acid which contains the genetic ‘blueprint’ of all cellular life 
forms and of many viruses. It is responsible for two major roles: conducting its 
own replication during cell division and directing the transcription of 
complementary molecules of RNA. 
In 1869, whilst researching the structure of white blood cells, Miescher 
isolated the first crude sample of DNA. At the time the exact composition and 
function of the substance was unknown.41 However, over the next century 
considerable research was carried out in this field. As a result of this research, 
in 1953, James D. Watson and Francis Crick were able to propose a structure 
for DNA.42 The double helical structure elucidated by Watson and Crick was 
that of B-DNA. It is now known that several other forms of DNA also exist, 
however, B-DNA is considered to be the most prevalent form found in biological 
systems.  
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1.7.2 Structure of DNA 
In groundbreaking research, Kossel and co-workers identified the purine 
(adenine and guanine) and pyrimidine (thymine and cytosine) bases that 
constitute the nitrogenous components of DNA (Figure 1.28 (a)).43 Each base is 
connected to a 2’-deoxyribose sugar molecule which is in turn linked to a 
phosphate group to form a ‘nucleotide’. DNA consists of four different 
nucleotides which link together to form polynucleotide chains (Figure 1.28 (b)). 
                             
 
 
 
 
 
 
Cytosine (C)     Thymine (T) 
 (b) 
(a) 
 
 Guanine (G)             Adenine (A) 
sugar
sugar
sugar
sugar
  
 
 
Figure 1.28. (a) The DNA bases and their Watson–Crick hydrogen-bond pattern 
and (b) the sugar-phosphate backbone.   
 
B-DNA consists of two polynucleotide strands which intertwine to form a      
right-handed double helix (duplex). Figure 1.29 (a) shows the hydrogen bonding 
which occurs between the bases of a pair of polynucleotide chains. As 
illustrated in the diagram, adenine will always pair up with thymine and cytosine 
with guanine.  
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(a)       (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.29. Schematic representations of B-DNA showing (a) DNA base 
pairing44 and (b) minor and major grooves45. 
 
 
As the bases are hydrophobic they are located in the core of the DNA duplex 
while the hydrophilic sugar-phosphate units point out into solution. The aromatic 
bases are approximately perpendicular to the helical axis and are stacked on 
top of each other through π-π stacking interactions. The attachment points of 
the bases to the sugar-phosphate backbone are offset with respect to the 
hydrogen bonds between the bases. This leads to the occurrence of two distinct 
grooves in the double-helical structure. These are called the minor groove and 
the major groove (Figure 1.29 (b)). 
In addition to the basic double helix, other forms of branched DNA 
structures called ‘junctions’ also exist. DNA junctions are formed when the 
polynucleotide chains of two or more double-helical fragments interconnect. 
David Lilley defines DNA junctions as ‘branch points where double-helical 
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segments intersect with axial discontinuities, such that strands are exchanged 
between the different helical sections’.46 Researchers are interested in DNA 
junctions as they are often present as intermediates in genetic processes such 
as DNA replication and genetic recombination. Therefore, the ability to 
recognise and manipulate these junctions could prove invaluable. Figure 1.30 
shows the crystal structures of a three- and four-way DNA junction. 46,47 
 
   
 
 
 
 
 
 
 
 
A DNA four-way 
junction  
A DNA three-way 
junction  
            
Figure 1.30. A DNA four-way46 and three-way47 junction bound by Cre. 
 
Thus far we have touched upon some of the conformations that are adopted by 
duplex DNA. In addition to these, other structures of DNA have also been 
identified. One example is triple-stranded or triplex DNA. This is formed when 
duplex DNA associates with another polynucleotide strand. The additional 
strand lies in the major groove of the duplex and is held in place by hydrogen 
bonding interactions between the base pairs. A schematic representation of 
triplex DNA is depicted in Figure 1.31.45 
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Figure 1.31. A schematic representation of triplex DNA.45 
 
Other DNA structures are also possible (Figure 1.32) but B-DNA is the principal 
form found in biological systems and is the focus of the study herein.  
     (a)                                   (b)         (c) 
 
 
 
 
 
 
 
 
 
Figure 1.32. (a) Z-DNA,48 (b) A-DNA49 and (c) Guanine tetramers (the basis for 
quadruplex formation). 
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1.7.3 DNA Recognition 
After Watson and Crick’s discovery, scientists were quick to recognise the 
potential of DNA as a key drug target for the treatment of genetic diseases such 
as cancer. Six different methods of drug-DNA recognition have since been 
discovered: intercalation between the DNA bases, covalent binding or        
metal-coordination to the bases, sugar–phosphate backbone binding, minor 
groove recognition, major groove recognition and recognition of DNA 
junctions.49,50 Well known examples of some of these modes of drug-DNA 
recognition are presented in the following section. 
 
1.7.3.1 DNA Intercalation  
Intercalation is the partial or full insertion of a planar aromatic molecule into the 
gap between two adjacent base pairs of DNA. While it does not disrupt the 
hydrogen bonding of the base pairs, the DNA helix lengthens slightly to 
accommodate the intercalated molecule. At the site of intercalation the helix is 
partially unwound, resulting in a localised distortion of the regular arrangement 
of the sugar-phosphate backbone. Addition of multiple intercalators has the 
effect of stiffening the DNA and causing the unwinding of supercoiled DNA. This 
causes the deactivation of the DNA, thus preventing replication and 
transcription from occurring.51 
Intercalating molecules are typically electron deficient planar              
poly-aromatic molecules. A well known example is ethidium bromide which is 
used to stain DNA in gel electrophoresis experiments (Figure 1.33).52 
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Br- 
Figure 1.33.Ethidium bromide. 
 
Another example is the anti-cancer drug doxorubicin which was discovered in 
the 1960s. Doxorubicin intercalates between DNA base pairs and works by 
inhibiting transcription and replication in rapidly growing cancer cells. The 
discovery of this drug was a milestone in the history of cancer chemotherapy as 
it has been found to be effective in the treatment of a vast range of different 
cancers.53 
 
 
 
 
  
 
Figure. 1.34. Structure of doxorubicin. 
 
In 1974, Lippard et al. reported the first metallo-intercalator constructed from a 
planar aromatic ligand bound to a square planar platinum(II) centre (Figure 
1.35). The incorporation of metal ions into the design of intercalators is an 
attractive way of introducing a positive charge.54  
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Figure 1.35. Structure of Lippard’s intercalator.  
 
More recently, the Barton group have created larger rhodium(II) and 
ruthenium(II) intercalators based on phzi and chrysi ligands  (Figure 1.36).55 
 
 
 
 
 
 
 
Figure 1.36. Barton’s rhodium(II) intercalators. 
 
 
The planar polycyclic aromatic ligands are too big to intercalate into normal 
DNA but show a strong preference for DNA mismatch sequences where the 
absence of Watson–Crick pairing will allow a larger intercalator to be 
accommodated. An application of the ruthenium(II) complexes is to detect DNA 
mismatches by fluorescence. 
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1.7.3.2 DNA alkylation    
Another way in which drugs can interact with DNA is by binding directly to the 
DNA bases, usually to the N7 of guanine or adenine. Nitrogen mustards such 
as chlorambucil (Figure 1.37) bind to the DNA bases by alkylation of the 
nitrogen resulting in the formation of a covalent bond. This interaction causes 
the irreversible deactivation of the DNA.56 
 
 
 
 
 
Figure 1.37. Structure of the Nitrogen Mustard, Chlorambucil. 
 
Cis-platin is one of the most successful ‘alkylating’ drugs found in the clinic. It 
binds to DNA with displacement of the two chlorides and the formation of two 
metal-coordination bonds to N7 of two adjacent guanine residues on the same 
polynucleotide strand (Figure 1.38).57 
 
Figure 1.38. Cis-platin bound to two adjacent guanine residues of DNA50 
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1.7.3.3 Binding within a DNA groove    
The intertwining of the two polynucleotide strands of DNA causes two distinct 
grooves to occur within its structure. Many drugs are the correct size and shape 
to fit into and bind within these grooves, often by hydrogen bonding and Van der 
Waals interactions.  
In their analysis of DNA groove binders, Goodsell and Dickerson58 
identified that minor groove binders tend to contain between two and five 
aromatic rings and are flanked at each end by cationic groups. A typical 
example is berenil which is a drug used for treating sleeping sickness in 
veterinary medicine (Figure 1.39).59  
 
 
 
Figure 1.39. A berenil drug molecule and the binding of the  
molecule in the minor groove of DNA50 
 
Numerous examples of DNA minor groove binders are known but synthetic 
agents that target the DNA major groove are rare. 
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Hannon and co-workers have developed a family of metallo-supramolecular 
cylinders which interact with the DNA major groove. One of these agents is the 
iron(II) triple-stranded helicate shown in Figure 1.40 (also described in section 
1.4.3). At ~2 nm in length and ~1 nm in diameter, Hannon’s iron(II) helicate is a 
similar size to the alpha-helical DNA recognition unit of zinc fingers.  
 
 
 
 
 
Figure 1.40. Hannon’s triple-stranded iron(II) cylinder. 
 
The helicate has been shown to bind in the DNA major groove and in addition 
causes the unexpected and dramatic intramolecular coiling of DNA (Figure 
1.41). Experimental evidence shows that it is the specific size and shape of the 
cylinder that is important in producing this coiling effect.60 
 
 
 
Figure. 1.41 Intramolecular DNA coiling induced  
by the supramolecular cylinder.60 
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1.7.3.4 DNA Junction Recognition 
Further work carried out in collaboration with Miquel Coll led to the 
crystallisation of Hannon’s iron(II) cylinder with a palindromic hexanucleotide. 
The results were remarkable and revealed the cylinder to be located at the 
heart of a three-way DNA junction. The crystal structure showed that the 
cylinder is the correct size and shape to fit perfectly into the cavity of the 
junction and is held in place by electrostatic and π-π stacking interactions 
(Figure 1.42).61 
 
   
 
 
 
 
 
Figure 1.42. Binding within a DNA three-way junction. 61 
 
As has been described, a wide range of metallo-supramolecular architectures 
can be self assembled by the mixing and matching of metal ions and ligands. 
 
In the following chapters the design, synthesis and characterisation of novel 
metallo-supramolecular complexes is presented. A number of these complexes 
have the potential to be used as DNA recognition agents. DNA binding studies 
and cytotoxic activities of these complexes are also reported in this work. 
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2.1 Introduction 
2.1.1 DNA Binding Complexes 
Metal complexes that form coordination bonds to the DNA bases are at the 
forefront of clinical treatment of a variety of cancers, with three cis-platin like 
drugs having worldwide approval and three more used regionally.1 Challenges 
remain including widening the spectrum of cancers that can be treated, 
circumventing acquired resistance and reducing side effects. A key design 
feature to address these issues is to develop drugs that have quite distinct 
molecular level actions from cis-platin. In this context, agents that bind non-
covalently to DNA have attracted recent attention.2  
In particular, the Hannon group have developed an array of           
metallo-supramolecular double and triple-stranded cylinders that bind           
non-covalently to DNA3 and which also show activity against cancer cell lines.4 
A key feature for their activity is their large supramolecular size and shape. 
They are around 2 nm in length and 1 nm in diameter which distinguishes them 
from traditional small molecule drugs. The most studied of Hannon’s complexes 
is the triple-stranded, dinuclear iron(II) cylinder shown in Figure 2.1 (also see     
chapter 1, section 1.4.3). This cylinder is helical in nature and is formed from 
three bis-pyridylimine ligands wrapped around two iron(II) metal centres.5 
3
2FeCl2
MeOH
N
N
N
N
 
 
 
Figure 2.1. Hannon’s triple-stranded, dinuclear Iron(II) cylinder. 
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As described in chapter 1, there are six ways in which drugs can bind to DNA. 
NMR experiments have confirmed that Hannon’s iron(II) cylinder binds in the 
major groove of duplex DNA.6 In addition, atomic force microscopy showed that 
it also causes dramatic intra-molecular coiling in linearised plasmid DNA; an 
effect that is unobserved among synthetic DNA binders.7 More recently, X-ray 
crystallographic studies with a palindromic hexanucleotide presented a totally 
unexpected mode of drug-DNA recognition. The crystal structure revealed the 
iron(II) cylinder to be located within the central cavity of a 3 way DNA junction 
(Figure 2.2).8 This represents a completely unprecedented, novel way in which 
drugs can bind to DNA. Many drugs target disease by interacting with DNA, 
however, they are non-specific in their approach which can result in a number of 
unwanted side effects. Targeting specific DNA structures, such as the 3 way 
junction, is a very attractive way of minimising the side effects caused by a 
drug.  
 
 
 
 
 
 
Figure 2.2. Hannon’s triple-stranded, dinuclear Iron(II) cylinder bound in a  
three-way DNA junction.8 
 
As discussed in chapter 1, DNA junctions occur when the polynucleotide chains 
of two or more double-helical fragments interconnect. Three way junctions are 
the simplest branched DNA structures and are involved in crucial biological 
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functions such as DNA replication. The most extensively researched junction is 
the four way junction (Holliday junction) which is generally accepted to be the 
central intermediate in homologous genetic recombination.  
 
2.1.2 Research Aims 
This study aims to extend the research in this area by designing and 
synthesising drug molecules which might be capable of recognising and binding 
within the central cavity of a Holliday junction (although as will be seen solubility 
issues have prevented Holliday junction binding studies). Therefore, the new 
drug needs to be the correct size and shape to target a junction with a square 
central cavity, rather than a triangular one. It is important to incorporate the key 
features of Hannon’s iron(II) cylinder into the design of the new drug to ensure 
that it interacts with DNA in a similar way. The approach that is best suited to 
this application is to synthesise tetra-stranded analogues of Hannon’s triple-
stranded cylinder. A literature review of previously reported tetra-stranded 
supramolecular complexes has been discussed in chapter 1. 
 
2.1.3 Molecular Design Approach 
           4+ 
        
 
 
M= Pd(II) / Pt(II)   
   
Figure 2.3. A schematic representation of our design approach, depicting two 
square planar metal centres linked by four ligand strands. 
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A schematic representation of the design approach is shown in Figure 2.3. 
Palladium(II) and platinum(II) metal centres were chosen to assemble the 
cylinders as they have the correct geometry to enable the formation of the 
required architectures. They also impart a positive charge to the cylinders which 
will allow for electrostatic interactions with the negatively charged DNA. The 
simplest of the ligands (L1) used in this investigation is shown in Figure 2.4. 
NN
 
Figure 2.4 Ligand L1. 
 
The ligand design incorporates a central bis-phenyl spacer unit which is 
important in DNA recognition. The spacer separates two monodentate binding 
sites and prohibits them from coordinating to the same metal centre. The pyridyl 
binding units are connected to the spacer in the 3-position. This ensures that 
the nitrogen donor atoms are perfectly positioned to accommodate the square 
planar coordination requirements of the metal centres.  
Four additional ligands with similar design features to ligand L1 have also 
been prepared (Figure 2.5). These ligands along with their resulting 
palladium(II) and platinum(II) complexes will be discussed in detail in the 
following section. 
 43
Chapter 2 
 
 
 
 
  
 
 
 
 
 L
5
L4L3
L2L1
     Figure 2.5. Bis-pyridyl Ligands. 
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2.2 Results and Discussion 
2.2.1 Ligand L1 
   
2)
 1)
, Na2CO3, THF/ H2O/ Ar2
Ligand L1
1)  nBuLi/ THF
1)  TFA
2)  NaBH4
    
2)  Pd(PPh3)4
 
 
Scheme 2.1. Synthesis of Ligand L1. 
 
Ligand L1 was synthesized by a Suzuki coupling reaction between              
bis(4-bromophenyl)methane9 and pyridine-3-yl-3-boronic acid using Pd(PPh3)4 
as a catalyst and Na2CO3 as a base (Scheme 2.1).10 As confirmed by 1H NMR, 
ligand L1 was formed as the predominant product, however, the mono-
substituted bromophenylmethane was also present as a side product. The 
 45
Chapter 2 
crude material was purified on a preparative RP-HPLC column using a linear 
gradient of 100 % water to 100 % methanol over 60 minutes. The product peak 
was collected at 50.15 minutes and the solvent removed under reduced 
pressure to yield the white product in 72 % yield.  
The EI mass spectrum is dominated by a single peak corresponding to 
{L1}+ at m/z 322 and partial microanalytical data are consistent with a {C23H18N2} 
formulation. The 1H NMR spectrum in d4-methanol reveals a single set of 
resonances and confirms the formation of the symmetrical ligand (Figure 2.6). 
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    H8/9   H8/9  
 H2     H6 & 4               H5         Water          H11 
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Figure 2.6. 1H NMR spectrum of Ligand L1  
(300 MHz, d4-methanol, 298 K). 
 
2.2.2 Palladium(II) complexes of L1  
Ligand L1 was coordinated to palladium(II) by stirring a solution of the ligand 
with tetrakis(acetonitrile)palladium(II) tetrafluoroborate for 16 hours, under an 
argon atmosphere. The solution was filtered to remove a small amount of 
suspended material and the solvent removed under vacuum. The crude product 
was washed with chloroform, acetone and diethyl ether to yield a white solid in 
a high yield of 83 %.  
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The IR spectrum of the complex shows a strong, broad absorption at 1034 cm-1; 
This is characteristic of non-coordinated tetrafluoroborate counter-ions. 
Elemental analysis data are consistent with an empirical formula of 
{Pd(C23H18N2)2(BF4)2}n and the ESI mass spectrum is dominated by peaks 
corresponding to [Pd2(L1)4(BF4)(F)]2+ (m/z 804), [Pd2(L1)4(BF4)]3+ (m/z 530) and 
[Pd2(L1)4]4+ (m/z 376), confirming the expected M2L4 formulation. The 1H NMR 
spectra of ligand L1 and [Pd2(L1)4][BF4]4 are shown in Figure 2.7. 
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(a) 
    H8/9     H8/9  
   H2             H6                 H4                            H5     
 
 (b)      H8/9  H8/9  
 H2        H6                                  H4                         H5       
 
7.07.27.47.67.88.08.28.48.68.89.09.29.49.6 
 
Figure 2.7. 1H NMR spectra of the aromatic region of (a) Ligand L1 and            
(b) [Pd2(L1)4][BF4]4 (300 MHz, d6-DMSO, 298 K). 
 
The 1H NMR spectrum of the complex exhibits one aliphatic and six aromatic 
proton resonances, indicating the presence of a single, symmetrical species in 
solution. There is a considerable downfield shift of the pyridine signals relative 
to those in the free ligand due to the metal-ligand complexation.  
The 19F NMR spectrum of the cylinder displays a single peak at               
-147.7 ppm. This indicates that, at 298 K, the fluorine atoms of each counter-ion 
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are equivalent and that on the NMR timescale, all of the anions are in the same 
chemical environment.  
Colourless crystals of this palladium(II) complex suitable for X-ray 
diffraction were obtained by the slow diffusion of benzene into a solution of the 
complex in DMSO.11  
 
 
                                 (a)                                                         (b) 
 
Figure 2.8. (a) Perspective view and (b) space-filling representation of 
[Pd2(L1)4]4+ cation. Hydrogen atoms, solvent molecules and anions are omitted 
for clarity.11 
 
The X-ray crystal structure (Figure 2.8) confirms the formation of a              
tetra-stranded, dinuclear palladium(II) cylinder. Each metal centre occupies a 
four-coordinate, square planar environment with Pd-N bond distances of 
1.983(4)-2.007(3) Å and N-Pd-N angles of 89.16(12)-90.74(12)º. The four 
ligands bridge the two palladium(II) centres resulting in a Pd···Pd separation of 
12.7 Å. Within the ligands, the phenyl rings are twisted with respect to one 
another (71º, 74º) and with respect to the pyridine rings (27º, 35º, 40º, 46º). The 
cavity formed by the ligands is home to two DMSO molecules aligned along the 
Pd···Pd axis, however, the remaining solvent molecules and the counter-ions 
are highly disordered, prohibiting further discussions. 
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In contrast to Hannon’s iron(II) cylinder which has a helical conformation, this 
palladium(II) cylinder crystallises with a plane of symmetry through the centre of 
the four ligands and is therefore achiral (Figure 2.9). The non-helical nature of 
this cylinder stems from the rigidity of L1 which also leads to an increase in the 
diameter of the cylinder (C···C 13.7 Å for Pd, 8.9 Å for Fe: H··H 14.9 Å for Pd, 
10.8 Å for Fe). At 12.7 Å, the metal-metal separation is slightly larger than in the 
iron(II) cylinder (11.5 Å) and as the ligand is shorter, the overall length of the 
cylinder is smaller (C···C 15.0 Å for Pd, 17.3 Å for Fe: H··H 16.6 Å for Pd, 19.5 Å 
for Fe).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9. Overlay of the X-ray crystal structures of [Pd2(L1)4]4+ (blue) 
and [Fe2(L)3]4+ (green). Hydrogen atoms are omitted for clarity. 
 
The crystal packing of [Pd2(L1)4][BF4]4 clearly shows that the cylinders are 
implicated in intermolecular π-π stacking interactions through the phenyl rings 
of the central spacer units with an inter-planar separation of 3.7 Å (Figure 2.10). 
This leads to the formation of chains of cylinders in which each cation is 
connected to its neighbour by two such interactions. Counter-ions and solvent 
molecules occupy the gaps between the cation chains. 
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SIDE VIEW OF THREE 
TETRA-CATION CHAINS 
FRONT VIEW OF 
CHAINS  
 
Figure 2.10. Packing diagrams for [Pd2(L1)4]4+ cations showing the π-π stacking 
interactions between the phenyl rings. Hydrogen atoms, anions and solvent 
molecules have been removed for clarity. 
 
Unfortunately, this palladium(II) cylinder did not prove to be water soluble, which 
is one of the preferred criteria for carrying out compound-DNA binding studies. 
However, changing the counter-ion of a complex often results in a variation in 
its aqueous solubility. Chloride ions are the most commonly used anions in 
commercial drugs.12 Thus an attempt was made to exchange the 
tetrafluoroborate counter-ions of our complex with chloride ions. This was done 
by stirring a methanolic suspension of the complex with the chloride form of 
Dowex (a strongly basic exchange resin) for one hour and then filtering through 
a Dowex column. Disappointingly, on removal of the methanol, the resultant 
material was still insoluble in water. A 1H NMR spectrum of the complex in      
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d6-DMSO was very messy, indicating that some sort of degradation reaction 
had occurred.  
In a second attempt the counter-ions in this cylinder were exchanged for 
nitrate ions which have also been shown to increase water solubility in several 
compounds. This was achieved by synthesising the complex in the normal way 
but precipitating the tetra-cation from the mother liqueur by the drop-wise 
addition of an acetonitrile solution of tetrabutylammonium nitrate. The resulting 
product was purified by washing with a range of organic solvents. Partial 
elemental analysis and ESI mass spectrometry confirm that the 
tetrafluoroborate counter-ions have been exchanged for nitrate anions. The 
microanalytical data support a {Pd2(L1)4(NO3)4} formulation and the ESI mass 
spectrum reveals peaks with the correct isotope patterns and mass/charge 
ratios to correspond to [Pd2(L1)4(NO3)2]2+ (m/z 813), [Pd2(L1)4(NO3)]3+ (m/z 521) 
and [Pd2(L1)4]4+ (m/z 376). The 1H NMR spectrum in d6-DMSO is analogous to 
that of [Pd2(L1)4][BF4]4. A single set of signals is observed indicating the 
presence of a single solution species at 298 K. Recrystallisation of the nitrate 
salt from a DMSO solution by the slow diffusion of benzene afforded colourless 
crystals which proved suitable for investigation by X-ray diffraction. As 
expected, the crystal structure reveals a tetra-stranded, dinuclear cylinder. The 
X-ray crystal structures of the nitrate and tetrafluoroborate salts are both shown 
in Figure 2.11. The structures of the tetra-cations are indistinguishable and both 
pack into a crystal lattice in an analogous way.  
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Figure 2.11. Overlays of the X-ray crystal structures of [Pd2(L1)4][NO3]4 and 
[Pd2(L1)4][BF4]4. Hydrogen atoms, solvent molecules and anions  
are omitted for clarity. 
 
Unfortunately, solubility studies did not show any enhancement in the aqueous 
solubility of the nitrate cylinder compared to that of the tetrafluoroborate one. 
Therefore, in a final attempt the counter-ions of our tetra-cationic complex were 
exchanged for trifluoroacetate anions. This was done by synthesising the 
complex as previously described and precipitating it with a solution of sodium 
trifluoroacetate. The crude material was soluble in some of the organic solvents 
that had previously been used to purify the tetrafluoroborate and nitrate salts by 
simple washing. Therefore, purification of the trifluoroacetate salt was achieved 
by semi-preparative RP-HPLC using a solvent gradient of 100 % H20(0.05 % TFA) 
to 100 % methanol(0.05 % TFA) over a 40 minute duration. The pure complex was 
observed and collected at 36.83 minutes.  
The partial microanalytical data are consistent with a [Pd2(L1)4][CF3CO2]4 
formulation. The ESI mass spectrum shows peaks (with the correct isotope 
distributions) corresponding to [Pd2(L1)4(TFA)2]2+ (m/z 864) and 
[Pd2(L1)4(TFA)]3+ (m/z 539). A fragment ion corresponding to [Pd2(L1)3(TFA)2]2+ 
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is also observed at m/z 703. As with the tetrafluoroborate and nitrate salts, the 
1H NMR spectrum of [Pd2(L1)4][CF3CO2]4 only displays one set of resonances 
(Figure 2.12). 
7.07.27.47.67.88.08.28.48.68.89.09.29.49.69.8
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Figure 2.12. 1H NMR spectrum of the aromatic region of [Pd2(L1)4][TFA]4                 
(300 MHz, d4-methanol, 298 K). 
 
Solubility studies proved the complex to be more soluble in organic solvents 
such as methanol compared to the tetrafluoroborate analogue, but it 
nevertheless remained insoluble in pure water.  
Attempts to grow crystals from methanolic or DMSO solutions of this 
pure trifluoroacetate complex were unsuccessful. However, X-ray quality 
crystals were obtained by the slow diffusion of benzene into a DMSO solution of 
the crude product resulting in an unexpected outcome (Figure 2.13).13 
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          (a)                                                        (b) 
 
Figure 2.13. (a) Perspective view and (b) space-filling representation of 
[Pd3(L1)6]6+ cation. Hydrogen atoms and anions are omitted for clarity.13 
 
Intriguingly, the solid state structure did not display the [Pd2(L1)4]4+ tetra-cation 
that had been expected, but instead revealed a double-walled, hexa-cationic 
[Pd3(L1)6]6+ structure. The three square-planar Pd(II) atoms reside in a single 
plane and occupy the three corners of a triangle. Some examples of previously 
reported supramolecular triangles have already been discussed in chapter 1, 
section 1.6.2. In this triangle, each metal centre is linked to the next by two 
bridging ligands, one extending behind the plane of the Pd(II) centres (shown in 
blue) and the other protruding in front of it (shown in red). The size of the unit 
cell was measured for a number of crystals from the sample confirming that this 
was the only structure that had crystallised from the crude mixture. The HPLC 
trace of the crude material showed one major peak and several smaller ones. 
Fractions were collected from an analytical column and ESI mass spectrometry 
confirmed that the large peak corresponded to the required [Pd2(L1)4][CF3CO2]4 
cylinder. Unfortunately the fractions of the other substituents did not contain 
enough material to give a mass spectrum. The HPLC trace showed that the 
tetra-stranded cylinder accounted for ~76 % of the crude mixture; therefore, 
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[Pd3(L1)6][CF3CO2]6 must only constitute a small percentage, but is evidently 
more inclined to crystallise out of solution in the conditions that were used. 
 
2.2.3 Platinum(II) complex of L1  
The corresponding complex of platinum(II) was formed by the reaction of two 
equivalents of ligand L1 with bis(benzonitrile)dichloroplatinum(II) in the presence 
of silver(I) nitrate (for chloride abstraction). A 1H NMR spectrum of the crude 
material shows the presence of one main product and several side products. 
Purification was achieved on two semi-preparative RP-HPLC columns; the first 
used a solvent gradient of 100 % water(0.05 % TFA) to 100 % methanol(0.05 % TFA) 
over 50 minutes and yielded the impure product after 34.00 minutes. The 
second column used a gradient of 100 % water to 100 % methanol over 40 
minutes and presented the pure product after 26.56 minutes. The trifluoroacetic 
acid used on the first column resulted in an exchange of the nitrate counter-ions 
for trifluoroacetate anions. The ESI mass spectrum of this complex displays 
peaks corresponding to [Pt2(L1)4(CF3CO2)2]2+ and [Pt2(L1)4(CF3CO2)]3+, 
confirming the change in counter-ion. The 1H NMR spectrum of this complex is 
shown in Figure 2.14. 
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Figure 2.14. 1H NMR spectrum of the aromatic region of (a) Ligand L1 and  
(b) [Pt2(L1)4][TFA]4 (300 MHz, d4-methanol, 298 K). 
 
The 1H NMR spectrum in d4-methanol reveals the presence of one set of 
signals which is consistent with a single solution species, symmetrically 
balanced through the central CH2 substituent. As with the palladium(II) complex, 
there is a significant downfield shift of the H2 and H6 pyridine signals relative to 
those of the free ligand in the same solvent. 
Unfortunately, attempts to crystallise the trifluoroacetate salt of this 
complex proved unsuccessful. However, colourless crystals were obtained by 
the slow diffusion of benzene into a solution of the crude nitrate salt in DMSO. 
The X-ray crystal structure unambiguously reveals a dimeric, tetra-stranded 
[Pt2(L1)4]4+ cation (Figure 2.15).13  
 56
Chapter 2 
 
 
 
 
 
 
  (a)                                                  (b) 
 
Figure 2.15. (a) Perspective view and (b) space-filling representation of 
[Pt2(L1)4]4+ cation. Hydrogen atoms and anions are omitted for clarity.13 
 
Each platinum(II) centre has square planar geometry with Pt-N bond distances 
ranging between 2.028(5)-2.036(5) Å and with N-Pt-N angles of 88.8(2)-
91.7(2)º. In the ligands the phenyl rings are twisted about the central CH2 by 74º 
and 75º. The phenyl rings are also twisted with respect to the pyridine rings 
(30º, 33º, 40º, 44º). The transannular Pt···Pt distance is 12.7 Å, which is the 
same as the Pd···Pd distance in the analogous [Pd2(L1)4][BF4]4 complex. This 
platinum cylinder has a tetra-cationic charge but only two nitrate counter-ions 
have been found. The remaining anions could not be successfully identified 
among the residual electron density as they are highly disordered. Along with 
four benzene rings and two DMSO molecules, the detected counter-ions are 
located in the gaps between the cylinders and do not make any obvious 
contacts to them or to each other. A crystal packing diagram of [Pt2(L1)4]4+ is 
shown in Figure 2.16. 
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Figure 2.16. Packing diagram for [Pt2(L1)4]4+ cations showing the π-π stacking 
interactions between the phenyl rings. Hydrogen atoms, anions and solvent 
molecules have been removed for clarity. 
 
Analysis of the crystal packing shows that the cylinders are packed in chains 
through π-π stacking interactions in the same way as for the analogous 
[Pd2(L1)4]4+. However, in this case the inter-planar distance between the phenyl 
rings is slightly smaller at 3.6 Å (compared to 3.7 Å in the palladium complex). 
Benzene, DMSO and nitrate counter-ions are found to occupy the gaps 
between the cationic chains. 
It is pertinent to compare the crystal structure of this platinum(II) cylinder 
with that of the previously described [Pd2(L1)4][BF4]4 complex. Therefore, an 
overlay of the structures is shown in Figure 2.17.  
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Figure 2.17. Overlays of the X-ray crystal structures of [Pd2(L1)4]4+ and 
[Pt2(L1)4]4+. Hydrogen atoms, solvent molecules and counter-ions  
are omitted for clarity. 
 
Figure 2.17 shows that the cations are almost structurally identical. Clearly the 
replacement of the palladium(II) ions with platinum(II) has had very little effect 
on the arrangement of the ligands within the cylinder. 
 Solubility studies show that [Pt2(L1)4][CF3CO2]4 is highly soluble in 
organic solvents such as DMF, DMSO and methanol but as with the 
palladium(II) complexes, it remains insoluble in pure water.  
Thus far this study shows that counter-ion exchange alone has proved to 
be an ineffective way of increasing the aqueous solubility of [Pd2(L1)4]4+ so 
another strategy needs to be employed. It is well known that ethers have the 
ability to act as hydrogen-bond acceptors. This trait enables them to engage in 
hydrogen bond interactions with water molecules resulting in an increase in the 
water solubility of the ether, relative to the same molecule without the hydrogen-
bond acceptor. Therefore, the next approach was to functionalise the ligand 
with an ether group in the hope that it will enhance the aqueous solubility of the 
resulting complex. 
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2.2.4 Ligand L2 
            
2)
2
Ligand L2
    
1)  Pd(PPh3)4, Na2CO3, Ar 
 
 
 Scheme 2.2. Synthesis of Ligand L2. 
 
Ligand L2 is analogous to L1 except that the central CH2 has been replaced by 
an oxygen atom. The ligand was prepared by a Pd(PPh3)4 catalyzed Suzuki 
coupling reaction between bis-4-bromophenylether and pyridine-3-yl-3-boronic 
acid (Scheme 2.2).10 It was purified on a preparative RP-HPLC column using a 
linear gradient of 100 % water to 100 % methanol over 40 minutes and a         
15 minute methanol wash. The product was collected at 49.58 minutes and the 
solvent removed to give the pure ligand in 64 % yield.  
Partial microanalytical data are consistent with a {C22H16N2O} formulation 
and the EI positive ion mass spectrum shows an intense peak at m/z 324 which 
corresponds to {L2}+. The 1H NMR spectrum in d1-chloroform reveals a single 
set of six aromatic resonances above 7 ppm confirming the formation of the 
symmetrical ligand (Figure 2.18). 
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Figure 2.18. 1H NMR spectrum of Ligand L2  
(400 MHz, d1-chloroform, 298 K). 
 
 
2.2.5 Palladium(II) complexes of L2  
Coordination of palladium(II) to ligand L2 was achieved by the reaction of 
tetrakis(acetonitrile)palladium(II) tetrafluoroborate with two equivalents of L2 in 
acetonitrile. The reaction took place over a 16 hour period under an inert argon 
atmosphere, presenting the white product in a near quantitative yield of 91 %. 
FT-IR spectroscopy confirms the presence of a non-coordinated 
tetrafluoroborate anion by the occurrence of a strong absorption band at      
1010 cm-1. The partial elemental analysis data supports the formation of a   
tetra-stranded, dinuclear palladium(II) complex and the ESI mass spectrum is 
dominated by peaks corresponding to [Pd2L4(BF4)2]2+, [Pd2L4(BF4)]3+ and 
[Pd2L4]4+ species. The 1H NMR spectrum of the complex was recorded in        
d6-DMSO and is presented in Figure 2.19. The spectrum shows a single set of 
resonances indicating the formation of a distinct symmetrical species. The 
metal-ligand coordination is confirmed by the significant downfield shift of the 
pyridine signals of the complex relative to those in the free organic ligand.  This 
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is especially apparent for H2 and H6 which are both downfield shifted by         
0.8 ppm relative to the same signals in the free ligand. 
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Figure 2.19. 1H NMR spectra of (a) Ligand L2 and (b) [Pd2(L2)4][BF4]4                 
(300 MHz, d6-DMSO, 298 K). 
 
On coordination to palladium(II) the phenyl signal that is furthest up-field 
becomes downfield shifted. In contrast, in the 1H NMR of [Pd2(L1)4][BF4]4 this 
phenyl signal is shifted up-field. The other main difference in the 1H NMR 
spectra of these two complexes occurs for H2 which is considerably more 
downfield shifted in [Pd2(L2)4][BF4]4 than in [Pd2(L1)4][BF4]4. These differences 
might occur due to a change in the twist between the pyridine and phenyl rings.  
Diffusion of benzene into a solution of the complex in DMSO gave single 
crystals suitable for X-ray diffraction studies. The crystal structure obtained from 
the studies is in agreement with that predicted from the spectroscopic evidence 
(Figure 2.20).11 
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(a) (b) 
 
Figure 2.20. (a) Perspective view and (b) space-filling representation of 
[Pd2(L2)4]4+ cation. Hydrogen atoms and anions are omitted for clarity.11 
 
Each square-planar metal centre is bound to one pyridyl unit from each of the 
four ligands. The Pd-N bond distances (2.031(3)-2.036(3) Å) and the N-Pd-N 
bond angles (88.07(14)-92.63(18)º) are unremarkable and analogous to those 
found in the [Pd2(L1)4]4+ cation. Within each ligand the phenyl rings are twisted 
about the central oxygen spacer at angles to each other of 64º and 72º. The 
phenyl rings are also twisted with respect to the pyridyl binding units (16º, 32º, 
39º, 50º). Encapsulated within the central cavity of the complex is a 
tetrafluoroborate counter-ion and a DMSO solvent molecule. These guest 
molecules are linearly located along the Pd···Pd axis as shown in Figure      
2.20 (a). The shortest Pd-F distance for the encapsulated anion is 3.1 Å and the 
Pd-O distance for the DMSO molecule is 3.0 Å. This suggests that the guest 
molecules make weak ionic interactions with the palladium(II) centres.  
The distance separating the two Pd(II)···Pd(II) centres is 12.4 Å which is 
slightly less (~2 %) than in the analogous [Pd2(L1)4][BF4]4 complex due to 
shorter Cphenyl-O bond distances (1.39(5)-1.40(5) Å) compared to the Cphenyl-CH2 
ones (1.47(4)-1.60(4) Å). An overlay of [Pd2(L1)4]4+ and [Pd2(L2)4]4+ is shown in 
Figure 2.21. 
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Figure. 2.21. An overlay of the X-ray structures of [Pd2(L1)4]4+ and [Pd2(L2)4]4+. 
Hydrogen atoms, solvent molecules & counter-ions are omitted for clarity. 
 
The crystal packing diagram for [Pd2(L2)4]4+ (Figure 2.22) is analogous to that of 
[Pd2(L1)4]4+ and shows that the tetra-stranded cylinders are stacked into linear 
chains which are held together by face-to-face π-π stacking interactions.  
 
 
 
 
 
 
SIDE VIEW OF THREE 
TETRA-CATION CHAINS 
FRONT VIEW OF 
CHAINS  
Figure 2.22. Packing diagrams for [Pd2(L2)4]4+ cations showing the π-π stacking 
interactions between the phenyl rings. Hydrogen atoms, anions and solvent 
molecules have been removed for clarity. 
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The inter-planar distance between the stacked phenyl rings is 3.4 Å. The gaps 
between the cation chains are occupied by tetrafluoroborate counter-ions and 
the crystallising solvents, benzene and DMSO. 
The complex is insoluble in 100 % water, however, there is an increase 
in the solubility of the complex in aqueous/organic solvent mixtures compared to 
the [Pd2(L1)4][BF4]4 cylinder. The palladium(II) complex of L2 was also 
synthesised as a nitrate salt by precipitating the complex from acetonitrile with 
tetrabutylammonium nitrate. [Pd2(L2)4][NO3]4 is still not soluble in water, 
however, there is a marked improvement in the solubility of the complex in high 
water component mixtures such as water:acetonitrile (2:1). In this solvent 
mixture the solubility was sufficient enough to obtain a weak 1H NMR. However, 
when spectroscopic DNA binding studies were attempted using this solvent 
system, the complex precipitated on encountering the buffer and DNA solution.  
 
2.2.6 Platinum(II) complex of L2  
Complexation was achieved by heating two equivalents of ligand L2 and silver(I) 
tetrafluoroborate with one equivalent of bis(benzonitrile)dichloroplatinum(II) in 
acetonitrile for 48 hours. The silver salt is required to abstract the chloride ions 
and ensure that each metal centre has four accessible coordination sites. The 
crude product was purified on a semi-preparative RP-HPLC column using a 
linear gradient of 100 % water(0.05 % TFA) to 100 % methanol(0.05 % TFA) over          
40 minutes and the pure product was observed and collected at 38.80 minutes. 
The use of TFA in the purification resulted in an exchange of the 
tetrafluoroborate counter-ions for trifluoroacetate anions.  
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The ESI mass spectrum exhibits two peaks which correspond to 
[Pt2(L2)4(CF3CO2)2]2+ and [Pt2(L2)4(CF3CO2)]3+, these have the correct isotopic 
distribution patterns and confirm a change in counter-ion has taken place. The 
mono- and tetra-cationic species are not observed.  
Although this platinum(II) complex does not prove to be soluble in pure 
water, it exhibits much better solubility in methanol and methanol/water 
solutions than its palladium(II) analogue. The 1H NMR spectrum of this complex 
was recorded in d4-methanol and is shown in Figure 2.23. 
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Figure 2.23. 1H NMR spectra of (a) Ligand L2 and (b) [Pt2(L2)4][TFA]4 
(300 MHz, d4-methanol, 298 K). 
 
The spectrum of this complex displays six aromatic signals indicating the 
presence of a single symmetrical species in solution. All of the pyridine proton 
signals are downfield shifted relative to those in the free ligand (in d4-methanol), 
confirming that metal-ligand coordination has occurred. The multiplicity and 
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chemical shifts of the signals are similar to those observed in the 1H NMR 
spectrum of the analogous [Pt2(L1)4][CF3CO2]4.  
Several attempts were made to grow X-ray quality crystals of this 
complex, however, unfortunately all efforts proved to be unsuccessful.   
 
2.2.7 Ligand L3 
The incorporation of the ether spacer led to a slight increase in the solubility of 
the resulting complexes, however, more progress is needed. Fluorine 
substituent’s are known to participate in hydrogen bonding.14 Fluorine is also a 
small functionalisation which would not affect the size and shape of the cylinder 
too much. Therefore fluorine was incorporated into ligand L3. 
                          
 1)
, Na2CO3, THF/ H2O/ Ar2
Ligand L3
    
2)  Pd(PPh3)4
 
 
Scheme 2.3. Synthesis of Ligand L3. 
 
Ligand L3 is analogous to L2 except that fluorine has been incorporated into the 
5 position of the pyridine rings. The ligand was synthesized via a Suzuki 
coupling reaction between bis-4-bromophenylether and two equivalents of       
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5-fluoropyridine-3-boronic acid. Na2CO3 was used to activate the boronic acid 
and the reaction was catalysed by Pd(PPh3)4 (Scheme 2.3).10 The crude 
product was worked up and purified by preparative RP-HPLC using a 
hexane:ethyl acetate (6:4) solvent system. The pure product was observed and 
collected at 28.12 minutes in 50 % yield.  
The EI mass spectrum of this ligand reveals an intense peak consistent 
with {L3}+ at m/z 360 and partial elemental analysis data support a 
{C22H14N2F2O} formulation. The 19F NMR spectrum exhibits a single peak at      
-125.9 ppm and the 1H NMR spectrum shows five resonances in the aromatic 
region which, as expected, indicates the formation of the required symmetrical 
ligand (Figure 2.24).  
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Figure 2.24. 1H NMR spectrum of Ligand L3  
(400 MHz, d1-chloroform, 298 K). 
 
From the 1H NMR spectrum it is difficult to distinguish between H2 and H6 as 
they are both displayed as singlets. Therefore a 1H-13C HSQC experiment was 
carried out to aid in their assignment. The 13C spectrum displays C2 as a singlet 
and C6 as a doublet (due to the coupling between 13C and 19F). The cross peaks 
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of the HSQC spectrum were used to correlate the carbon signals with the 
corresponding proton signals so that H2 and H6 could be assigned. 
  
2.2.8 Palladium(II) complex of L3  
The palladium(II) complex of ligand L3 was formed by stirring two equivalents of 
ligand with one equivalent of tetrakis(acetonitrile)palladium(II) tetrafluoroborate 
under an argon atmosphere. After 16 hours the resulting solution was 
concentrated in vacuo and diethyl ether added drop-wise to precipitate the white 
product. 
ESI mass spectrometry analysis of the product shows two peaks with the 
correct isotope pattern and charge to correspond to [Pd2(L3)4(BF4)2]2+ (m/z 914) 
and [Pd2(L3)4(BF4)]3+ (m/z 580). The tetra- and mono-cationic peaks were not 
observed. The d6-DMSO 1H NMR spectra of ligand L3 and the corresponding 
palladium(II) complex are shown in Figure 2.25.  
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Figure 2.25. 1H NMR spectra of (a) Ligand L3 and (b) [Pd2(L3)4][BF4]4                  
(300 MHz, d6-DMSO, 298 K). 
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The 1H NMR spectrum of this complex reveals five aromatic signals indicating 
the formation of a single solution species with a symmetrical arrangement of 
ligands around the metal centres. There is a significant downfield shift of the 
proton signals in the complex relative to those in the free ligand. The greatest 
change is seen for H2 and H6 which are adjacent to the coordinating nitrogen 
atom and are both downfield shifted by 0.9 ppm. 
 Attempts to grow X-ray quality crystals of this complex were 
unfortunately unsuccessful. However, ligand L3 readily crystallised from a CDCl3 
solution of the ligand in an NMR tube (Figure 2.26).13 
 
 
 
 
 
Figure 2.26. A perspective view of Ligand L3.13 
 
As expected, the X-ray crystal structure depicts two fluorine atoms located on 
the 5 position of the pyridine rings and an oxygen atom as the central spacer. 
This data can be used as a means of visualising the structure of the [Pd2(L3)4]4+ 
tetra-cation. An illustration displaying the expected structure of the cylinder is 
shown in Figure 2.27. 
 
 
 
 
 
 
Figure 2.27. A representation of the proposed structure of [Pd2(L3)4]4+ cylinder 
based on the structures of [Pd2(L2)4]4+ and L3. 
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Unfortunately, the aqueous solubility of this complex has not been greatly 
enhanced by the fluorination of the ligand. The complex is soluble in 
water/organic solvent mixtures but remains insoluble in pure water. 
 
2.2.9 Ligand L4 
2
Ligand L4
H2SO4
NaNO2
KI
CuI/ Pd(PPh3)2Cl2
diisopropylamine/ THF
Argon
N2HSO4O4SHN2
I I
N N
NH2 NH2
N
 
 
Scheme 2.4. Synthesis of Ligand L4. 
 
A fourth ligand was synthesized to investigate the effects of increasing the 
ligand length on the formation and behaviour of the resulting complexes. Ligand 
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L4 was synthesized by a Sonogashira coupling reaction between                
bis(4-iodophenyl)methane15 and 3-ethynylpyridine using Pd(PPh3)2Cl2 as a 
catalyst and Cu(I) as a co-catalyst (Scheme 2.4).16 The crude product consisted 
of a mixture between the desired ligand L4, the half-ligand and a side product 
formed through the homocoupling of 3-ethynylpyridine. Purification was 
achieved by column chromatography on an alumina column using an            
ethyl acetate:hexane (1:1) eluent and gave the pure product in 72 % yield. The 
resulting ligand is longer than those previously described due to the 
incorporation of ethynyl bonds linking the central phenyl rings to the pyridyl 
binding units.  
The EI mass spectrum of this ligand is dominated by a single peak 
corresponding to {L4}+ (m/z 370) and the partial microanalytical data support a 
{C27H18N2} formulation. The 1H NMR spectrum of L4 in d1-chloroform is shown in 
Figure 2.28.  
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Figure 2.28. 1H NMR spectrum of Ligand L4  
(300 MHz, d1-chloroform, 298 K). 
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As expected, the spectrum shows six resonances in the aromatic section and 
one resonance in the aliphatic region indicating the formation of the symmetrical 
ligand.  
 
2.2.10 Palladium(II) complex of L4  
The palladium(II) cylinder of ligand L4 was synthesized by stirring two 
equivalents of ligand with tetrakis(acetonitrile)palladium(II) tetrafluoroborate in 
acetonitrile overnight. The solvent was removed and the crude product washed 
to obtain the pure complex in a high yield of 95 %.  
An IR spectrum of this complex shows a strong absorption at 1084 cm-1 
which is characteristic of free tetrafluoroborate vibrations. Partial microanalytical 
data are consistent with an empirical formula of {Pd(C27H18N2)2(BF4)2}n and the 
ESI mass spectrum is dominated by a peak at m/z 424 corresponding to 
[Pd2(L4)4]4+. A small peak corresponding to [Pd2(L4)4(BF4)2]2+ is also observed 
but the mono- and tri-cationic species are not apparent. The 1H NMR spectrum 
of the complex in d6-DMSO indicates the presence of a single solution species 
with a symmetrical arrangement of the ligands around the two metal centres 
(Figure 2.29). There is a significant downfield shift of the pyridine proton signals 
relative to those in the free ligand. This is especially highlighted for H2 and H6 
which are adjacent to the coordination site and are downfield shifted by           
0.7 ppm.  
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Figure 2.29. 1H NMR spectra of the aromatic region of (a) Ligand L4 and  
(b) [Pd2(L4)4][BF4]4 (300 MHz, d6-DMSO, 298 K). 
 
Crystals suitable for X-ray diffraction were grown over a two week period by the 
slow diffusion of benzene into a DMSO solution of the complex. The resulting    
X-ray crystal structure is shown in Figure 2.30.11 
 
 
 
 
 
 
 
(a)             (b) 
 
 
Figure 2.30. (a) Perspective view and (b) space-filling representation of 
[Pd2(L4)4]4+ cation. Hydrogen atoms and anions are omitted for clarity.11 
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As predicted, the solid state structure of the cation reveals a tetra-stranded, 
dinuclear palladium(II) complex. The cylindrical structure is analogous to that of 
[Pd2(L1)4]4+ and [Pd2(L2)4]4+ except that it is significantly larger with a Pd···Pd 
separation of 17.5 Å. The Pd-N bond distances (2.004(1) Å and 2.007(8) Å) and 
N-Pd-N bond angles (89.7(2)º- 90.5(4)º) are typical and similar to those 
observed in the palladium(II) cylinders of L1 and L2. The two metal centers 
adopt a square planar geometry and are linked via the four ligands. In each 
ligand, one of the Cpyridine-CΞC links is almost planar with a bond angle of 178º, 
however at 175º, the other is slightly distorted to enable the formation of the 
tetra-stranded architecture. The phenyl rings of each ligand are twisted by    
51º- 53º relative to one another and by 18º-33º relative to the adjacent pyridyl 
units. Intriguingly, in this cylinder the aromatic rings are twisted less than in the 
analogous [Pd2(L1)4][BF4]4 and [Pd2(L2)4][BF4]4. Two disordered 
tetrafluoroborate counter-ions and a disordered DMSO molecule are located 
within the central cavity of this palladium(II) cylinder. The remaining        
counter-ions, a DMSO molecule and three benzene molecules are situated 
around the cationic structure.  
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CROSS-SECTION OF 
TWO TETRA-CATION 
SHEETS 
π-π STACKING IN 
ONE OF THE PLANAR 
SHEETS 
 
Figure 2.31. Packing diagrams for [Pd2(L4)4]4+ cations showing the π-π stacking 
interactions between the phenyl rings. Hydrogen atoms, anions and solvent 
molecules have been removed for clarity. 
 
Figure 2.31 shows the crystal packing diagram for [Pd2(L4)4]4+. The tetra-cations 
are arranged into planar sheets held together by inter-molecular face-to-face   
π-π stacking interactions. Each cylinder is engaged in stacking interactions with 
four other cylinders enabling this large framework to be formed. Solvent 
molecules and anions fill the gaps formed between the cationic sheets.  
As can be seen in Figure 2.32, [Pd2(L4)4]4+ packs differently from 
[Pd2(L1)4]4+ and [Pd2(L2)4]4+. In diagrams A and B the cylinders are packed into 
chains but in C they are packed into 3 dimensional sheets. This difference 
explains why the aromatic rings of [Pd2(L4)4]4+ are less twisted than in the 
analogous palladium(II) complexes.  
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Figure 2.32. Packing diagrams for (A) [Pd2(L1)4]4+, (B) [Pd2(L2)4]4+ and  
(C) [Pd2(L4)4]4+. Hydrogen atoms, anions and solvent molecules have been 
removed for clarity. 
 
Unfortunately, increasing the size of the cylinder did not effect the solubility as 
[Pd2(L4)4][BF4]4 also proves to be insoluble in water. 
 
2.2.11 Platinum(II) complex of L4  
The platinum(II) complex of ligand L4 was synthesized by heating an acetonitrile 
solution of bis(benzonitrile)dichloroplatinum(II) with two equivalents of L4 and 
silver(I) hexafluorophosphate for 48 hours. The solution was filtered to remove 
silver(I) chloride and the crude product washed with a range of solvents. A 1H 
NMR spectrum of the resultant material showed a single set of resonances and 
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indicated that, unlike for the platinum(II) complexes of L1 and L2, in this case no 
further purification was required. The 300 MHz 1H NMR spectrum of 
[Pt2(L4)4][PF6]4 in d6-DMSO is shown in Figure 2.33. The spectrum displays one 
aliphatic signal and six aromatic signals, indicating that all four ligands are in an 
equivalent chemical environment. The spectrum is very similar to that of 
[Pd2(L4)4][BF4]4 and on coordination to the platinum(II) centres, the pyridine 
signals have shifted downfield relative to those in the free ligand. 
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Figure 2.33. 1H NMR spectra of the aromatic region of (a) Ligand L4 and         
(b) [Pt2(L4)4][PF6]4 (300 MHz, d6-DMSO, 298 K). 
 
The elemental analysis data support a {Pt2(C27H18N2)4(PF6)4} formulation and 
the ESI mass spectrum is dominated by a peak at m/z 468 which corresponds 
to [Pt2(L4)4]4+. The tri-cationic species [Pt2(L4)4(PF6)]3+ is also observed at      
m/z 672. The FT-IR spectrum shows absorption bands at 830 cm-1 and        
2228 cm-1, which can be attributed to the hexafluorophosphate and ethynyl 
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vibrations, respectively. These data are consistent with the formation of the 
desired tetra-stranded, dinuclear platinum(II) array.   
 Numerous attempts were made to grow X-ray quality crystals of the 
platinum complex, however, unfortunately these efforts were unsuccessful. 
 
2.2.12 Ligand L5 
In keeping with the same theme of exploring variations in cylinder structure, a 
fifth ligand, ligand L5, was synthesised. Ligand L5 is analogous to L1 except that 
the central methylene group has been replaced with an ethylene.  
 
        
Ligand L5
1) HBr/ EtOH 
2) NaNO2
3) CuBr/ HBr
1) Pd(PPh3)4/ DME/ Na2CO3/ Ar
2)  2
N
B
OH
OH
N N
Br
Br
NH2
NH2
 
 
Scheme 2.5. Synthesis of Ligand L5. 
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L5 was synthesized via a Pd(PPh3)4 catalysed Suzuki coupling reaction 
between bis(4-bromophenyl)ethane17 and two equivalents of                
pyridine-3-yl-3-boronic acid (Scheme 2.5).10 The crude ligand was purified on a 
silica column with a 2:1 mixture of petroleum ether:ethyl acetate as the eluent. 
The pure product was obtained as a white solid in 63 % yield.  
 Partial microanalytical data support a {C24H20N2} formulation and the 
results obtained from EI mass spectrometry show singly and doubly charged 
ions corresponding to {L5}+ (m/z 336) and {L5}2+ (m/z 168). Analysis of the 1H 
NMR spectrum reveals a single set of resonances consisting of six aromatic 
signals and one aliphatic one (Figure 2.34). The spectrum is similar to the 1H 
NMR spectrum of L1 except that the aliphatic signal has an integration of 4H 
instead of 2H. 
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Figure 2.34. 1H NMR spectrum of Ligand L5 
(400 MHz, d6-DMSO, 298 K). 
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2.2.13 Palladium(II) complexes of L5  
Ligand L5 was coordinated to naked palladium(II) by stirring two equivalents of 
ligand with tetrakis(acetonitrile)palladium(II) tetrafluoroborate under an argon 
atmosphere. The crude product was washed with a range of organic solvents 
and characterized.  
 The ESI mass spectrum of the product shows numerous positively 
charged peaks (Figure 2.35). Intriguingly, analysis of these peaks suggests that 
the reaction of palladium(II) with ligand L5 has not synthesised the expected 
tetra-stranded cylinder, but has instead led to the formation of the two distinct 
species [Pd3(L5)6][BF4]6 and [Pd4(L5)8][BF4]8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.35. An expansion of part of the ESI mass spectrum of  
[Pd3(L5)6][BF4]6 and [Pd4(L5)8][BF4]8. 
 
The ESI mass results cannot be confirmed by elemental analysis as both 
structures have the same empirical formula of {Pd(C24H20N2)2(BF4)2}n.  
The synthesis of [Pd3(L)6][X]6 and [Pd4(L)8][X]8 type structures has 
previously been reported by Fujita et al..18 In his paper, Fujita describes the 
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formation of two structures that are believed to be analogous to ours (Figure 
2.36). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A)                                                      (B) 
 
Figure 2.36. Fujita’s (A) [Pd3(L)6][X]6 and (B) [Pd4(L)8][X]8 complexes.  
Ligands in different chemical environments are shown along Pd···Pd axis of 
different colour. 
 
Fujita’s triangle (A) contains six equivalent ligands which all lie along the same 
Pd···Pd axis (green) and yield a 1H NMR spectrum with one set of signals. The 
pyramid (B) contains eight ligands, equally split into two different chemical 
environments, one lying along the blue Pd···Pd axis and the other lying along 
the red. Therefore, the 1H NMR spectrum of (B) displays two sets of signals of 
equal integration. The 1H NMR spectrum of the palladium(II) complexes of L5 is 
shown in Figure 2.37. 2D COSY and NOESY experiments were used to aid in 
the assignment of the peaks. 
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Figure 2.37. 1H NMR spectrum of the aromatic region of   
[Pd3(L5)6][BF4]6 and [Pd4(L5)8][BF4]8 
(300 MHz, d6-DMSO, 298 K). 
   
The spectrum shows two sets of signals, one contains protons in an equivalent 
chemical environment, corresponding to [Pd3(L5)6][BF4]6 and the other contains 
ligands in two chemical environments and corresponds to [Pd4(L5)8][BF4]8. This 
implies that a mixture of structures analogous to Fujita’s triangle (A) and 
pyramid (B) are indeed present. The ratio of our triangle to pyramid is 1:0.3. 
 X-ray quality crystals were successfully grown by the slow diffusion of 
THF into a solution of the complexes in DMSO. 1H NMR studies confirmed that 
the triangle structure is the most abundant species in our solution, therefore it is 
no surprise that this is the species that crystallised (Figure 2.38).  
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Figure 2.38. (a) Perspective view and (b) space-filling representation of 
[Pd3(L5)6]6+ cation. Hydrogen atoms are omitted for clarity.11 
 
As expected, each palladium(II) centre occupies a four coordinate square 
planar environment and is bound to pyridyl units from four different ligands. The 
metals occupy the corners of a triangle with Pd-Pd-Pd angles of ~60º and 
Pd···Pd separations of 17.7 Å, 17.8 Å and 18.0 Å. The Pd-N bond distances 
(1.948(12)-2.054(12) Å) and N-Pd-N angles (88.4(5)-92.9(8)º) are unremarkable 
and similar to those found in the other palladium(II) complexes that have been 
described in this chapter. The side view shows that three ligands rise above the 
plane of the metals and three sit below it (Figure 2.39).  
 
 
 
 
 
 
 
Figure 2.39. The side view of [Pd3(L5)6]6+.  
 
Encapsulated within the cavity of the complex are three of the tetrafluoroborate 
counter-ions, one in each corner of the triangle (Figure 2.38a). The Pd-F 
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distances for the encapsulated anions are 2.7 Å, 3.2 Å and 3.4 Å, suggesting 
that the counter-ions make weak ionic interactions with the metal centres. The 
remaining counter-ions and solvent molecules occupy the spaces between the 
hexa-cationic triangles.   
 A crystal packing diagram of the complex is shown in Figure 2.40. The 
structures pack together in a head to tail fashion, however there are no obvious 
inter-molecular forces holding them together.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.40. Crystal packing diagram of [Pd3(L5)6][BF4]6.  
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2.3 Conclusions 
In this chapter the synthesis and characterisation of five new ligands has been 
described. The ligands were successfully utilised in the synthesis of four novel 
tetra-stranded, dinuclear palladium(II) cylinders, three tetra-stranded,             
dinuclear platinum(II) cylinders, two Pd3L6 triangles and a Pd4L8 pyramid.  
 
The aim of this chapter was to synthesise tetra-stranded, dinuclear cylinders 
which have a potential to be biologically active. Therefore, chapter 3 reports the 
cytotoxicity and DNA binding studies of four of these new complexes. 
 86
Chapter 2 
2.4 Experimental  
2.4.1 General  
All solvents and reagents were purchased from Aldrich, Fisher and Fluorochem 
and were used without further purification. 1H NMR spectra were recorded on 
AC300, AV300 and AV400 Brüker spectrometers and processed using standard 
Brüker software. Infrared spectra were recorded from KBr pellets on a Perkin 
Elmer Paragon 1000 FT-IR spectrometer. Electrospray Ionisation (ESI) spectra 
were recorded on a Micromass LCT Time of flight mass spectrometer in positive 
ionization mode. Microanalyses data were obtained using a CE Instruments 
EA1110 elemental analyser. HPLC was performed using a Dionex HPLC 
system with a reverse phase preparative or semi-preparative column. 
X-ray crystal analyses were performed by Dr Benson Kariuki and              
Dr Louise Male using a Bruker Smart 6000 CCD diffractometer equipped with 
an Oxford Cryosystem Cooler and structural refinements used SHELXTL. 
 
2.4.2.1 Synthesis of Bis(4-bromophenyl)methanol intermediate9 
3
5
42
1
Br Br
OH
 
C13H10Br2O 
FW: 339.91 
 
n-Butyl lithium (14.6 ml, 22.0 mmol, 1.51 M in hexane) was added dropwise to a 
nitrogen purged flask containing a THF (50 ml) solution of                 
1,4-dibromobenzene (5.66 g, 24.0 mmol) cooled to -78 ºC. The cream slurry 
was stirred under a nitrogen atmosphere for 40 minutes before adding to a 
solution of 4-bromobenzylaldehyde (3.70 g, 20.0 mmol) in THF (40 ml) which 
had also been cooled to -78 ºC. The resulting solution was allowed to warm to 
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room temperature and was stirred for 2 hours before pouring into water        
(250 ml). The suspension was extracted with ethyl acetate (3 X 20 ml), washed 
with water (2 X 20 ml) and dried over magnesium sulphate. The solvent was 
removed in vacuo and the crude material washed with hexane to yield the 
required product (5.55 g, 82 % yield). 
1H NMR (300 MHz, CDCl3, 298 K): δ 7.45 (4H, d, J = 8.3 Hz, H2/3), 7.21 (4H, d, 
J = 8.3 Hz, H2/3), 5.73 (1H, s, H5), 2.27 (1H, s, HOH).  
 
2.4.2.2 Synthesis of Bis(4-bromophenyl)methane intermediate9 
3 5
42
1
Br Br  
C13H10Br2 
FW: 323.91 
 
Over a 10 minute duration, sodium borohydride (1.89 g, 50.0 mmol) was added 
to a solution of bis(4-bromophenyl)methanol (1.71 g, 5.0 mmol) in TFA (40 ml). 
The solution was stirred for 40 minutes at room temperature and then poured 
into water (250 ml). Aqueous sodium hydroxide was added slowly in order to 
make the suspension alkaline. The mixture was extracted with diethyl ether     
(3 X 20 ml) and the combined fractions washed with water (2 X 30 ml) and brine 
(1 X 30 ml) and dried over magnesium sulphate. The diethyl ether was removed 
in vacuo and the material dissolved in hexane and filtered through a short silica 
column to yield the required white product (1.18 g, 73 % yield).  
1H NMR (300 MHz, CDCl3, 298 K): δ 7.40 (4H, d, J = 8.1 Hz, H2/3), 7.02 (4H, d, 
J = 8.1 Hz, H2/3), 3.87 (2H, s, H5).  
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2.4.2.3 Synthesis of Ligand (L1)10 
6
35
4
2
7
8
9
10
11
NN  
C23H18N2 
FW: 322.15 
Method adapted from procedure of postdoctoral researcher Ekaterina Ryabova: 
Argon was bubbled through a mixture of bis(4-bromophenyl)methane (0.50 g, 
1.53 mmol), pyridine-3-yl-3-boronic acid (0.56 g, 4.59 mmol), sodium carbonate 
(6.12 mmol), water (12 ml) and THF (12 ml) prior to the addition of the catalyst, 
tetrakis(triphenylphosphine)palladium(0) (0.18 g, 0.15 mmol). The slurry was 
heated at 80 °C for 48 hours. On conclusion of the reaction the mixture was 
diluted with water (30 ml) and extracted with ethyl acetate (3 X 20 ml). The 
combined organic fractions were washed with water (2 X 30 ml) and brine        
(1 X 30 ml) and dried over anhydrous magnesium sulphate. The solvent was 
evaporated to give the crude product which was purified by preparative         
RP-HPLC using a linear gradient of 100 % water to 100 % methanol over        
60 minutes with a 10 minute methanol wash. The product peak was observed 
and collected at 50.15 minutes (355 mg, 72 % yield).  
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 8.88 (2H, d, J= 2.3 Hz, H2), 8.56 (2H, 
dd, J= 4.8, 1.6 Hz, H6), 8.07 (2H, ddd, J= 8.1, 2.3, 1.6 Hz, H4), 7.67 (4H, d,      
J= 8.4 Hz, H8/9), 7.48 (2H, dd, J= 8.1, 4.8 Hz, H5), 7.41 (4H, d, J= 8.4 Hz, H8/9), 
4.06 (2H, s, H11). 
13C NMR (400 MHz, CD2Cl2, 300 K): δ 146.4 C2/6, 146.2 C2/6, 139.5 C3/7/10, 
134.6 C3/7/10, 134.0 C3/7/10, 132.5 C4, 127.9 C5/8/9, 125.5 C8/9, 121.9 C5/8/9, 39.5 
C11. 
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Mass Spectrum (EI): m/z 322 {Ligand}+.  
Elemental analysis (%) calculated for C23H18N2·0.5CH3CN: C: 84.1; H: 5.7;     
N: 10.2; Found: C: 84.2; H: 5.8; N: 10.31. 
IR (KBr): ν= 1473(s), 1440(w), 1426 (m), 1395(m), 1023(m), 1001(s), 865(s), 
798(s), 787(s), 758(s), 712(s), 611(s), 551(m) cm-1. 
 
2.4.2.4 Synthesis of [Pd2(L1)4][BF4]4 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.017 g, 0.038 mmol) was 
added to a degassed solution of ligand L1 (0.024 g, 0.076 mmol) in acetonitrile 
(5 ml). The yellow solution was stirred overnight under an argon atmosphere. 
The solution was then filtered and the solvent removed under reduced pressure 
to yield an off white solid. The crude product was washed with chloroform        
(5 ml), acetone (5 ml) and diethyl ether (5 ml) and dried in vacuo (29.0 mg,          
83 % yield). 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.51 (2H, s, H2), 9.27 (2H, d,              
J= 6.0 Hz, H6), 8.34 (2H, d, J= 8.1 Hz, H4), 7.83 (2H, dd, J= 8.1, 6.0 Hz, H5), 
7.53 (4H, d, J= 8.0 Hz, H8/9), 7.35 (4H, d, J= 8.0 Hz, H8/9), 4.17 (2H, s, H11). 
19F NMR (300 MHz, (CD3)2SO, 298 K): δ -147.7 (s, FBF4). 
Mass Spectrum (E.S.I): m/z  837.8 {Pd2L4 + 2BF4}2+, 804.4 {Pd2L4 + F + BF4}2+, 
529.9 {Pd2L4 + BF4}3+, 375.6 {Pd2L4}4+, 323.2 {L + H}+.  
Elemental analysis (%) calculated for [Pd2(C23H18N2)4][BF4]4·6H2O: C: 56.4;   
H: 4.3; N: 5.7; Found: C: 56.4; H: 4.3; N: 5.6. 
IR (Neat): ν= 3092(br), 1602(m), 1510(w), 1480(m), 1438(m), 1401(w), 
1284(w), 1243(m), 1194(w), 1034(br,s), 799(s), 763(m), 701(s), 665(m) cm-1. 
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2.4.2.5 Synthesis of [Pd2(L1)4][NO3]4 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.017 g, 0.038 mmol) was 
added to a degassed solution of ligand L1 (0.024 g, 0.076 mmol) in acetonitrile 
(5 ml). The solution was stirred overnight under an argon atmosphere. Excess 
tetrabutylammonium nitrate was dissolved in acetonitrile and added dropwise to 
the reaction mixture until a white precipitate appeared. The crude product was 
filtered off, washed with chloroform (5 ml), acetone (5 ml) and diethyl ether      
(5 ml) and dried in vacuo (21.5 mg, 65 % yield). 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.67 (2H, s, H2), 9.27 (2H, d,              
J= 5.9 Hz, H6), 8.33 (2H, d, J= 7.9 Hz, H4), 7.81 (2H, dd, J= 7.9, 5.9 Hz, H5), 
7.60 (4H, d, J= 8.1 Hz, H8/9), 7.34 (4H, d, J= 8.1 Hz, H8/9), 4.14 (2H, s, H11). 
Mass Spectrum (E.S.I): m/z 813.2 {Pd2L4 + NO3}2+, 547.4 {Pd2L4 + NO3 + 
(CH3)2SO}3+, 521.5 {Pd2L4 + NO3}3+, 375.4 {Pd2L4}4+. 
Elemental analysis (%) calculated for [Pd2(C23H18N2)4][NO3]4·5.5H2O: C: 59.7; 
H: 4.5; N: 9.1; Found: C: 59.1; H: 4.7; N: 9.5.  
 
2.4.2.6 Synthesis of [Pd2(L1)4][TFA]4 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.017 g, 0.038 mmol) was 
added to a degassed solution of ligand L1 (0.024 g, 0.076 mmol) in acetonitrile 
(5 ml). The solution was stirred overnight under an argon atmosphere and then 
treated with an acetonitrile solution of sodium trifluoroacetate. The crude 
material was purified on a semi-preparative RP-HPLC column using a gradient 
of 100 % H20(0.05 % TFA) to 100 % methanol(0.05 % TFA) over 40 minutes followed by 
a 10 minute methanol(0.05 % TFA) wash. The pure complex was observed and 
collected at 36.83 minutes (15.3 mg, 41 % yield). 
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1H NMR (300 MHz, CD3OD, 298 K): δ 9.53 (2H, s, H2), 9.07 (2H, d, J= 5.4 Hz, 
H6), 8.18 (2H, d, J= 8.3 Hz, H4), 7.63 (2H, dd, J= 8.3, 5.4 Hz, H5), 7.37 (4H, d, 
J= 8.0 Hz, H8/9), 7.17 (4H, d, J= 8.0 Hz, H8/9), 4.02 (2H, s, H11). 
Mass Spectrum (E.S.I): m/z 864.3 {Pd2L4+ 2TFA}2+, 703.2 {Pd2L3+ 2TFA}2+, 
538.5 {Pd2L4+ TFA}3+. 
Elemental analysis (%) calculated for [Pd2(C23H18N2)4][C 
F3CO2]4·2.25NaF3C2O2 C: 55.5; H: 3.2; N: 5.0; Found: C: 55.1; H: 3.5; N: 5.1.  
 
2.4.2.7 Synthesis of [Pt2(L1)4][TFA]4 
Bis(benzonitrile)dichloroplatinum(II) (0.018 g, 0.038 mmol), ligand L1 (0.024 g, 
0.076 mmol) and silver(I) nitrate (0.013 g, 0.076 mmol) were heated under 
reflux for 48 hours in acetonitrile (6 ml). The reaction mixture was filtered to 
remove the silver(I) chloride and the solvent evaporated to give the crude 
product. The material was purified by semi-preparative RP-HPLC using a 
gradient of 100 % water(0.05 % TFA) to 100 % methanol(0.05 % TFA) over 50 minutes. 
The impure product peak was observed and collected at 34.00 minutes. The 
obtained solid was further purified on another semi-preparative RP-HPLC 
column using a gradient of 100 % water to 100 % methanol over 40 minutes. 
The pure product was collected at 26.56 minutes, the solvent removed and the 
white product dried in vacuo (10.9 mg, 27 % yield). 
1H NMR (300 MHz, CD3OD, 298 K): δ 9.59 (2H, s, H2), 9.03 (2H, d, J= 5.3 Hz, 
H6), 8.18 (2H, d, J= 8.0 Hz, H4), 7.60 (2H, dd, J= 8.0, 5.3 Hz, H5), 7.40 (4H, d, 
J= 8.3 Hz, H8/9), 7.16 (4H, d, J= 8.3 Hz, H8/9), 4.01 (2H, s, H11). 
Mass Spectrum (E.S.I): m/z 952.3 {Pt2L4 + 2TFA}2+, 597.5 {Pt2L4 + TFA }3+. 
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2.4.3.1 Synthesis of Ligand (L2)10 
6
35
4
2
7
8
9
10
N
O
N  
C22H16N2O 
FW: 324.13 
Method adapted from procedure of postdoctoral researcher Ekaterina Ryabova: 
A solution of tetrakis(triphenylphosphine)palladium(0) (0.051 g, 0.044 mmol) in 
dimethoxyethane (2 ml) and aqueous sodium carbonate (1 M, 3.52 ml) was 
added to an argon filled glass vial containing bis-4-bromophenylether (0.289 g, 
0.88 mmol). A slurry of pyridine-3-yl-3-boronic acid (0.324 g, 2.33 mmol) in 
ethanol (2 ml) was added, the vial purged with argon once again and the 
mixture heated at 90 °C for 1 hour. The solution was cooled to room 
temperature and left stirring overnight. On conclusion of the reaction, the 
mixture was diluted with water (30 ml) and extracted with ethyl acetate             
(3 X 20 ml). The combined organic fractions were washed with water                
(2 X 30 ml) and brine (1 X 30 ml) and dried over anhydrous magnesium 
sulphate. The solvent was evaporated to give the crude product which was 
purified by preparative RP-HPLC using a linear gradient of 100 % water to    
100 % methanol over 40 minutes with a 15 minute methanol wash. The product 
peak was observed and collected at 49.58 minutes. 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 8.90 (2H, d, J= 2.7 Hz, H2), 8.56 (2H, 
d, J= 4.6 Hz, H6), 8.08 (2H, d, J= 8.1 Hz, H4), 7.78 (4H, d, J= 8.4 Hz, H8/9), 7.48 
(2H, dd, J= 8.1, 4.6 Hz, H5), 7.20 (4H, d, J= 8.4 Hz, H8/9). 
13C NMR (400 MHz, CDCl3, 300 K): δ 159.9 C3/7/10, 151.0 C2/6, 150.8 C2/6, 138.6 
C3/7/10, 136.8 C4, 135.9 C3/7/10, 131.3 C8/9, 126.2 C5, 122.2 C8/9.  
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Mass Spectrum (EI): m/z 324 {Ligand}+. 
Elemental analysis (%) calculated for C22H16N2O: C: 81.5; H: 5.0; N: 8.6; 
Found; C: 81.3; H: 4.8; N: 8.4. 
IR (KBr): ν= 1596(m), 1565(w), 1519(s), 1478(s), 1432(m), 1396(w), 1339(w), 
1278(s), 1170(s), 1134(w), 1108(w), 1016(m), 836(s), 795(s), 697(s),        
543(m) cm-1. 
 
2.4.3.2 Synthesis of [Pd2(L2)4][BF4]4 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.017 g, 0.038 mmol) was 
added to a degassed solution of ligand L2 (0.025 g, 0.076 mmol) in acetonitrile 
(5 ml). The solution was stirred overnight under an argon atmosphere. The 
solution was filtered and treated with diethyl ether resulting in the precipitation 
of an off white solid. The crude product was washed with chloroform (5 ml), 
acetone (5 ml), ethanol (5 ml) and diethyl ether (5 ml) and dried in vacuo     
(31.8 mg, 90 % yield). 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.73 (2H, s, H2), 9.32 (2H, d,              
J= 5.7 Hz, H6), 8.36 (2H, d, J= 8.1 Hz, H4), 7.83 (2H, dd, J= 8.1, 5.7 Hz, H5), 
7.72 (4H, d, J= 7.5 Hz, H8/9), 7.29 (4H, d, J= 7.5 Hz, H8/9). 
Mass Spectrum (E.S.I): m/z 841.8 {Pd2L4 + 2BF4}2+, 532.5 {Pd2L4+ BF4}3+, 
377.6 {Pd2L4}4+. 
Elemental analysis (%) calculated for [Pd2(C22H16N2O)4][BF4]4· 
0.5CH3CN·4CHCl3: C: 47.4; H: 3.0; N: 5.1; Found: C: 47.4; H: 3.1; N: 5.3. 
IR (Neat): ν= 3087(br), 1599(m), 1509(m), 1480(s), 1440(m), 1281(w), 1244(s), 
1179(m), 1010(br,s), 875(m), 804(s), 700(s), 666(m) cm-1. 
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2.4.3.3 Synthesis of [Pd2(L2)4][NO3]4 
Under an argon atmosphere, tetrakis(acetonitrile)palladium(II) tetrafluoroborate 
(0.017 g, 0.038 mmol) was stirred overnight with ligand L2 (0.025 g,            
0.076 mmol) in acetonitrile (5 ml). Excess tetrabutylammonium nitrate was 
dissolved in acetonitrile and added drop wise to the reaction mixture until a 
white solid precipitated. The crude product was filtered off, washed with 
chloroform (5 ml), acetone (5 ml) and diethyl ether (5 ml) and dried in vacuo. 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.87 (2H, s, H2), 9.36 (2H, d,              
J= 5.7 Hz, H6), 8.36 (2H, d, J= 7.8 Hz, H4), 7.83 (2H, dd, J= 7.8, 5.7 Hz, H5), 
7.78 (4H, d, J= 8.1 Hz, H8/9), 7.31 (4H, d, J= 8.1 Hz, H8/9). 
Mass Spectrum (E.S.I): m/z 817.3 {Pd2L4 + 2NO3}2+, 576.2 {Pd2L4 + NO3 + 
2(CH3)2SO}3+, 550.2 {Pd2L4 + NO3 + (CH3)2SO}3+, 524.2 {Pd2L4 + NO3}3+. 
Elemental analysis (%) calculated for [Pd2(C22H16N2O)4][NO3]4·6H2O·CH3CN:  
C: 56.7; H: 4.2; N: 9.5; Found: C: 56.7; H: 4.2; N: 9.6.  
 
2.4.3.4 Synthesis of [Pt2(L2)4][TFA]4 
Bis(benzonitrile)dichloroplatinum(II) (0.018 g, 0.038 mmol), ligand L2 (0.024 g, 
0.076 mmol) and silver(I) tetrafluoroborate (0.015 g, 0.076 mmol) were heated 
under reflux for 48 hours in acetonitrile (6 ml). The reaction mixture was filtered 
to remove the silver(I) chloride. The solvent was evaporated to give the crude 
product which was purified by semi-preparative RP-HPLC using a gradient of 
100 % water(0.05 % TFA) to 100 % methanol(0.05 % TFA) over 40 minutes and the pure 
product was observed and collected at 38.80 minutes. The solvent was 
removed under reduced pressure and the white product dried in vacuo. 
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1H NMR (300 MHz, CD3OD, 298 K): δ 9.81 (2H, s, H2), 9.28 (2H, d, J= 5.4 Hz, 
H6), 8.30 (2H, d, J= 8.1 Hz, H4), 7.76 (2H, dd, J= 8.1, 5.4 Hz, H5), 7.70 (4H, d, 
J= 8.8 Hz, H8/9), 7.20 (4H, d, J= 8.8 Hz, H8/9). 
Mass Spectrum (E.S.I): m/z 956.2 {Pt2L4 + 2TFA}2+, 917.8 {Pt2L4 + TFA + Cl}2+, 
599.8 {Pt2L4 + TFA}3+, 574.2 {Pt2L4 + Cl}3+. 
 
2.4.4.1 Synthesis of Ligand (L3)10 
6
3
5
4
2
7
8
9
10
N
F
O
N
F
 
C22H14N2F2O 
FW: 360.11 
 
Argon was bubbled through a mixture of bis-4-bromophenylether (0.310 g, 
0.946 mmol), 5-fluoropyridine-3-boronic acid (0.400 g, 2.839 mmol), sodium 
carbonate (3.785 mmol), water (12 ml) and THF (12 ml) prior to the addition of 
the catalyst, tetrakis(triphenylphosphine)palladium(0) (0.109 g, 0.095 mmol). 
The slurry was heated at 80 °C for 48 hours. On conclusion of the reaction, the 
mixture was diluted with water and extracted with ethyl acetate (3 X 20 ml). The 
combined organic fractions were washed with water (2 X 30 ml) and brine        
(1 X 30 ml) and dried over anhydrous magnesium sulfate. The solvent was 
evaporated to give the crude product which was purified by preparative         
RP-HPLC using a hexane:ethyl acetate (6:4) solvent system for 44.00 minutes. 
The product peak was observed and collected at 28.12 minutes (0.162 g,        
48 % yield). 
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1H NMR (400 MHz, CDCl3, 298 K): δ 8.65 (2H, s, H2), 8.43 (2H, s, H6),        
7.54-7.57 (2H, m, H4), 7.56 (4H, d, J= 8.8 Hz, H8/9), 7.16 (4H, d, J= 8.8 Hz, 
H8/9). 
13C NMR (400 MHz, (CD3)2SO, 300 K): δ 159.9 C10, 155.7 C7, 142.5 C2, 135.4 
C3/5, 134.8 C6, 129.8 C3/5, 127.8 C8/4, 119.4 C8/4, 118.1 C9. 
19F NMR (300 MHz, CDCl3, 298 K): δ -125.9 (s, F5). 
Mass Spectrum (EI): m/z 360 {Ligand}+.  
Elemental analysis (%) calculated for C22H14N2F2O: C: 73.3; H: 3.9; N: 7.8; 
Found: C: 73.1; H: 3.7; N: 7.6. 
IR (Neat): ν= 3019(br), 1599(m), 1568(w), 1509(s), 1434(s), 1300(w), 1395(s), 
1275(m), 1260(s), 1230(s), 1199(s), 1150(s), 1110(m), 1023(m), 1015(m), 
936(w), 885(s), 874(m), 827(s), 838(s), 704(s), 689(s), 642(m) cm-1. 
 
2.4.4.2 Synthesis of [Pd2(L3)4][BF4]4 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.017 g, 0.038 mmol) was 
added to a degassed solution of ligand L3 (0.027 g, 0.076 mmol) in acetonitrile 
(5 ml) and the clear solution stirred under argon. After 16 hours the solution was 
filtered, concentrated in vacuo and treated with diethyl ether resulting in the 
precipitation of a white solid. The crude product was washed with chloroform    
(5 ml) and diethyl ether (5 ml) and dried in vacuo (29.0 mg, 76 % yield). 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.87 (2H, s, H2), 9.65 (2H, s, H6), 8.61 
(2H, d, J= 9.0 Hz, H4), 8.22 (4H, d, J= 8.4 Hz, H8/9), 7.81 (4H, d, J= 8.4 Hz, 
H8/9). 
Mass Spectrum (E.S.I): m/z 914.3 {Pd2L4 + 2BF4}2+, 580.5 {Pd2L4 + BF4}3+. 
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2.4.5.1 Synthesis of 4,4'-diiododiphenylmethane intermediate15 
3 5
42
1
I I  
  
4,4'-diaminodiphenylmethane (17.0 g, 85.9 mmol) was dissolved in conc 
sulphuric acid (300 ml) and cooled to 0 ºC. The temperature was maintained 
below 5 ºC during the drop wise addition of aqueous sodium nitrite solution 
(17.0 g 0.239 mol, 30 ml). The slurry was stirred at 5 ºC for 30 minutes and then 
poured into an aqueous solution of potassium(I) iodide (100 g, 1 L) heated to   
55 ºC. Stirring was continued at this temperature for 1 hour after which the 
mixture was allowed to cool to room temperature. After the addition of 
dichloromethane (1 L), the mixture was neutralized by the addition of aqueous 
sodium hydroxide and then decolorized with a saturated solution of aqueous 
sodium bisulfite solution. The organic phase was washed with 10 % aqueous 
hydrochloric acid (500 ml), distilled water (2 X 100 ml), saturated aqueous 
sodium bicarbonate   (2 X 50 ml), water (2 X 50 ml) again and dried over 
magnesium sulphate. The solvent was removed in vacuo to afford a yellow oil 
which was purified on a silica column using hexane as the eluant. Removal of 
the hexane afforded the desired product as a white solid (13.34 g, 37 % yield). 
1H NMR (300 MHz, CDCl3, 298 K): δ 7.60 (4H, d, J= 8.6 Hz, H2/3), 6.90 (4H, d, 
J= 8.6 Hz, H2/3), 3.85 (2H, s, H5).  
Mass Spectrum (EI): m/z 420 {Spacer}+.  
 
 
 
C13H10I2 
FW: 419.89 
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.4.5.2 Synthesis of Ligand (L4)16 
N N
2
13
12
6
3
5
4
2
7
8
9
10
11
 
 
3-Ethynylpyridine (0.184 g, 1.79 mmol) was added to a degassed mixture of 
       
.74 (2H, d, J= 1.9 Hz, H2), 8.58 (2H, 
C27H18N2 
FW: 370.15 
bis(4-iodophenyl)methane (0.300 mg, 0.71 mmol), copper (I) iodide (0.009 g, 
0.04 mmol) and bis(triphenylphospine)dichloropalladium(II) (0.030 mg,   
0.04 mmol) dissolved in diisopropylamine (7 ml) and dry THF (3 ml). The 
suspension was stirred under an argon atmosphere at 50 oC for 48 hours. The 
solvents were then removed under reduced pressure and the crude product 
dissolved in diethyl ether (20 ml). The organic layer was then washed with 
saturated sodium hydrogen carbonate (20 ml) solution and water (20 ml) and 
the combined washings extracted with diethyl ether (3 X 20 ml). The combined 
organic portion was dried under anhydrous magnesium sulphate and the 
solvent evaporated under reduced pressure. The crude product was purified by 
column chromatography on an alumina column (ethyl acetate:hexane 1:1) to 
yield a white solid (0.189 g , 72 % yield).  
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 8
dd, J= 5.0, 1.9 Hz, H6), 7.96 (2H, d, J= 8.1 Hz, H4), 7.53 (4H, d, J= 8.1 Hz, 
H10/11), 7.46 (2H, dd, J= 8.1, 5.0 Hz, H5), 7.33 (4H, d, J= 8.1 Hz, H10/11), 4.05 
(2H, s, H13).  
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13C NMR (400 MHz, CDCl3, 300 K): δ 152.0 C2, 148.2 C6, 141.1 C3/9/12, 138.1 
C4, 131.6 C10/11, 128.8 C10/11, 122.7 C5, 120.2 C3/9/12, 92.3 C7/8, 85.6 C7/8, 41.5 
C13.  
Mass Spectrum (EI): m/z 370 {Ligand}+.  
Elemental analysis (%) calculated for C27H18N2: C: 87.5; H: 4.9; N: 7.6; Found: 
C: 87.8; H: 4.8; N: 7.5. 
IR (Neat): ν= 3029(br), 2218(m), 1581(w), 1560(m), 1505(m), 1475(m), 1405(s), 
1188(m), 1123(m), 1100(m), 1038(w), 1021(s), 950(m), 923(w), 824(m), 801(s), 
785(s), 701(s), 624(s) cm-1. 
 
2.4.5.3 Synthesis of [Pd2(L4)4][BF4]4  
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.017 g, 0.038 mmol) was 
added to a degassed solution of ligand L4 (0.028 g, 0.076 mmol) in acetonitrile 
(5 ml). The light yellow solution was stirred overnight under an argon 
atmosphere. The solution was filtered and the solvent removed under reduced 
pressure to yield a cream solid. The crude product was washed with chloroform 
(5 ml) and diethyl ether (5 ml) and dried in vacuo (0.037 g, 95 % yield). 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.43 (2H, s, H2), 9.23 (2H, d,              
J= 6.0 Hz, H6), 8.24 (2H, d, J= 8.1 Hz, H4), 7.78 (2H, dd, J= 8.1, 6.0 Hz, H5), 
7.55 (4H, d, J= 8.3 Hz, H10/11), 7.25 (4H, d, J= 8.3 Hz, H10/11), 4.12 (2H, s, H13). 
Mass Spectrum (E.S.I): m/z 934.9 {Pd2L4 + 2BF4}2+, 900.9 {Pd2L4 + BF4 + F}2+, 
594.2 {Pd2L4 + BF4}3+, 571.6 {Pd2L4 + F}3+, 463.2 {Pd2L4 + 2(CH3)2SO}4+, 423.9 
{Pd2L4}4+, 371.4 {Ligand + H}+. 
Elemental analysis (%) calculated for [Pd2(C27H18N2)4][BF4]4·9H2O: C: 58.9;   
H: 4.1; N: 5.1; Found: C: 58.9; H: 3.9; N: 5.1. 
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IR (Neat): ν= 3441(br), 3389(br), 3081(br), 2227(m), 1598(w), 1572(w), 
1509(m), 1479(w), 1420(w), 1196(w), 1084(s), 813(m), 790(w), 695(m), 666(w), 
520(w) cm-1. 
 
2.4.5.4 Synthesis of [Pt2(L4)4][PF6]4 
Ligand L4 (0.028 g, 0.076 mmol), bis(benzonitrile)dichloroplatinum(II) (0.018 g, 
0.038 mmol) and silver(I) hexafluorophosphate (0.019 g, 0.076 mmol) were 
heated under reflux in acetonitrile (10 ml) for 48 hours. The solution was filtered 
and the solvent removed under reduced pressure to yield an off white solid. The 
crude product was washed with chloroform (5 ml), acetone (5 ml) and diethyl 
ether (5 ml) and dried in vacuo (0.016 g, 35 % yield). 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.36 (2H, s, H2), 9.19 (2H, d,              
J= 5.9 Hz, H6), 8.24 (2H, d, J= 8.0 Hz, H4), 7.78 (2H, dd, J= 8.0, 5.9 Hz, H5), 
7.56 (4H, d, J= 8.3 Hz, H10/11), 7.29 (4H, d, J= 8.3 Hz, H10/11), 4.12 (2H, s, H13). 
Mass Spectrum (E.S.I): m/z 672.4 {Pt2L4 + PF6}3+, 662.2 {Pt2L4 + Cl + 
(CH3)2SO}3+, 635.8 {Pt2L4 + Cl}3+, 507.1 {Pt2L4 + 2(CH3)2SO}4+, 487.4 {Pt2L4 + 
(CH3)2SO}4+, 467.9 {Pt2L4}4+. 
Elemental analysis (%) calculated for [Pt2(C27H18N2)4][PF6]4·7H2O: C: 50.3;     
H: 3.4; N: 4.3; Found: C: 50.2; H: 3.3; N: 4.3. 
IR (Neat): ν= 3087(br), 2228(m), 1650(br), 1600(w), 1573(w), 1509(w), 
1478(w), 1416(m), 1194(w), 1019(w), 829(br,s), 739(m), 694(s) cm-1. 
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2.4.6.1 Synthesis of Bis(4-bromophenyl)ethane intermediate17 
 
1
3
54
2
 
 
 
A solution of Bis(4-aminophenyl)ethane (1 g, 4.7 mmol) was dissolved in HBr 
(48 %, 2.8 ml) and ethanol (11 ml) and cooled to 0 ºC prior to the addition of 
aqueous sodium nitrite (0.86 g, 12,05 mmol in 1.5 ml of H2O). After stirring for 
15 minutes the solution was added to a solution of copper(I) bromide (0.746 g, 
4.98 mmol) in HBr (14 ml) at 95 °C. After stirring at 95 °C for 15 minutes, the 
solution was cooled to room temperature and diluted with water (50 ml). The 
mixture was extracted with ethyl acetate (3 X 20 ml), washed with a saturated 
solution of sodium hydrogen carbonate and dried over magnesium sulphate. 
The crude material was purified on a silica column with petroleum ether:ethyl 
acetate (1:1) eluent. The solvent was removed in vacuo and bis(4-
bromophenyl)ethane isolated as a white solid (0.901 g, 57 % yield). 
1H NMR (300 MHz, CDCl3, 298 K): δ 7.37 (4H, d, J= 9.0 Hz, H2/3), 6.98 (4H, d, 
J= 9.0 Hz, H2/3), 2.82 (4H, s, H5). 
 
2.4.6.2 Synthesis of Ligand (L5)10 
 
6
11
3
5 4
2
7
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C24H20N2 
FW: 336.43 
C14H12Br2 
FW: 337.93 
 
 
Method adapted from procedure of postdoctoral researcher Ekaterina Ryabova: 
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A solution of tetrakis(triphenylphosphine)palladium(0) (5 mol %, 51 mg,      
0.044 mmol) in dimethoxyethane (2 ml) and aqueous sodium carbonate (1 M, 
3.52 ml, 3.52 mmol) were added to an argon purged Schlenk flask containing 
bis(4-bromophenyl)ethane (0.3 g, 0.88 mmol). The flask was purged with argon 
once again and the resultant solution stirred at room temperature for               
15 minutes. An ethanolic (2 ml) solution of pyridine-3-yl-3-boronic acid       
(0.324 g, 2.33 mmol) was added to the Schlenk and the mixture heated at       
90 °C under an argon atmosphere. After 1 hour, the solution was cooled to 
room temperature and left stirring overnight. On completion of the reaction the 
mixture was filtered, the solvent removed and the solid residue dissolved in 
ethyl acetate (50 ml). The solution was dried over magnesium sulfate, filtered 
and the solvent removed under vacuum to afford the crude product. The ligand 
was purified on silica gel using petroleum ether:ethyl acetate (2:1) as the eluent. 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 8.88 (2H, d, J= 2.0 Hz, H2), 8.55 (2H, 
dd, J= 4.6, 2.0 Hz, H6), 8.06 (2H, dt, J= 8.1, 2.0 Hz, H4), 7.66 (4H, d, J= 8.4 Hz, 
H8/9), 7.47 (2H, dd, J= 8.1, 4.6 Hz, H5), 7.40 (4H, d, J= 8.4 Hz, H8/9), 2.99 (4H, s, 
H11). 
Mass Spectrum (EI): m/z 336 {Ligand}+, 168 {Ligand}2+. 
Elemental analysis (%) calculated for C24H20N2: C: 85.7; H: 6.0; N: 8.3; Found: 
C: 85.6; H: 6.0; N: 8.2. 
IR (KBr): ν= 1607(w), 1475(s), 1449(w), 1433(m), 139.6(m), 1340(w), 1186(m), 
1021(m), 999(m), 840(s), 802(vs), 758(w), 706(s), 621(w), 555(m) cm-1. 
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2.4.6.3 Synthesis of [Pd3(L5)6][BF4]6 and [Pd4(L5)8][BF4]8 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.017 g, 0.038 mmol) was 
added to a degassed solution of ligand L5 (0.025 g, 0.076 mmol) in acetonitrile 
(5 ml). The solution was stirred overnight under an argon atmosphere, filtered 
and treated with diethyl ether resulting in the precipitation of a yellow solid. The 
crude product was washed with chloroform (5 ml), acetone (5 ml), ethanol (5 ml) 
and diethyl ether (5 ml) and dried in vacuo. 
Triangle NMR 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.89 (2H, s, H2), 9.31 (2H, d,              
J= 5.4 Hz, H6), 8.37 (2H, d, J= 8.3 Hz, H4), 7.82 (2H, dd, J= 8.3, 5.4 Hz, H5), 
7.62 (4H, d, J= 8.0 Hz, H8/9), 7.51 (4H, d, J= 8.0 Hz, H8/9), 3.00 (4H, s, H11). 
Pyramid NMR 
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.95 (2H, s, H2’), 9.58 (2H, d,             
J= 5.7 Hz, H6’), 9.50 (2H, s, H2), 9.04 (2H, d, J= 5.4 Hz, H6), 8.37 (2H, d,          
J= 8.1 Hz, H4’), 8.34 (2H, m, H4), 7.96 (2H, dd, J= 8.1, 5.7 Hz, H5’), 7.76-7.78 
(2H, m, H5), 7.55-7.72 (8H, m, H8/9 & 8’/9’), 3.00 (8H, s, H11 & 11’). 
Mass Spectrum (E.S.I): m/z 1342.5 {Pd3L6 + 4BF4}2+, 1184.2 {Pd4L8 + 5BF4}3+, 
675.2 {Pd4L8 + 3BF4}5+, 628.2 {Pd3L6 + 2BF4}4+, 548.5 {Pd4L8 + 2BF4}6+, 484.9 
{Pd3L6 + BF4}5+. 
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Tetra-Stranded, Dinuclear  
Cylinders and their Biological 
Activities 
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3.1 Introduction 
Metal ion directed self assembly has proved to be a useful tool in the 
construction of a vast array of discrete molecular architectures.1 As described in 
chapter 1, scientists have taken advantage of this method for the synthesis of a 
library of structures including helicates,2 boxes,3 grids4 and cages.5 The 
resulting metallo-structures have a general formula of MxLy, with varying 
numbers of metal ions and ligands employed. They are of particular interest due 
to their uses in applications such as storage,6 recognition7 and catalysis.8 
However, our interest in these types of complexes is different and stems from 
their potential to be used as metallo-drugs in the treatment of genetic diseases.  
 
In chapter 2, the synthesis and characterisation of a collection of novel,        
tetra-stranded, dinuclear cylinders of formula [M2L4][X4] has been discussed. In 
this chapter, the biological activity of four of these cylinders (Figure 3.1) is 
investigated.  
 
 
   1 2  3       
1 2  
1 2 
1 2 3  4  5 6  7  8  9 10 
4 5  6 7 8 9 10        
  7  9
Cylinder A 
 3 4 5 6  8  10            
3  4  5  6 7  8 9 10               
[Pd2(C23H18N2)4][BF4]4 
Cylinder B 
[Pd2(C22H16N2O)4][BF4]4  
 
 
 
Cylinder C 
[Pd2(C22H14N2OF2)4][BF4]4 
 
Cylinder D 
[Pd2(C27H18N2)4][BF4]4  
 
 
 
Figure 3.1. Tetra-stranded, dinuclear palladium(II) cylinders 
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In the following sections the DNA binding studies of cylinders A, B, C and D are 
described. In addition, the cytotoxic activities of these cylinders against human 
ovarian (A2780/ A7280cr) and breast (T47D) cancer cell lines is discussed and 
the genotoxicity and mutagenicity of the more active of the complexes 
presented. 
3.2 Results and Discussion 
3.2.1 DNA Binding Studies 
In order to investigate DNA binding via circular dichroism (CD) and linear 
dichroism (LD), compounds must be added to an aqueous solution of DNA. 
However, as discussed in chapter 2, the cylinders are insoluble in pure water 
and only sparingly soluble in some water/solvent mixtures. This prevents 
detailed spectroscopic DNA binding studies from being carried out. Therefore, 
confirmation of their ability to bind to DNA comes from gel electrophoresis and 
atomic force microscopy (AFM) studies.  
 
3.2.1.1 Agarose gel electrophoresis 
Agarose gel electrophoresis is a technique which can be used to separate DNA 
molecules according to their size or conformation.9 The DNA used in this work 
is the circular plasmid pBR322. In solution, the plasmid exists in two 
interchangeable forms, an open circular (OC) form and a negatively-supercoiled 
(NS) form (Figure 3.2).10 If the OC form is twisted about the helical axis, these 
twists are accommodated for by the coiling of the DNA and results in the 
formation of the supercoiled form and vice versa. 
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OPEN 
CIRCULAR 
 
 
NEGATIVELY 
SUPERCOILED 
 
 
 
 
 
 
Figure 3.2. Microscope images of the two solution forms of pBR322.10 
 
Agarose gel electrophoresis was used to detect the binding of the cylinders to 
the DNA plasmid. To overcome the issues with solubility the cylinders were 
dissolved in 2 % DMSO/water solutions. Different concentrations of the 
cylinders were then incubated with aqueous solutions of the plasmid for 1 hour 
(Table 1).  
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Base pairs: 
Cylinder 
 
Control  
(2 % DMSO) 
 
15/1 
 
10/1 
 
8/1 
 
6/1 
 
5/1 
 
4/1 
 
3/1 
 
2/1 
 
Control 
(no DMSO) 
 
Table 1. Ratios of plasmid and cylinder used in gel electrophoresis studies. 
 
After incubation, the plasmid-cylinder aliquots were injected into the wells of the 
agarose gel and an electrical current (5 Vcm-1) applied for 3 hours. During 
electrophoresis the negatively charged plasmid molecules migrate towards the 
positively charged anode. The rate of migration is dependent on the size and 
conformation of the DNA. The gel was subsequently stained with ethidium 
bromide and the positions of the plasmid detected using a UVIPro Platinum 2.0 
system at 312 nm. 
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3.2.1.2 Results and Discussion 
Figure. 3.3 shows the electrophoretic mobility of the plasmid-cylinder structures. 
-
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Figure 3.3. Agarose gel electrophoresis of pBR322 treated with cylinders A-D. 
 
At low cylinder concentrations, distinct OC and NS bands can be seen. As the 
concentration of the cylinder is increased, the mobility of the NS band 
decreases. In the case of cylinders A and C, at high concentrations the mobility 
of the OC band is also accelerated. These results show that all four cylinders 
bind to and lengthen and/or stiffen the structure of the DNA. It is also apparent 
that an increase in the concentration of cylinder results in an increase in DNA 
binding. 
Some agents, for example intercalators, unwind the DNA double helix on 
binding. Therefore, as the concentration of the drug is increased, an increase in 
the unwinding of the helix is observed. Further binding will result in the positive-
supercoiling of the OC form of the plasmid (Figure 3.4), explaining any increase 
in the mobility of this band at high compound concentrations.10 
 111
Chapter 3 
 
 
 
 
 
 
 
Negatively-supercoiled 
Plasmid (NS) 
Open circular plasmid  
(OC) 
Positively-supercoiled 
Plasmid (PS) 
 
Figure 3.4. The positive supercoiling of the plasmid resulting 
from drug intercalation 
 
If enough complex is added to the DNA the OC and NS bands will co-migrate 
and the DNA unwinding angle (φ)11 can be calculated using the following 
formula: 
φ = −18σ / r(c) 
r(c) is the ratio of cylinders bound per plasmid when the NS and OC bands       
co-migrate. The number of cylinders bound is taken to be equal to the mixing 
ratios based on the assumption that all cylinders present in the sample are 
completely bound to the DNA. r(c) can be easily determined by experiment. It is 
well known that cis-platin has a DNA unwinding angle of 13°, this along with the 
experimentally determined r(c) can be used to calculate the value of the 
superhelicity constant (σ = -0.059).12  
The DNA unwinding angles have been calculated for cylinders A-D and 
are compared with a racemic mixture of Hannon’s triple-stranded, dinuclear 
iron(II) cylinder (see chapter 2, section 2.1.1) and its ruthenium(II) analogue13 in 
Table 2. 
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  Unwinding Angle (φ) 
 
              A 
4º 
    
              B 
< 4º 
      
              C 
6º 
 
 
 
 
 
 
 
 
 
 
 
 
 
             
              D 
< 4º 
                          
                        Fe(II)   
                     cylinder     
27º 13 
                   
                   Ru(II)   
                     cylinder     
13º 13 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Angle of unwinding of pBR322 caused by cylinders A-D and  
Hannon’s iron(II) and ruthenium(II) cylinders. 
 
The results show that Hannon’s iron(II) cylinder is the most effective at 
unwinding the plasmid DNA. Intriguingly, the analogous ruthenium(II) cylinder 
has an unwinding angle that is about half that of the iron(II) cylinder. Of the 
tetra-stranded cylinders, C has the highest unwinding angle followed by cylinder 
A. An unwinding angle could not be calculated for cylinders B and D as the OC 
and NS bands did not co-migrate at the concentrations used in these 
experiments. All four tetra-stranded cylinders show less unwinding than both of 
the triple-stranded agents. The iron(II) cylinder unwinds the DNA duplex by 
binding non-covalently to the major groove of DNA. It is possible that cylinders 
A-D also have a similar mode of action, but due to their bulkier sizes they only 
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partially insert and bind within the groove, resulting in a smaller amount of 
unwinding.  
 
3.2.1.3 Atomic Force Microscopy  
The next step was to get some molecular-level images of the cylinders with 
DNA, this was done using an atomic force microscope (AFM). An AFM is a 
mechanical imaging instrument that measures the 3D topography of a surface 
using a sharpened tip. A sample is added to a substrate such as mica or 
graphite and a magnified image is generated by monitoring the motion of the tip 
as it is scanned back and forth over the surface. AFMs are capable of 
measuring images at nanoscale (even individual atoms) and therefore have a 
vast number of applications in many areas of science and technology.14 Of 
particular interest is the ability of AFMs to image DNA molecules and          
DNA-compound adducts that are attached to the surface of a substrate.15  
 The AFM studies were conducted during a visit to the Universidad 
Autónoma de Madrid. The experiments were carried out in the laboratory of    
Dr Felix Zamora and under the guidance of Dr Lorena Weltze. Unfortunately a 
sample of cylinder C was not available when the work was carried out. 
Therefore, only the studies with cylinders A, B and D will be reported in this 
work. All experiments were carried out on muscovite mica which is commonly 
used to immobilize DNA molecules onto a flat surface.  
 DNA samples were prepared by depositing a drop of ct-DNA solution and 
nickel chloride (10 μM) solution onto a freshly cleaved mica surface. After 
adsorption for 2 minutes, the surface was rinsed in a jet of ultra-pure water and 
blow dried with compressed argon. The nickel(II) cations act as a bridge in the 
immobilisation of the negatively charged DNA onto the negatively charged mica 
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surface.16 DNA-cylinder adducts were prepared by mixing the DNA with 
different concentrations of the cylinders. The freshly prepared DNA-cylinder 
solutions and nickel chloride were adsorbed onto the mica surface and washed 
and dried as previously described. The AFM images were obtained in tapping 
mode using a Nanotec Electrónica AFM and analysed using WSxM software.17 
5 
 
3.2.1.4 Results and Discussion 
Figure 3.5 shows an AFM image of two ct-DNA molecules adsorbed onto a 
mica surface using nickel(II) chloride. Without cylinders, the free DNA exists as 
long fibres with little twisting or coiling of the DNA strands. At 1 nm, the 
molecular height is typical for AFM measurements.15 However, as depicted in 
Figure 3.5, the lengths of the molecules vary considerably.  
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Figure 3.5. AFM topographic image showing ct-DNA adsorbed 
onto a mica substrate.  
 
Upon interaction with cylinder A (0.03 μM) the ct-DNA started to bend and coil 
(Figure 3.6(a)) and the long fibres of the free DNA are no longer obvious. On 
increasing the concentration of the cylinder to 0.075 μM, the coiling of the DNA 
fibres is even more apparent and the DNA molecules appear to cluster together 
to form large aggregates (Figure 3.6(b)). A further increase in the cylinder 
concentration (10 μM) results in the condensation of several DNA molecules 
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into small, compact nano-structures (Figure 3.6(c)). However, due to the high 
concentration of the cylinder, it is possible that these structures may also 
contain nano-particles of the crystallised cylinders.  
 
 
 
 
 
 
 
 
 
 
 
400nm
  (b) 
600nm
  (c) 
680nm
  (a) 
Figure 3.6. AFM topographic images of ct-DNA with (a) 0.03 μM 
(b) 0.075 μM and (c) 10 μM of cylinder A. 
 
Cationic condensing agents are believed to work by neutralizing the negative 
charge of the DNA sugar-phosphate backbone. This decreases the electrostatic 
repulsions between the DNA fibres, allowing them to tightly pack together.18 A 
well-studied example is the inorganic cation cobalt(III) hexamine which 
condenses and aggregates DNA into intermolecular clusters. An AFM image of 
cobalt(III) hexamine with the linearised DNA plasmid pBR322 is shown in Figure 
3.7.19 The result obtained with the cobalt(III) complex is similar to that seen for 
the highest concentration of cylinder A. 
 
  
 
 
 
 
 
 
Figure 3.7. AFM images of linear plasmid pBR322  
with cobalt(III) hexamine (Taken from reference 19). 
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Spermine is another well known DNA condensation agent. Drew and 
Dickerson’s crystal structure of DNA with spermine showed that the tetra-cation 
is located in the DNA major groove and results in the kinking of the double 
helix.20 Figure 3.8 shows AFM images of spermine with the DNA plasmid pCmV 
luciferase.21 The effects are similar to those observed at low and high 
concentrations of cylinder A (Figure 3.6(a) and (b)) except that much higher 
concentrations of spermine are required. 
 
 
 (a)                    (b) 
 
 
 
 
Figure 3.8. AFM images of DNA with (a) 10 mM and (b) 500 mM of spermine 
(Taken from reference 21). 
 
 
Similar trends were also seen in the AFM experiments of ct-DNA with cylinder 
B. Figure 3.9 shows the AFM topographic images of ct-DNA with cylinder B, 
adsorbed onto muscovite mica.  
770nm
 
760nm600nm
  (a)    (b)    (c) 
 
 
 
 
 
 
 
 
Figure 3.9. AFM topographic images of ct-DNA with (a) 0.03 μM 
(b) 0.075 μM and (c) 10 μM of cylinder B. 
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This cylinder clearly binds to the DNA and an increase in the concentration of B 
results in an increase in the aggregation of the DNA. Figure 3.9(c) shows the 
condensation of the DNA at high cylinder concentrations (10 μM). A close look 
shows that some of the nano-structures appear to be in the process of being 
formed as they are surrounded by DNA fibres.  
 As with cylinders A and B, on mixing with ct-DNA, an increase in the 
concentration of cylinder D results in an increase in the aggregation of the DNA 
(Figure 3.10). 
 
 
 
 
 
 
 
 
 
Figure 3.10. AFM topographic images of ct-DNA with (a) 0.03 μM 
(b) 0.075 μM and (c) 10 μM of cylinder D. 
 
Interestingly, the AFM images of DNA with cylinders A, B and D differ from 
those reported for Hannon’s iron(II) cylinder which causes intramolecular  DNA 
coiling.19 The coiling process is cooperative and at some concentrations 
uncoiled, bent DNA strands are observed in the presence of other fully coiled 
ones (Figure 3.11(a)). At higher concentrations all of the DNA strands are coiled 
(Figure 3.11(b)).  
600nm 680nm 520nm
  (c)   (a)    (b) 
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  (a)                   (b) 
Figure 3.11. AFM images of linear plasmid DNA with Hannon’s iron(II) cylinder 
in base pair to metal complex ratios of  (a) 10:3 and (b)10:5 
(Taken from reference 19). 
 
 
The difference in the results might be because the iron(II) cylinder acts by 
binding in the DNA major groove whereas the tetra-stranded cylinders are too 
large to fully insert into this binding site.  
 
3.2.2 Cytotoxicity Tests 
3.2.2.1 The MTT Assay 
To explore the anti-cancer activity of the cylinders their cytotoxicity was 
determined using the 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium 
bromide (MTT) assay.22 Cultured cancer cells were grown in 96 well plates in 
the presence of different concentrations of the cylinders (25 μM – 1.5 μM). After 
72 hours the amount of living cells present were determined by the addition of 
MTT. In viable (living) cells the mitochondrial enzyme succinate dehydrogenase 
converts the yellow water soluble MTT (a tetrazole) into blue formazan crystals 
(Figure 3.12).  
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Figure 3.12. Reduction of MTT to Formazan crystals. 
 
 
These blue crystals were then dissolved in DMSO to give a pink/purple solution 
& the UV absorbance measured at 590 nm. A dose response curve was plotted 
from which the IC50 values were determined. The IC50 is the concentration of 
complex required to inhibit 50 % cell growth. In other words, it is the 
concentration of the cylinder in wells that contain half the number of cells that 
are present in the control wells.23 
In the studies herein, the MTT assay was carried out using the ovarian 
cancer line A2780 and its cis-platin resistant subline A2780cr and the breast 
cancer cell line T47D.  
 
3.2.2.2 Results and Discussion 
The IC50 values of cylinders A-D were determined by the MTT assay and are 
compared to those of cis-platin and Hannon’s iron(II) cylinder in Table 3.  
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 A2780 A2780cr T47D 
Cylinder A 8.1 ± 1.3 10.3 ± 1.2 5.6 ± 0.5* 
Cylinder B 5.1 ± 1.1 9.0 ± 0.9 4.8 ± 1.1* 
Cylinder C >100 >100 >100 
Cylinder D >100 >100 >100* 
Iron(II) Cylinder 8.7 ± 1.1 24 13.1 ± 2.3 24 52.0 ± 10 25 
Cis-platin 4.5 ± 0.8 16.0 ± 1.8 28.3 ± 1.7* 
 
 
Table 3. IC50 values (µM) of cylinders A-D, Hannon’s iron(II)  
cylinder  and cis-platin in cancer cell lines. The results represent  
the mean of 4 separate experiments ± SD (n=4) 
*experiments performed by Carlos Sanchez-Cano 
 
Cylinders A and B show good activity in all of the cell lines that were tested and 
the IC50 data are comparable to or better than those of cis-platin. The cylinders 
are also active in the cis-platin resistant cell line, consistent with their expected 
different mode of action. The mechanism by which the cylinders enter the cells 
is unknown and has not yet been investigated. However, it is unlikely that they 
enter the cells in the same was as cis-platin because they are much bigger and 
exhibit different solubility. Intriguingly the fluorinated cylinder (C) and the large 
ethynyl cylinder (D) are inactive giving IC50 values >100 μM. As the structures of 
A and B are very similar, this could indicate that it is their precise size and 
shape that is important in their activity. It is not possible to compare these 
results with those of the other literature Pd2L4 complexes as their cytotoxic 
activities have not been reported. However, comparison with Hannon’s triple-
stranded iron(II) cylinder is particularly interesting with cylinders A and B 
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showing comparable activity in the ovarian carcinoma cell lines but much higher 
activity in the T47D breast cancer cell line. 
These results demonstrate that metallo-supramolecular structures may 
be very powerful for the design of new types of anti-tumour agent. However, in 
the development of new drug candidates the potential risks of the drugs need to 
be carefully evaluated. Numerous tests need to be carried out to confirm that 
the drug is safe to use in humans.26 With this in mind, additional biological 
studies were carried out to further probe the suitability of the two more cytotoxic 
cylinders (A and B) as potential anti-cancer drugs.  
 
3.2.3 Toxicological Studies 
3.2.3.1 Bacterial Mutagenicity (Ames) Test 
A Mutagen is a chemical that causes changes to DNA, for example insertions or 
deletions of one or more of the nucleotide bases. Mutagenic substances are 
also typically carcinogenic. The Ames test is a biological assay which is used to 
assess the mutagenic potential of new drug candidates.27 A negative result in 
the Ames test indicates that the tested drug is also non-carcinogenic.  
The test utilises strains of Salmonella typhimurium (HIS-) that carry 
mutations in the genes used to synthesise histidine. Therefore, the bacteria 
require an external supply of histidine in order to grow. Addition of a mutagenic 
compound to these bacteria leads to a genetic reversion in some of the 
bacteria, resulting in a resumption in their ability to synthesise histidine. The 
Salmonella typhimurium strains used in these experiments are the TA98 strain 
and the TA100 strain which carry frameshift and base pair substitution 
mutations, respectively.28 
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Promutagens are non-mutagenic compounds that must be activated via 
a chemical modification (e.g. oxidation) in order to become mutagenic. In vivo, 
this activation process is carried out by the metabolizing enzymes of the liver. 
Bacteria do not produce the enzymes required to activate promutagens and are 
therefore treated with a mixture of rat liver enzymes (S9) in order to mimic in 
vivo metabolic activation.29 
 
 
 
 
 
 
 
 
 
 
Figure 3.13. A schematic representation of the Ames Test.30 
 
 
Figure 3.13 shows a schematic representation of the Ames test which has been 
adapted from reference 30. The bacteria and test compound were spread onto 
a minimal-agar plate (both with and without S9) and molten top-agar poured on 
top. A small amount of histidine was added to allow the bacteria to grow for a 
short period of time. When the histidine is exhausted only bacteria that have 
undergone a reverse mutation and regained their ability to synthesise histidine 
will survive. Some of the bacteria are also able to revert spontaneously so the 
results are compared with a negative control (without test compound). Positive 
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controls (consisting of a known mutagen or promutagen) were also used to 
demonstrate that the test is working and reagent controls confirm that the 
reagents used were uncontaminated. The plates were prepared in triplicate and 
incubated in the dark at 37 °C. After 48 hours the number of colonies on each 
plate was counted. As a rule of thumb: the number of revertant colonies present 
after exposure to a compound should be more than double those found in the 
negative control if the substance is to be classed as a mutagen.31  
 
3.2.3.2 Results and Discussion 
The Ames bacterial mutagenicity test was carried out on the cytotoxic cylinders, 
A and B. A range of cylinder concentrations were tested with the highest 
concentration being well over the IC50 value for each cylinder. Figure 3.14 
shows the results from the tests with the TA98 strain of Salmonella 
typhimurium.  
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The graph clearly shows that there is no dose-dependent response across the 
range of concentrations tested, both with and without S9. Even at high 
concentrations there is no significant difference in the number of colonies 
present in the negative control and in the plates containing the cylinders. 
Therefore, the result of the test is negative and cylinders A and B do not cause 
frame-shift mutations in DNA.  
Figure 3.15 shows the results obtained for the tests carried out with the 
TA100 strain of Salmonella Typhimurium. 
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Figure 3.15. Ames Test Results for cylinders A and B  
With Salmonella Typhimurium  TA100 
(Positive Controls: Promutagen- chrysoidine Y & Mutagen- sodium azide) 
 
It is well known that Salmonella Typhimurium TA100 has a naturally higher 
reversion rate than the TA98 strain and this is confirmed by these results.28 As 
with the TA98 strain, the experiments with TA100 demonstrate that there is no 
significant difference in the number of colonies present with or without the 
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cylinders. This is also the case for the experiments carried out with the S9 
enzymes. Therefore, the result of the test is negative and reveals that A and B 
do not cause base pair substitution mutations in DNA. 
The Ames test results confirm that cylinders A and B have no 
promutagenic or mutagenic effects on the Salmonella typhimurium strains 
tested. Therefore, neither of the cylinders causes base-pair substitution or 
frameshift mutations under the conditions that were used. A negative result at 
this point is invaluable as it takes the cylinders one step closer to clinical trials.  
 
3.2.3.3 Single Cell Gel Electrophoresis (Comet) assay  
Besides the Ames test, pharmaceutical companies also routinely screen for the 
genotoxicity of drug candidates by way of the comet assay.32 Originally 
described in 1984 by Ostling and Johannson, the comet assay is a simple, well 
established method used for the measurement of DNA strand breaks in 
eukaryotic cells.33 Over the years, many variations of the assay have been 
reported, each employing subtle changes to make it more suited for the 
measurement of different types of DNA damage. The procedure described here 
is the alkaline version of the comet assay reported by Singh et al. in 1988.34 
Figure 3.16 shows a schematic representation of the alkaline comet assay 
adapted from reference 35. 
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Figure 3.16. A schematic representation of the alkaline comet assay.35 
 
A2780 (ovarian) carcinoma cells were seeded in 6-well plates and treated with 
cylinders A (9 μM) and B (6 μM). Following a 24 hour treatment the cells were 
detached from the wells by gentle scrapping and suspended into low melting 
point agarose (LMPA). The suspension was spread onto a glass microscope 
slide which had been pre-coated with normal melting point agarose (NMPA). 
The LMPA was allowed to set and the slides incubated in lysis buffer for 1 hour. 
The role of the lysis buffer is to remove all of the proteins, RNA, membranes 
and cytoplasmic constituents of the cell, leaving only the supercoiled DNA or 
‘nucleoid’ behind. Following lysis, the slides were incubated in the alkaline 
Lysis 
Alkaline unwinding of DNA 
Neutralisation and Staining 
Treat cells with compound 
 
Suspend cells in LMPA and 
spread onto NMPA Cells in LMPA 
NMPA 
Glass Slide 
   -    + Electrophoresis 
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electrophoresis buffer to allow the DNA duplex to unwind. Electrophoresis was 
then carried out for 20 minutes. During electrophoresis, the intact DNA remains 
tightly wound in the nucleoid, or comet ‘head’, but the loops of DNA around any 
strand breaks migrate out towards the positively charged anode and result in 
the formation of the comet ‘tail’. Finally, the slides were stained with a solution 
of sybr gold and examined under a fluorescence microscope (Zeiss Axiovery 
10, Germany). Figure 3.17 shows fluorescence microscope images of 
undamaged and damaged A2780 nuclei. 
 
 HEAD               TAIL 
(a) (b) 
 
 
 
 
Figure 3.17. Fluorescence microscope images of carcinoma cells                            
(a) without and (b) with DNA damage.  
 
The intensity and length of the comet tail was quantified for 100 comets per 
slide and is directly proportional to the extent of DNA damage that has 
occurred.  
 
3.2.3.4 Results and Discussion 
The alkaline comet assay was used to ascertain whether the formation of DNA 
strand breaks might be involved in the mechanism of action of cylinders A and 
B. The results of the assay are shown in Figure 3.18.  
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Figure 3.18. Results of comet assay expressed in terms of the % of DNA in the 
comet tail in A2780 cells exposed to cylinders A and B and cis-platin. 
 
The results demonstrate that for cylinders A and B, the % tail intensity is not 
significantly higher than that observed in the DMSO control. Also, parallel 
experiments carried out with cis-platin showed that just 3 µM of the drug 
produced a median % tail intensity of over 5 %, much greater than is seen with 
A and B. This is a significant result as the genotoxicity of some currently 
available drugs, such as cis-platin, are responsible for the formation of 
secondary cancers (especially leukemias) in patients that are undergoing 
treatment with them.36 Therefore, the design and synthesis of drug candidates 
which are cytotoxic but not genotoxic is very important. 
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3.3 Conclusions 
Agarose gel electrophoresis experiments show that on incubation with the 
plasmid pBR322, cylinders A, B, C and D bind to and cause the unwinding of 
supercoiled DNA (C > A > D > B). AFM imaging has illustrated that A, B and D 
also cause the aggregation of ct-DNA. The MTT assay has demonstrated that A 
and B show considerable cytotoxic activity against ovarian (A2780 and 
A2780cr) & breast cancer (T47D) cell lines but cylinders C and D are inactive. 
Preliminary toxicological studies show that A and B are also non-mutagenic and 
non-genotoxic. These results are very exciting as drug candidates that possess 
cytotoxic activities against cancer cells without being mutagenic and genotoxic, 
present a considerable advancement in this research field.  
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3.4 Experimental 
3.4.1 Gel Electrophoresis  
Gel electrophoresis experiments were carried out using an Amersham 
Biosciences HE99X Max submarine kit. The agarose (Fisher) gel was prepared 
by heating 2 g of agarose (1 %) in 200 ml of TAE (1X) buffer and allowing the 
gel to cool and set. The plasmid pBR322 (New England Biolabs) was dissolved 
in ultra-pure water (1 μg/μl) and the cylinders dissolved in 2 % dmso/water 
solutions. Aliquots of the plasmid and varying amounts of complex were mixed 
together and incubated at 37 ºC for 1 hour. 4 μl of loading buffer (30 % glycerol, 
0.05% bromophenol blue and 0.025 % cyanol xylene) was added to each 
mixture and 16 μl loaded onto the agarose gel.  The gel was run in TAE (1X) 
electrophoresis buffer at 5 Vcm -1 for 180 minutes. Gel staining was performed 
in the same buffer containing ethidium bromide (0.5 mgml-1).  The gel was 
visualized using a UVIPro Platinum 2.0 system (UViDoc, Cambridge, UK) at 
312 nm. 
 
3.4.2 Atomic Force Microscopy  
The AFM images were obtained in dynamic mode using a Nanotec Electrónica 
AFM. Olympus cantilevers (RC800PSA (ORC8)) were used with a nominal 
force constant of 0.75 Nm-1 and < 20 nm nominal radius tip. The samples were 
measured in air at a scan rate of 1 Hz. Data was acquired at room temperature 
and analysed using WSxM software, which is freely distributed by Nanotec 
Electrónica (www.nanotec.es).  
Highly polarised, ct-DNA (Sigma-Aldrich) was dissolved in ultra-pure water and 
kept frozen until the day of the experiment. Stock solutions of cylinders             
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A (541 μM), B (538 μM) and D (490 μM) were made up in 5 % dmso/water on 
the day of use. Muscovite mica was purchased from Electron Microscopy 
Sciences and a flat, freshly cleaved surface prepared by lifting off the top layers 
of the mica with adhesive tape. DNA samples were prepared by depositing 8 μl 
of ct-DNA (0.002 μgμl-1) solution and 2 μl of nickel chloride (10 μM) solution 
onto the cleaved mica surface. After adsorption for 2 minutes, the surface was 
rinsed for 10 seconds in a jet of ultra-pure water and blow dried with 
compressed argon. DNA-cylinder samples were made by mixing 5 μl of ct-DNA 
with 5 μl of the required concentration of cylinder and adding 8 μl of this final 
solution to a 2 μl drop of nickel chloride (10 μM) on the mica surface. The 
solution was allowed to adhere for 2 minutes and was then washed and dried 
as previously described. 
 
3.4.3 Cell Culture 
Materials: The media were obtained from Invitrogen and the supplements were 
purchased from Sigma-Aldrich unless otherwise stated. 
The A2780 (human ovarian carcinoma) and A2780cr (cis-platin-resistant) cell 
lines were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) and the 
T47D (human breast carcinoma) cell line was maintained in Roswell Park 
Memorial Institute (RPMI-1640) medium. Both media were supplemented with 
10 % FBS (Invitrogen), 1 % L-glutamine, 1 % hepes buffer, 1 % sodium 
pyruvate and an antibiotics-antimycotic solution (1X). All three cell lines were 
cultured in T25 flasks (Nunc) and kept in a humid, 5 % CO2 atmosphere at        
37 ºC. Cells were removed from confluent monolayers by trypsinisation with      
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1 % trypsin-EDTA in PBS. The trypan blue dye exclusion test was used to 
determine the cell viability. 
 
3.4.4 Cytotoxicity Assay 
Cells were seeded in 100 μl of complete medium in 96-well microtitre plates 
(Corning Costar®). 4,000 cells/well were seeded for A2780 and A2780cr and 
25,000 cells/well were seeded for T47D.  Before treating, the cells were allowed 
to adhere to the bottom of the wells by incubating the plates at 37 ºC for          
24 hours. Due to the poor aqueous solubility of the complexes, the stock 
solutions of A, B, C and D (100 μM) were freshly prepared in solutions of 2 % 
DMSO and 98 % complete medium. Cis-platin was dissolved directly in 
complete medium.  For each concentration (50 μM, 25 μM, 12.5 μM, 6.3 μM, 
3.1 μM), 100 µl of compound was added to the 100 µl of medium and cells in 
each well. In the control groups only complete medium or complete medium 
with 2 % DMSO was added. Each experiment was performed in quadruplicate 
and independently repeated at least four times. The plates were incubated 
under standard cell culture conditions (5 % CO2 atmosphere, 37 ºC) for           
72 hours. Cell proliferation was evaluated by the addition of 50 μl MTT                
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) solution       
(5 mg/ml in PBS) to each well and incubating the plates at 37 ºC for a further    
2 hours. The medium was subsequently removed from the wells and the purple 
formazan crystals dissolved in 100 μl DMSO. The absorbance was measured at 
590 nm using a microplate reader (Bio-Rad). IC50 values were obtained by 
GraphPad Prism software, version 3.05, 2000. 
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3.4.5 Bacterial Mutagenicity Assay 
The procedure used was based on the protocol of Maron and Ames.31 All 
reagents and equipment were sterilised in advance and only one strain of 
bacteria was assayed on any one day to avoid cross contamination. 
 
Controls: Chrysoidine Y (20 μg/plate) and sodium azide (3 μg/plate) were used 
as positive controls, DMSO was used as a reagent control and PBS was 
employed as the negative control.  
 
Minimal agar (11.5 g Agar, 700 ml water, 15 ml Vogel-Bonner salts 
(MgSO4.7H2O, citric acid monohydrate, K2HPO4, NaNH4PO4.4H2O), 38 ml 40 % 
glucose) plates were prepared a week in advance to allow the agar to dry 
thoroughly. 16 hours prior to the experiment, 10 ml of nutrient broth was 
inoculated with a loopful (10 μl) of the required bacterial strain. Light was 
excluded and the bacteria were incubated on a rotary shaker at 37 °C. On the 
day of the assay the master culture was kept on ice. The top agar (0.6 g agar 
bacteriological, 0.5 g NaCl in 100 ml H20) was supplemented with 0.05 mM 
histodine and biotin (1 ml per 9 ml agar) and poured into top-agar tubes in a 
heating block set to 42 °C. The rat liver S9-mixture was freshly prepared and 
kept on ice until needed. The stock solutions and the dilutions of the test 
compounds were also freshly prepared in 100 % dmso. Compounds and 
controls were incubated with bacteria (both with and without S9) for 20 mins at 
37 ºC. The mixtures were subsequently poured onto the minimal agar plates 
with the molten top agar and incubated in the dark in an oven set to 37 °C. After 
24 hours the background bacterial lawn was checked under a microscope. After 
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a further 24 hours the plates were placed on a light-box and the bacterial 
colonies were counted. Each experiment was performed in triplicate.  
 
3.4.6 Comet Assay 
This method is based on that of Singh et al.34 1.25 X 106 A2780 carcinoma cells 
were seeded per well in 6 well plates. The plates were incubated at 37 °C, 
under standard cell culture conditions (37 ºC, 5 % CO2) for 24 hours prior to cell 
treatment. The stock solutions of the complexes were freshly prepared in 2 % 
DMSO and 98 % complete medium and directly used for dilutions. Cells were 
treated with 3 different concentrations of compound and a 2 % DMSO control. 
Cis-platin was directly dissolved in complete medium and further diluted. The 
compounds were tested up to a top concentration just above the calculated 
IC50. Following treatment the cells were incubated for 24 hours at 37 ºC. 
Subsequently, cells were washed with cold PBS and gently scraped into fresh 
PBS (1 ml). The cell suspension was centrifuged (8000 x g, 5 min) and the 
resulting pellets re-suspended in fresh PBS (100 µl). 5 µl of the re-suspended 
cells were added to a sterile eppendorf containing 300 µl low melting point 
agarose pre-warmed to 37 °C. The suspension was mixed and transferred onto 
a glass microscope slide (150 µl per slide, VWR International) which had been 
pre-coated with 0.5 % normal melting point agarose. The cell suspension was 
spread over the slide and covered using a glass coverslip (VWR International). 
The slides were put on a metal tray over ice to allow the agarose to solidify. 
After 10 minutes, the coverslips were removed and the samples incubated at     
4 ºC in cold lysis buffer (2.5 M NaCl, 0.1 M Na2EDTA, 10 mM Tris base, 1 % 
sodium N-lauryl sarcosinate, 10 % DMSO and 1 % Triton X-100) for 1 hour. 
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Following lysis, the slides were positioned in a horizontal electrophoresis tank 
containing electrophoresis buffer (300 mM NaOH and 1 mM Na2EDTA) which 
had been prepared 16 hours earlier and kept at 4 ºC. The slides were left in the 
dark for 20 minutes to allow the unwinding of DNA before electrophoresis. 
Electrophoresis was performed in the same buffer (25 V, 0.8 Vcm-1) for           
20 minutes. Slides were washed three times (5 minutes) with cold neutralising 
buffer (0.4 M Tris, adjusted to pH 7.5), stained with 50 µl Sybr gold solution 
(Invitrogen, 1X solution) and covered with coverslips. The samples were left in 
the dark at 4 °C prior to examination.  
The slides were analysed at 320X magnification using a fluorescence 
microscope (Zeiss Axiovert 10, Germany), fitted with a 515 - 560 nm excitation 
filter and a barrier filter of 590 nm. A USB digital camera (Merlin, Allied Vision 
Technologies) received the images, which were analysed using a personal 
computer-based image analysis system, Comet assay IV (Perceptive 
instruments). For each slide, one hundred randomly selected comets were 
examined and each experiment was performed in triplicate. 
 
Measurement of median percent tail DNA was chosen to assess the extent of 
DNA damage as this has been shown to experience much less inter-run 
variation than other comet parameters due to being independent of 
electrophoresis run time and voltage.  
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4.1 Introduction 
Cis-platin is a potent anticancer drug widely used in the chemotherapeutic 
treatment of testicular and ovarian cancers.1 The structure of cis-platin is shown 
in Figure 4.1 and its mode of action has previously been discussed in chapter 1 
section 1.7.3.2.  
Pt
Cl
Cl NH3
NH3
                                               
Figure 4.1. Structure of cis-platin. 
Although cis-platin is an effective drug, its clinical utility is restricted by its toxic 
side effects which include kidney damage (nephrotoxicity), nervous system 
damage (neurotoxicity), nausea and vomiting.2 Its usefulness is also limited by 
the development of acquired resistance and by the intrinsic resistance of 
cancerous tumors to the drug.3 Therefore, much attention has been devoted to 
the development of new cis-platin type antitumor agents which portray fewer 
side effects, treat a broader spectrum of cancers and remain active against    
cis-platin resistant cells. In this context, tetravalent platinum(IV) complexes,4 
sterically hindered platinum(II) complexes,5 carboxy-ligand derivatives6 and 
Schiff base ligand derivatives7 have been studied.  
In 2006, Moreno et al. developed eight mononuclear palladium(II) and 
platinum(II) complexes based on four pyridylimine ligands (Figure 4.2).8  
        
Cl
MN
N
Cl
R3 R2
R1
 
M= Pt(II) or Pd(II) 
4-ime R1= CH3; R2=R3=H  
3-ime R2= CH3; R1=R3=H  
2-ime R3= CH3; R1=R2=H  
4-iol R1= OH; R2=R3=H  
Figure 4.2. Moreno’s palladium(II) and platinum(II)  
pyridylimine compounds. 
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Moreno reported the DNA-binding studies of these compounds and compared 
them to those of cis-platin. The cytotoxicity of the platinum(II) compounds was 
also investigated (Table 4.1).  
 
  A2780 
 
A2780cr 
 
4-ime 9 52 
3-ime 8 54 
2-ime 9 50 
4-iol 5 55 
Cis-platin 2 38 
 
Table 4.1. IC50 values (µM) of Moreno’s  
platinum(II) pyridylimine compounds. 
 
Although they are not as active as cis-platin, in the cell lines tested the 
pyridylimine based compounds still showed good activity. Unfortunately, the 
cytotoxic activity of the palladium(II) compounds was not reported. 
 
4.1.1 Molecular Design 
Hannon et al. have pioneered the use of pyridylimine ligands in the formation of 
a vast range of supramolecular architectures. A library of ligands has been 
synthesised by the simple, one-step reaction of an amine with an aldehyde. Due 
to the large number of inexpensive, commercially available starting materials, 
the ligands have proved to be versatile tools in the design of complex 
supramolecular structures.9 Ligand L6 was first reported by Hannon in 1997 and 
has since been used in the synthesis of numerous dinuclear, metallo-
supramolecular complexes (Figure. 4.3).10  
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Figure. 4.3. Ligand L6. 
 
The ligand comprises of two pyridylimine binding units and is analogous to two 
of Moreno’s 4-imine ligands bound together at the R1 position (see Figure 4.2). 
The approach that was taken herein was to utilise L6 in the synthesis of 
dinuclear analogues of Moreno’s palladium(II) and platinum(II) 4-imine 
compounds in hope of further enhancing their cytotoxic activities. The design 
approach is illustrated schematically in Figure. 4.4. 
                  
 
 
 
 
      M= Pd(II) or Pt(II) 
   
Figure 4.4. Design Approach. 
 
In this chapter, the synthesis of palladium(II) and platinum(II) compounds of 
ligand L6 are reported and their DNA-binding potential investigated. The 
cytotoxicity of the novel compounds is also discussed. The techniques used in 
these investigations are circular and linear dichroism, gel electrophoresis and 
the MTT cytotoxicity assay.  
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4.1.2 Circular Dichroism Spectroscopy 
Circular dichroism (CD) is a spectroscopic technique which measures the 
difference in absorption (A) of left and right-handed circularly polarised light. It is 
used to provide information about the chirality of optically active molecules and 
can be expressed by the equation: 
 
CD = Al -Ar 
 
Chiral refers to asymmetric objects which are non-superimposable on their 
mirror-images. A pair of chiral molecules are termed enantiomers. Enantiomers 
differ in their absorption of left and right circularly polarised light resulting in the 
occurrence of induced CD signals which are equal in magnitude but opposite in 
sign. Where a racemic (50:50) mixture is present, the CD signals of each 
enantiomer will cancel out the other and no signal will be seen on the spectrum. 
Therefore, CD is often used as an indication of enantiomeric purity or excess.  
More recently, CD spectroscopy has been used to study the secondary 
structures of large biological molecules such as proteins and DNA. As 
discussed in chapter 1, DNA consists of a sugar-phosphate backbone and a 
combination of four aromatic bases. The phosphates and bases alone are 
achiral and do not produce a CD signal. However, on binding to the chiral 
sugars, all components of the DNA molecule inherit this chirality and a CD 
signal is produced. As discussed in chapter 1, DNA can portray several double 
helical conformations including A, B and Z-forms. Calf thymus (ct) DNA exhibits 
the typical characteristics of DNA with a B-conformation. A CD spectrum of      
ct-DNA is shown in Figure 4.5. 
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Figure 4.5. Circular dichroism spectrum of ct-DNA. 
 
The CD signals below 190 nm are due to the sugar molecules of the DNA 
backbone. The negative band at ~245 nm is assignable to the right-handed 
helicity of the B-DNA and the positive band at ~275 nm arises from the stacking 
of the DNA bases. CD spectroscopy can be used for probing changes in DNA 
structure caused by the binding of DNA recognition agents. 
 
4.1.3 Linear Dichroism Spectroscopy  
Linear dichroism (LD) is a spectroscopic technique which measures the 
difference in absorption (A) of light linearly polarised parallel and perpendicular 
to the direction of an orientation axis: 
 
LD = All - A┴ 
 
To measure the LD of a sample the molecules within it must be oriented. Small 
molecules require the use of strong orienting methods such as stretched film 
LD. However, longer molecules are easier to align and can often be oriented by 
mere flow. DNA (minimum length ~250 base pairs) systems are commonly 
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studied by flow LD using a couette flow cell such as the one shown in        
Figure 4.6.  
  SAMPLE CHAMBER 
 y 
ROTATING QUARTZ 
CYLINDER 
STATIONARY 
CHAMBER 
x 
z 
 
 
 
 
 
 
Figure 4.6. Schematic representation of a Couette cell. 
 
A solution of the DNA is injected into the narrow channel between the rotating 
quartz cylinder and the stationary chamber. The viscous drag created in the 
channel results in the orientation of the DNA molecules in the same direction as 
the flow. An LD spectrum of ct-DNA is shown in Figure 4.7. 
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Figure 4.7. Linear dichroism spectrum of ct-DNA. 
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The LD signal at ~260 nm corresponds to the electron transitions between the 
DNA bases which lie approximately perpendicular to the orientation of the DNA 
double helix. Any coiling or kinking of the DNA caused by the binding of 
synthetic agents is observed by changes in the LD spectrum. 
 
4.2 Results and Discussion 
4.2.1 Ligand L6 
There is literature precedent for the use of this ligand in the successful 
synthesis of an array of metallo-supramolecular architectures.9,10 
EtOH
3hrs, rt
Ligand L6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4.1. Synthesis of Ligand L6. 
 
The ligand was synthesised in ethanol via a condensation reaction between two 
equivalents of 2-pyridine carboxaldehyde and one equivalent of                
4,4’-methylenedianiline. The product precipitated as a white solid and was 
characterised by 1H NMR, 13C NMR, ESI mass spectrometry, FT-IR and 
elemental analysis (see experimental). 
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4.2.2 Synthesis of Pd2(L6)Cl4 
A DMSO solution of ligand L6 was heated at 90 °C with two equivalents of 
palladium(II) chloride for 30 minutes. On completion of the reaction a yellow 
solid was precipitated by the addition of a 1:1 chloroform:diethyl ether solution. 
The crude product was purified by washing with a range of organic solvents to 
give the pure compound in 83 % yield. 
Partial microanalytical data are consistent with a formulation 
{Pd2(C25H20N4)Cl4}n and the ESI mass spectrum shows peaks assignable to 
{Pd2L4Cl2}+ and {Pd2L4Cl}+ indicating the formation of a single-stranded, 
dinuclear compound. The charge of these peaks suggests that on electrospray 
ionisation, the palladium(II) ion can become reduced to palladium(I). The 
solution behaviour of the complex was further investigated by 1H NMR 
spectroscopy in d6-DMSO (Figure 4.8).  
      
 
 
 
 
        
(a) 
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       H6     H7                          H3          H4                           H5 
 
 
      H6                           H4            H3            H5                H7 H9/10 
 
 
Figure 4.8. 1H NMR spectra of the aromatic region of (a) Ligand L6 and  
(b) Pd2(L6)Cl4 (300 MHz, d6-DMSO, 298 K). 
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The 1H NMR spectrum shows a single set of resonances. Unsurprisingly, the 
multiplicity and integration of the signals is the same as for the free ligand, 
however, the signals in the complex are significantly downfield shifted due to 
the effects of the metal-ligand coordination. Unfortunately, attempts to grow     
X-ray quality crystals of this complex have, so far, proved unsuccessful.  
 
4.2.3 Synthesis of Pt2(L6)Cl4 
A methanolic solution of dichlorobis(dimethylsulphoxide)platinum(II)11 was 
heated under reflux prior to the addition of ligand L6. The solution was heated at 
80 °C for a further hour after which it was cooled resulting in the precipitation of 
the desired product.  
Elemental analysis data indicate that the complex has an empirical 
formula of {Pt2C25H20N4Cl4}n and the ESI mass spectrum displays peaks 
corresponding to [Pt2L6Cl2]2+ at m/z 419 and [Pt2L6Cl4 + Na]+ at m/z 931.        
D6-DMSO 1H NMR spectra of the ligand L6 and Pt2L6Cl4 are shown in Figure 
4.9. The spectrum of the complex displays a single set of signals which is 
consistent with the formation of a single solution species, symmetrically 
balanced through the central CH2 constituent. Metal-ligand complexation is 
confirmed by the downfield shift of the proton signals relative to those in the 
uncoordinated ligand. The most predominant downfield shift is for H6 and H7, 
the protons which are adjacent to the coordinating nitrogen donors.  
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Figure 4.9. 1H NMR spectra of the aromatic region of (a) Ligand L6 and 
(b) Pt2(L6)Cl4 (300 MHz, d6-DMSO, 298 K). 
 
Despite making several attempts, we were unfortunately unable to obtain X-ray 
quality crystals of this complex.  
 
4.3 Biological Studies 
4.3.1 Circular Dichroism Spectroscopy 
CD spectra of ct-DNA exhibit a positive signal at 275 nm due to the DNA base 
stacking and a negative signal at 240 nm which is characteristic of the right-
handed B-conformation of the DNA double helix.  
A CD titration experiment was carried out with ct-DNA as described in 
section 4.6.1. The concentration of the DNA (300 μM) was kept constant 
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throughout the experiment. The DNA was incubated with the compounds 
(DNA:compound ratios of 40:1, 20:1, 10:1 and 8:1) at 37 °C for 24 hours prior to 
measuring the CD spectra. The results of the titration are displayed in       
Figure 4.10. 
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Figure 4.10. CD Spectra of ct-DNA in the presence of compounds  
Pd2(L6)Cl4 and Pt2(L6)Cl4. 
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The spectroscopy of the DNA appears altered by the addition of both Pd2(L6)Cl4 
and Pt2(L6)Cl4. The basic shape of the B-DNA is retained. However, there is a 
decrease in the ellipticity of both the positive and negative bands. This is most 
dramatic for Pt2(L6)Cl4 and indicates that the orientation and stacking of the 
base pairs has been perturbed as a result of the compounds binding to the 
DNA. This disturbance is most likely due to the binding of the compounds in the 
minor groove and/or the covalent binding of the compounds to the DNA bases.  
 
4.3.2 Linear Dichroism Spectroscopy 
A flow LD titration was conducted as described in section 4.6.1. The 
concentration of the ct-DNA was kept at 300 µM throughout the experiment. 
DNA:compound aliquots were made in ratios of 60:1 to 8:1 and were incubated 
at 37 °C for 24 hours prior to measuring the LD. The results of the experiments 
are shown in Figure 4.11. 
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Figure 4.11. LD Spectra of ct-DNA in the presence of  
Pd2(L6)Cl4 and Pt2(L6)Cl4. 
 
ct-DNA alone exhibits a negative signal at 260 nm. This band corresponds to 
the electron transitions between the DNA bases which lie approximately 
perpendicular to the orientation of the DNA double helix. The titration 
experiments reveal that on addition of increasing concentrations of Pd2(L6)Cl4 
and Pt2(L6)Cl4, the magnitude of the negative band decreases. This indicates a 
loss of the DNA orientation which is consistent with compound-induced bending 
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or coiling of the DNA. The spectra of the compounds reveal that Pt2(L6)Cl4 
causes a greater decrease in the DNA signal than Pd2(L6)Cl4, indicating that it 
has a higher coiling/bending effect on the DNA.  
 
4.3.3 Agarose Gel Electrophoresis 
Gel electrophoresis was used to probe whether the compounds alter the tertiary 
structure of DNA. A detailed description of this technique can be found in 
chapter 3. Due to the low solubility of the compounds, the stock solutions were 
made up in an aqueous solution of DMSO (5 %). The circular plasmid, pBR322, 
was mixed with different ratios of the compounds and L6 (Table 1) and 
incubated at 37 °C for 24 hours.  
 
 
 
WELL 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
Base pairs: 
Compound 
 
Control  
(5 % DMSO) 
 
15/1 
 
10/1 
 
8/1 
 
6/1 
 
5/1 
 
WELL 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
Base pairs: 
Compound 
 
4/1 
 
3/1 
 
2/1 
 
15/1 
(ligand) 
 
2/1 
(ligand) 
 
Control 
(no DMSO) 
 
Table 1. Ratios of plasmid and compounds/ ligands  
used in gel electrophoresis studies 
 
The wells were loaded with the samples and loading buffer and the gel was run 
at 180 V for 3 hours. Following electrophoresis, the gel was stained with 
ethidium bromide and visualised using a UVIPro Platinum 2.0 system at        
312 nm. The resulting gels are shown in Figure 4.12. 
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             Pd2(L6)Cl4                                        Pt2(L6)Cl4 
 
 
  OC 
  NS 
 
 
WELL:        1   2   3  4   5  6   7  8  9  10 11 12                    1   2   3   4  5   6   7  8  9  12 
 
 
Figure 4.12. Agarose gel electrophoresis of pBR322 treated with ligand L6, 
Pd2L6Cl4 and Pt2L6Cl4. 
 
It is evident that the ligands alone (wells 10 & 11) have no effect on the tertiary 
structure of the plasmid. However, on incubation with the compounds, the 
mobility of both the open circular (OC) and negatively supercoiled (NS) forms of 
the plasmid have significantly changed. On increasing the concentration, both 
compounds display an increase in the migration rate of the OC form and a 
decrease in that of the NS form. This suggests that on binding to the DNA, the 
compounds cause it to kink and bend leading to the positive supercoiling of the 
DNA double helix. This phenomenon would result in the uncoiling of the NS 
DNA and the positive supercoiling of the OC form. In the case of the platinum 
compound, at the highest concentrations (wells 8 and 9) the DNA band 
disappears altogether. This implies that compound binding may prohibit the 
intercalation of the ethidium bromide dye. 
 
4.3.4 Cytotoxicity Testing  
The anti-cancer properties of the compounds were tested via the MTT cell 
viability assay. The effect of the compounds were examined on the human 
breast cancer cell line T47D and the ovarian cancer cell lines A2780 and its cis-
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platin resistant subline A2780cr. The IC50 values of the compounds are listed in 
Table 2 and are compared to those of cis-platin. 
 
 A2780 A2780cr T47D 
Pd2(L6)Cl4 54.0 ± 1.0 >100 75.2 ± 1.3 
Pt2(L6)Cl4 39 ± 1.9 >100 58.3 ± 1.1 
Cis-platin 4.5 ± 0.8 16.0 ± 1.8 28.3 ± 1.7 
 
Table 2. IC50 values (µM) of cis-platin and Pd2(L6)Cl4 and Pt2(L6)Cl4 in ovarian 
and breast cancer cell lines 
 
In the A2780 and T47D cell lines, Pt2(L6)Cl4 is the more active of the dinuclear 
compounds. However, in the A2780cr cell line, both compounds appear to be 
inactive. In all three cell lines, Pd2(L6)Cl4 and Pt2(L6)Cl4 are unfortunately less 
active than cis-platin. The activity of Pt2(L6)Cl4 is also less than Moreno’s      
Pt(4-imine)Cl2 compound. This lower activity may be due to the compounds 
entering the cells via different mechanisms or because they have different 
modes of action. 
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4.4 Conclusions 
Two novel dinuclear, cis-platin type compounds have been synthesised and 
characterised. The results of this study reveal that both Pd2(L6)Cl4 and 
Pt2(L6)Cl4 bind to ct-DNA, disturbing the orientation and stacking of the 
nucleotide base pairs. However, the B-conformation of the DNA is retained. Gel 
electrophoresis studies suggest that the compounds cause the DNA plasmid, 
pBR322, to kink and bend. At high concentrations, Pt2(L6)Cl4 may also be 
intercalating between the DNA base pairs. The MTT assay showed that the 
compounds are active in the A2780 and T47D cell lines, although they were 
inactive in the cis-platin resistant cell line A2780cr. Unfortunately, the 
compounds proved less active than cis-platin in all three cell lines.  
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4.5 Experimental 
4.5.1 General  
All solvents and reagents were purchased from Aldrich, Fisher and Fluorochem 
and were used without further purification. 1H NMR spectra were recorded on 
AC300, AV300 and AV400 Brüker spectrometers and processed using standard 
Brüker software. Infrared spectra were recorded from KBr pellets on a Perkin 
Elmer Paragon 1000 FTIR spectrometer. Electrospray Ionisation (ESI) spectra 
were recorded on a Micromass LCT Time of flight mass spectrometer in positive 
ionization mode. Microanalyses data were obtained using a CE Instruments 
EA1110 elemental analyser.  
 
4.5.2 Synthesis of Ligand (L6)10 
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FW: 376.45   
 
 
 
 
2-Pyridine carboxaldehyde (1.4 ml, 15.1 mmol) and 4,4’-methylenedianiline 
(1.50 g, 7.6 mmol) were stirred together in ethanol (28 ml) for 3 hours. The 
precipitate was isolated by vacuum filtration and washed with cold ethanol. The 
crude material was recrystallised from hot ethanol, filtered and dried in vacuo 
over P4O10 to give the cream product (2.44 g, 86 % yield). 
1H NMR (300 MHz, CDCl3, 298 K): δ 8.73 (2H, d, J= 4.5 Hz, H6), 8.65 (2H, s, 
H7), 8.23 (2H, d, J= 7.6 Hz, H3), 7.83 (2H, td J= 7.6, 1.6 Hz, H4), 7.39 (2H, ddd,         
J= 7.6, 4.5, 1.6 Hz, H5), 7.29 (8H, m, H9 &10), 4.07 (2H, s, H12). 
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13C NMR (400 MHz, CDCl3, 300 K): δ 162.0 C7, 156.6 C2/8/11, 151.6 C6, 151.0 
C2/8/11, 141.7 C2/8/11, 138.6 C4, 131.7 C9/10, 127.0 C5, 123.8 C3, 123.3 C9/10. 
Mass Spectrum (E.S.I): m/z 377.0 {L + H}+.  
Elemental analysis (%) calculated for C25H20N4: C: 79.8; H: 5.4; N: 14.9; 
Found: C: 79.9; H: 5.4; N: 14.8.  
IR (KBr): ν= 3062(w), 2927(w), 1625(m), 1582(s), 1566(w), 1503(s), 1466(s), 
1434(s), 828(s), 818(w), 784(s), 742(m) cm-1. 
 
4.5.3 Synthesis of Pd2(L6)Cl4 
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Pd2C25H20N4Cl4 
FW: 731.10 
Ligand L6 (0.015 g, 0.04 mmol) and palladium(II) chloride (0.014 g, 0.08 mmol) 
were dissolved in DMSO (3 ml) and heated at 90 °C for 30 minutes. The 
solution was filtered and a yellow solid precipitated on the addition of a 1:1 
solution of chloroform:diethyl ether. The crude product was washed with 
chloroform, methanol and diethyl ether and dried in vacuo over P4O10 to afford 
the pure yellow compound (24 mg, 83 % yield).  
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.05 (2H, d, J= 5.7 Hz, H6), 8.73 (2H, 
s, H7), 8.39 (2H, td, J= 8.0, 1.2 Hz, H4), 8.15 (2H, d, J= 8.0 Hz, H3), 7.95-7.90 
(2H, m, H5), 7.37-7.31 (8H, m, H9 & 10), 4.04 (2H, s, H12). 
Mass Spectrum (E.S.I): m/z 660.0 {Pd2LCl2}+, 625.0 {Pd2LCl}+. 
Elemental analysis (%) calculated for Pd2C25H20N4Cl4: C: 41.1; H: 2.8; N: 7.7; 
Found: C: 41.4; H: 2.8; N: 7.2. 
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IR (KBr): ν= 2921(w), 1637(m), 1618(s), 1598(m), 1501(s), 1474(w), 1445(w), 
1416(w), 866(w), 821(w), 789(m), 775(s) cm-1. 
UV/Vis (DMSO): λmax (nm) = 257, 335. 
 
4.5.4 Synthesis of Pt2(L6)Cl4 
6
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Pt2C25H20N4Cl4 
FW: 908.42 
Dichloro(dimethylsulphoxide)platinum(II)11 (0.034 g, 0.08 mmol) was dissolved 
in methanol (3 ml) and stirred under reflux for 1 hour. A methanolic solution     
(5 ml) of ligand L6 (0.015 g, 0.04 mmol) was added and the solution stirred at  
80 oC for another hour. On cooling, an orange solid precipitated from the 
solution. The crude product was collected by vacuum filtration, washed with 
methanol, chloroform and diethyl ether and dried over P4O10 (32 mg,                
87 % yield).  
1H NMR (300 MHz, (CD3)2SO, 298 K): δ 9.46 (2H, d, J= 5.9 Hz, H6), 9.33 (2H, 
s, H7), 8.43 (2H, td, J= 7.7, 1.1 Hz, H4), 8.18 (2H, d, J= 7.7 Hz, H3), 8.01-7.94 
(2H, m, H5), 7.45-7.41 (8H, m, H9 & 10), 4.10 (2H, s, H12). 
Mass Spectrum (E.S.I): m/z 931.0 {Pt2LCl4 + Na}+, 418.7 {Pt2LCl2}2+. 
Elemental analysis (%) calculated for Pt2C25H20N4Cl4: C: 33.1; H: 2.2; N: 6.2; 
Found: C: 32.9; H: 1.9; N: 5.9.  
IR (solid): ν= 3429(br), 2919(w), 2850(w), 2360(w), 2343(w), 1625(s), 1582(s), 
1566(m), 1503(s), 1467(s), 1434(s), 1384(m), 1348(m) cm-1. 
UV/Vis (DMSO): λmax (nm) = 258, 284, 330. 
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4.6 Experimental for Biological Testing 
4.6.1 Circular Dichroism and Linear Dichroism 
Ultra-pure (18.2 MΩ cm-1) water was used in all CD and LD experiments. Highly 
polarised, ct-DNA (Sigma-Aldrich) was dissolved in ultra-pure water and the 
stock solutions kept frozen until the day of the experiment. The absorbance of 
the DNA was measured at 260 nm using UV-Vis spectroscopy and its 
concentration determined using the Beer-Lambert law (molar-extinction 
coefficient of 6600 mol-1 dm3 cm-1 per DNA base).  
Stock solutions of the compounds (300 μM) were made in 5 % DMSO/water 
and 1000 µl aliquots of ct-DNA (100 μM) were made using ultra-pure water, 
sodium chloride (20 mM) and sodium cacodylate buffer (0.89 mM, pH 6.8). 
Aliquots of the DNA and compound were mixed together in different ratios 
(DNA:compound of 60:1 to 8:1) and incubated at 37 ºC for 24 hours. Circular 
dichroism spectra were recorded on a Jasco J-810 spectropolarimeter using 1 
cm pathlength cuvettes. Linear dichroism Flow spectra were collected in a 
Jasco J-715 spectropolarimeter adapted for LD measurements using a flow 
couette cell (Krometek) with a 1 mm pathlength. In between titrations the 
cuvette and couette cell were washed thoroughly with water and ethanol and 
dried well with a stream of nitrogen.  
 
 
4.6.2 Gel Electrophoresis  
Gel electrophoresis experiments were carried out using an Amersham 
Biosciences HE99X Max submarine kit. The agarose (Fisher) gel was prepared 
by heating 2 g of agarose (1 %) in 200 ml of TAE (1X) buffer (Sigma) until it 
dissolved. The gel then was allowed to cool in a gel tray (21-15 cm) containing 
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a 15-tooth comb which was used to form the wells. The plasmid pBR322 (New 
England Biolabs) was dissolved in ultra-pure water (1 μg/μl) and the 
compounds dissolved in 5 % DMSO/water solutions. Varying ratios of the 
plasmid and compound/ligand (base pairs:compound of 15:1 to 2:1) were mixed 
together (16 μl) and incubated at 37 ºC for 24 hours. 4 μl of loading buffer (30 % 
glycerol and 0.25 % bromophenol blue in ultra-pure water) was added to each 
mixture and 16 μl loaded onto the agarose gel.  The gel was run in TAE (1X) 
electrophoresis buffer at 180 V and 125 mA for 3 hours. Gel staining was 
performed in the same buffer containing 1 ml of ethidium bromide solution     
(0.5 mg/ml).  The gel was visualized using a UVIPro Platinum 2.0 system 
(UViDoc, Cambridge, UK) at 312 nm. 
 
4.6.3 Cell Culture 
Materials: The media were obtained from Invitrogen and the supplements were 
purchased from Sigma-Aldrich unless otherwise stated. 
The A2780 (human ovarian carcinoma) and A2780cr (cis-platin-resistant) cell 
lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) and the 
T47D (human breast carcinoma) cell line was maintained in Roswell park 
memorial institute (RPMI-1640) medium. Both media were supplemented with 
10 % FBS (Invitrogen), 1 % L-glutamine, 1 % hepes buffer, 1 % sodium 
pyruvate and an antibiotics-antimycotic solution (1X). All three cell lines were 
cultured in T25 flasks (Nunc) and kept in a humid, 5 % CO2 atmosphere at       
37 ºC. Cells were removed from confluent monolayers by trypsinisation with      
1 % trypsin-EDTA in PBS. The trypan blue dye exclusion test was used to 
determine the cell viability. 
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4.6.3.1 Cytotoxcity Assay 
Cells were seeded in 100 μl of complete medium in 96-well microtitre plates 
(Corning Costar®). 4,000 cells/well were seeded for A2780 and A2780cr and 
25,000 cells/well were seeded for T47D.  Before treating, the cells were allowed 
to adhere to the bottom of the wells by incubating the plates at 37 ºC for          
24 hours. Due to the poor aqueous solubility of the compounds, the stock 
solutions of Pd2(L6)Cl4 and Pt2(L6)Cl4 were freshly prepared in solutions of 2 % 
DMSO and 98 % complete medium. Cis-platin was dissolved directly in 
complete medium.  For each concentration, 100 µl of compound was added to 
the 100 µl of medium and cells in each well. In the control groups only complete 
medium or complete medium with 2 % DMSO was added. Each experiment 
was performed in quadruplicate and independently repeated at least three 
times. The plates were incubated under standard cell culture conditions for      
72 hours. Cell proliferation was evaluated by the addition of 50 μl MTT                
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) solution       
(5 mg/ml in PBS) to each well and incubating the plates at 37 ºC for a further      
2 hours. The medium was subsequently removed from the wells and the purple 
formazan crystals dissolved in 100 μl DMSO. The absorbance was measured at 
590 nm using a microplate reader (Bio-Rad). IC50 values were obtained using 
GraphPad Prism software, version 3.05, 2000. 
 
 
 
 
 
 163
Chapter 4 
4.7 References 
1. D. T. Sleijfer, S. Meijer, N. H. Mulder, Pharm. Weekbl. Sci., 1985, 7,     
237-244. 
2. B. J. S. Sanderson, L. R. Ferguson, W. A. Denny, Mutat. Res., 1996, 
355, 59-70; T. Boulikas, A. Pantos, E. Bellis, P. Christofis, Cancer 
Therapy, 2007, 5, 537-583. 
3. C. A. Rabik, M. E. Dolan, Cancer Treat Rev., 2007, 33, 9-23; V. Brabec, 
J. Kasparkova, Drug Resistance Updates, 2005, 8, 131–146;                
D. J. Stewart, Crit. Rev. Oncol./Hematol., 2007, 63, 12–31. 
4. G. N. Kaludjerović, D. Miljković, M. Momcilović, V. M. Djinović,              
M. Mostarica Stojković, T. J. Sabo, V. Trajković, Int. J. Cancer, 2005, 
116, 479–486; V. Horváth, O. Blanárová, L. Švihálková-Šindlerová,       
K. Souček, J. Hofmanová, P. Sova, A. Kroutil, P. Fedoročko, A. Kozubík, 
Gynecol. Oncol., 2006, 102, 32–40. 
5. K. T. Flaherty, J. P. Stevenson, M. Redlinger, K. M. Algazy,                
B. Giantonio, P. J. O'Dwyer, Cancer Chemother. Pharmacol., 2004, 53, 
404-408.   
6. R. Canetta, M. Rozencweig, S. K. Carter, Cancer Treat Rev., 1985, 12, 
125-36. 
7. O. E. Offiong, E. Nfor, A. A. Ayi, S. Martelli, Transition Met Chem., 2000, 
25, 369-373; M. A. Ali, A. H. Mirza, R. J. Butcher, M. T. H. Tarafder,       
T. B. Keat , A. M. Ali, J. Inorg. Biochem, 2002, 92, 141-148.   
8.  G. García-Friaza, A. Fernández-Botello, J. M. Pérez, M. J. Prieto,          
V. Moreno, J. Inorg. Biochem, 2006, 100, 1368-1377.   
9. L. J. Childs, N. W. Alcock, M. J. Hannon, Angew. Chem., Intl. Ed., 2001, 
40, 1079-1081; F. Tuna, J. Hamblin, G. Clarkson, W. Errington,             
N. W. Alcock, M. J. Hannon, Chem., Eur. J., 2002, 8, 4957-4964;           
F. Tuna, J. Hamblin, A. Jackson, G. Clarkson, N. W. Alcock,                
M. J. Hannon, Dalton Trans., 2003, 2141-2148; M. J. Hannon,                
L. J. Childs, Supramol. Chem., 2004, 16, 7-22; L. C. Childs, M. Pascu,   
A. J. Clarke, N. W. Alcock, M. J. Hannon, Chem. Eur. J., 2004, 10,   
4291-4300; C. Uerpmann, J. Malina, M. Pascu, G. J. Clarkson,              
V. Moreno, A. Rodger, A. Grandas, M. J. Hannon, Chem. Eur. J., 2005, 
11, 1750-1756;  M. Pascu, G. J. Clarkson, B. M. Kariuki, M. J. Hannon, 
 164
Chapter 4 
Dalton Trans., 2006, 22, 2635-2642; G. I. Pascu, A. C. G. Hotze,           
C. Sanchez Cano, B. M. Kariuki, M. J. Hannon, Angew. Chem. Int. Ed., 
2007, 46, 4374-4378; A. C. G. Hotze, B. M. Kariuki, M. J. Hannon, 
Angew. Chem., Int. Ed., 2006, 45, 1. M. J. Hannon, L. Cardo, Inorganica 
Chimica Acta., 2009, 362, 784–792. 
10. M. J. Hannon, C. L. Painting, A. Jackson, J. Hamblin, W. Errington, 
Chem. Commun., 1997, 1807-1808.  
11. J. H. Price, A. S. Williamson, R. F. Schramm, B. B. Wayland, Inorg. 
Chem., 1972, 11, 1280-1284. 
 165
Chapter 5 
 
 
 
 
 
 
 
Chapter 5 
Silver(I) Supramolecular Polymers 
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5.1 Introduction 
For almost half a decade, the principles of supramolecular chemistry have been 
employed in the design and synthesis of a multitude of complex molecular 
architectures. The approach exploits the self-assembly of small molecular 
subunits into larger arrays via non-covalent interactions such as hydrogen 
bonding, π-π stacking, van der Waals forces and metal-metal interactions.1  
 
5.1.1 Research Aims 
In chapter 2, the synthesis of a range of palladium(II) and platinum(II) 
supramolecular structures using bis-pyridyl ligands was described. The purpose 
of this chapter is to explore the coordination chemistry of silver(I) with three of 
these ligands- L1, L2 and L5 (Figure 5.1).  
 
 
L1 L2
L5
Figure 5.1. Bis-pyridyl ligands L1, L2 and L5. 
 
Silver(I) is attractive as it can adopt various coordination numbers from two to 
six and is accompanied by a variety of coordination geometries such as linear, 
trigonal, tetrahedral and octahedral. However, this also makes it difficult to 
predict and control the structure of the resulting complexes. Therefore, the 
reaction of silver(I) with ligands L1, L2 and L5 could result in the synthesis of 
discrete structures such as double, triple or quadruply-stranded helicates or 
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prismatic cages (discussed in chapter 1), or another possibility is the formation 
of metallo-supramolecular polymers.2  
 
5.1.2 Metallo-Supramolecular Polymers 
Metallo-supramolecular polymers (MSPs) are attracting a great deal of attention 
due to their potential to be used in a range of applications including electrical 
conductivity,3 catalysis,4 enantiomeric separation5 and light-emitting devices6. 
They are formed by self assembly and consist of monomer units that are 
normally held together by reversible metal-ligand interactions (Scheme 5.1). 
This reversibility enables the polymers to lengthen, shorten and rearrange, 
making them potentially self-healing.7 
 
 
    
n-1  
 
Scheme 5.1. Schematic representation of a metallo-supramolecular polymer.  
M represents a metal ion and U represents a monomer. 
 
This chapter focuses on the reactions of silver(I) with ligands L1, L2 and L5, 
which might result in the formation of MSPs. To gain insight into the type of 
structures that could be formed, some examples of silver(I) supramolecular 
polymers generated from bis-pyridyl ligands are reviewed herein. 
 Zhao et al. have reported the synthesis of a heterocyclic ligand (La') 
containing sulphur and nitrogen donor atoms (Figure 5.2).8  
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Figure 5.2. Zhao’s Ligand La'. 
On reaction of this ligand with silver(I), a cationic supramolecular polymer was 
formed. However, due to steric effects, the nitrogen atoms in the quinoxaline 
and the sulphur atoms do not coordinate to the metal ions. The pyridyl nitrogen 
atoms do coordinate and are forced to bind to two different silver(I) ions 
resulting in the formation of the polymer (Figure 5.3). 
 
 
Figure 5.3. Zhao’s silver(I) supramolecular polymer.  
 
Kawano and co-workers have used ligand Lb' to generate a silver(I) 
supramolecular polymer. The rigid bis-pyridyl ligand adopts a trans orientation, 
resulting in the formation of a one dimensional chain with a helical conformation 
(Figure 5.4).9 
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  (a) 
 
 
 
(b) 
 
 
 
Figure 5.4. (a) Kawano’s ligand Lb' and (b) Silver(I) supramolecular polymer. 
 
 
The polymer consists of two types of silver(I) ions, one is bound to two pyridine 
nitrogen atoms and a nitrate anion and the other to two pyridine nitrogen atoms, 
a nitrate anion and a water molecule.  
 The bis-pyridyl ligand Lc', reported by Hannon et al., is based on a     
1,5-naphthalene spacer which sterically prevents the formation of dinuclear 
species with tetrahedral metal ions. On reaction of this ligand with silver(I) 
acetate a chiral isotactic polymer was formed (Figure 5.5).10 
N N
NN
 
 
 
 
 
 
Figure 5.5. Hannon’s silver(I) chiral isotactic polymer.  
 170
Chapter 5 
The counter-ion of this complex was exchanged for trifluoromethanesulfonate 
and on crystallisation, two types of crystals were observed. One of them 
corresponded to an isotactic polymer analogous to that shown in Figure 5.5 and 
the other corresponded to the achiral syndiotactic polymer shown in Figure 5.6.  
This shows that the counter-ion can play a vital role in determining the solid-
state structure adopted. 
  
Figure 5.6. The X-ray crystal structure of  
Hannon’s silver(I) achiral syndiotactic polymer. 
 
More recently, Paine and co-workers reported the synthesis and 
characterisation of three silver(I) polymers formed from ligands Ld', Le' and Lf' 
(Figure 5.7).11 
 
 
 
 
 
 
 
 
 
Figure 5.7. Paine’s ligands and silver(I) supramolecular polymers. 
 
 
 
 
 
Ld' 
 
 
 
 
 
Le' 
 
 
 
 
 
 
Lf' 
 
 
 
 
 
 Ag(I) 
 Ag(I) 
 Ag(I) 
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The X-ray crystal structures showed that on reaction with silver(I), ligand Ld' 
had formed an achiral syndiotactic polymer analogous to Hannon’s, whereas 
ligands Le' and Lf' had formed chiral isotactic polymers. These results 
demonstrate how changes in the structure of the ligand can have a big impact 
on the geometry of the final product.  
 
5.2 Results and Discussion 
5.2.1 Silver(I) complexes of L1  
Silver(I) was coordinated to ligand L1 by the reaction of silver(I) 
hexafluorophosphate with one equivalent of L2 for 3 hours. The reaction was 
conducted in the dark and resulted in the precipitation of the product in 73 % 
yield. The same product was also obtained from a 1:2 metal:ligand ratio 
reaction. 
 The FT-IR spectrum clearly shows an absorption band at 825 cm-1 which 
is characteristic of non-coordinated hexafluorophosphate vibrations. Elemental 
analysis data show that this complex has an empirical formula of 
{Ag(C23H18N2)(PF6)}n. Unfortunately, despite trying several conditions, the  ESI 
mass spectra from acetonitrile or nitromethane solutions were uninformative as 
the samples did not fly well. 1H NMR spectra of the complex have been 
recorded in both deuterated acetonitrile and nitromethane solutions. At room 
temperature, a single set of resonances is observed in both solvents indicating 
the formation of a single solution species (Figure 5.8). 
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Figure 5.8. 1H NMR spectrum of the aromatic region of  
{Ag(C23H18N2)(PF6)}n (300 MHz, d3-nitromethane, 298 K). 
 
The flexibility of the silver(I) coordination sphere leads to the formation of 
complexes with reversible Ag(I)-ligand interactions. This reversibility enables 
the resulting structures to lengthen, shorten and reorganize (potentially         
self-healing).4 Low temperature NMR experiments were carried out to explore 
the possibility that the silver(I) complex of L1 contains more than one rapidly     
inter-converting species (Figure 5.9).  
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Figure 5.9. 1H NMR spectra of the aromatic region of {Ag(C23H18N2)(PF6)}n  
at 243 K, 263 K and 283 K  (400 MHz, d3-acetonitrile). 
 
The low temperature NMR spectra show a downfield shift of the H4 and H5 
signals, however, this is probably because the rotation of the pyridine rings 
slows down on decreasing the temperature. Even at 243 K, the peaks remain 
sharp indicating that if more than one species is present, they are in rapid 
exchange on the NMR timescale. 
Recrystallisation from acetonitrile by the slow diffusion of diethyl ether 
presented colourless crystals suitable for X-ray diffraction studies.12 The crystal 
structure is shown in Figure 5.10. In contrast to what was seen in solution, the 
solid state structure reveals two distinct, cationic coordination polymers, P1 and 
P2.  
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(c) 
(b) 
(a) 
Polymer 1 (P1) 
Polymer 2 (P2) 
Figure 5.10. Silver(I) complex of L1 (a) unit cell (b) polymeric chains (c) 
additional view exhibiting zigzag motif. Hydrogen atoms are omitted for clarity. 
 
Both of the polymers display zigzag architecture but differ in their coordination 
environment. In P1, the metal centres adopt an almost linear (Npy-Ag-Npy = 
176.97(13)°), two-coordinate environment with 1:1 metal:ligand stoichiometry. 
Each silver(I) ion is bound to two separate pyridyl ligands with typical Ag-Npy 
bond lengths of 2.133(3) Å and a Ag···Ag separation of 15.0 Å. The silver(I) ions 
also make weak contacts to the PF6- counter-ions (Ag···F 3.16 Å, Ag···F-P angle 
162º). Conversely, the cationic chain of P2 is based on a 
{Ag(C23H18N2)(CH3CN)}∞ repeating unit in which the silver(I) centres occupy a 
three-coordinate, distorted trigonal planar geometry. The silver(I) ions are 
bound to two nitrogen atoms from the organic ligands (Ag-Npy = 2.159(3) Å) and 
one from an acetonitrile molecule (Ag-NMeCN = 2.489(4) Å) resulting in a        
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Npy-Ag-Npy bond angle of 158.30(12)° and Npy-Ag-NMeCN bond angles of 
98.37(13)° and 103.11(13)°. As in P1, the bridging ligands separate the silver(I) 
ions by a distance of 15.0 Å. The crystal packing of the polymers is shown in 
Figure 5.11.  
  (a) 
 (b) 
 (c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11. Packing in cationic sheets of (a) P1 (b) P2 and (c) P1 + P2 
Hydrogen atoms, anions and solvent molecules have been omitted for clarity. 
 
The polymeric chains are aggregated into two dimensional pleated sheets, each 
consisting of repeating units of P1 (Figure 5.11 (a)) or P2 ((Figure 5.11 (b)). 
These well-defined sheets run antiparallel to one another and the gaps between 
them are occupied by counter-ions and solvent molecules. There are also a 
number of short F···H contacts between the PF6- counter-ions and the protons 
of the organic and acetonitrile ligands (2.5-2.9 Å). Remarkably, despite the large 
Chapter 5 
number of aromatic residues, there does not seem to be any significant π-π 
stacking interactions between the polymers (shortest π-π centroid-centroid 
distances are 4.3 Å in P1 and 3.8 Å in P2).5 
 
5.2.2 Silver(I) complex of L2  
The silver(I) complex of Ligand L2 was self-assembled by the reaction of 
silver(I) hexafluorophosphate with one equivalent of the ligand in 
methanol:chloroform (1:1). The reaction took place over 3 hours with the 
exclusion of light.  
 In contrast to the silver(I) complex of L1 for which a mass spectrum could 
not be recorded, it was possible to record an ESI mass spectrum of this 
complex from an acetonitrile solution. The spectrum shows peaks 
corresponding to the dinuclear species [Ag2(L2)2(PF6)]+ (m/z 1009) and the 
mononuclear species  [Ag(L2)2]+ (m/z 757) and  [Ag(L2)(CH3CN)]+ (m/z 472). 
Although this may indicate the presence of multiple distinct complexes in 
solution, the peaks may be due to fragmentation of a high molecular weight 
polymer. Partial microanalytical data are consistent with a formulation 
{Ag(C22H16N2O)(PF6)}n and a FT-IR spectrum confirms the presence of 
hexafluorophosphate anions by the occurrence of a strong absorption band at 
836 cm-1. 1H NMR spectra of the complex have been recorded in both 
deuterated acetonitrile and nitromethane solutions. At room temperature, a 
single set of peaks were observed in each case. The 300 MHz 1H NMR 
spectrum of this complex in d3-nitromethane is shown in Figure 5.12.  The 
spectrum is analogous to that of {Ag(L1)(PF6)}∞ with the pyridyl protons occurring 
at similar chemical shifts.  
 177
Chapter 5 
        
6
3
5
4
2
7
8
9
10
N
O
N  
 H2                       H6         H4                                        H5                                                                      
H8/9                    H8/9  
 
 
 
 
Figure 5.12. 1H NMR spectrum of {Ag(C22H16N2O)(PF6)}n 
(300 MHz, d3-nitromethane, 298 K). 
 
The ESI mass spectrum of this complex suggested that multiple solution 
species might be present, this was investigated by carrying out low temperature 
NMR experiments in d3-acetonitrile. At lower temperatures the peaks remain 
sharp, being consistent either with a single solution species or with the 
presence of multiple species inter-converting rapidly within the temperature 
range of this solvent (Figure 5.13).  
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Figure 5.13. 1H NMR spectra of the aromatic region of {Ag(C22H16N2O)(PF6)}n   
at 243 K, 263 K and 283 K  (400 MHz, d3-acetonitrile). 
 
X-ray quality, colourless crystals were obtained by the slow diffusion of diethyl 
ether into an acetonitrile solution of this complex. The crystal structure revealed 
a linear polymeric chain with 1:1 metal:ligand stoichiometry (Figure 5.14).12 
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  Polymer 3 (P3) 
 
Figure 5.14. (a) Perspective view and (b) space-filling representation of polymer 
3. Hydrogen atoms, solvent molecules and anions are omitted for clarity. 
 
Polymer 3 is based on a {Ag(C22H16N2O)(PF6)} repeating unit in which all of the 
silver(I) centres are equivalent and occupy a linear, two-coordinate 
environment. The silver(I) centres are bound to two pyridyl units from two 
separate ligands with inter-metallic distances of 18.4 Å. The Npy-Ag-Npy bonds 
of the polymer are perfectly linear with bond angles of 180.00(2)º and typical 
Ag-Npy bond lengths at 2.141(13) Å and 2.142(14) Å. The cationic chains are 
packed together as shown in Figure 5.15.  
 
 
 
 
 
 
 
 
Figure 5.15. Packing diagram for polymer 3 showing the π-π stacking 
interactions between the phenyl rings. Hydrogen atoms, anions and solvent 
molecules have been removed for clarity. 
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The polymeric chains are interconnected into sheets supported by extensive 
face-to-face π-π stacking interactions. The interactions are between two parallel 
pyridyl rings from neighbouring chains with centroid-centroid distances of 3.6 Å. 
There are also secondary interactions between the phenyl rings of the spacers 
and the Ag(I) ions of the adjacent chains. As is typical for Ag···π interactions, η2 
rather than η6 coordination is observed; however, the shortest Ag···Cphenyl 
distance (3.2 Å) is towards the long end of the range proposed for such 
interactions (Munakata et al. proposed an upper limit of 3 Å) and it is unclear 
whether this contributes significantly to the bonding. Disordered 
hexafluorophosphate counter-ions and non-coordinating solvent molecules are 
located in the channels between the polymer sheets. 
In P3 the pyridyl binding sites adopt a syn-conformation and are oriented 
towards the central aromatic spacer (Figure 5.16 (a)). L2 can also adopt two 
other conformations in the solid state, these are shown in Figure 5.16 (b) and 
(c). 
  (a) 
  (c) 
  (b)
 
 
 
 
 
 
 
 
 
Figure 5.16. (a) Syn-orientation of ligand in silver(I) complex of L2 
(b) anti-conformation of L2 (c) other syn-orientation of L2. 
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Contrary to what is seen in the crystal structure of P3, ligand L1 adopts an     
anti-conformation in P1 and P2. The conformational flexibility of these ligands 
arises from the rotation about the pyridyl-phenyl bond and plays an important 
role in enabling the analogous ligands L1 and L2 to bind to silver(I) with different 
orientations. 
 
5.2.3 Silver(I) complex of L5  
One equivalent of ligand L5 was reacted with silver(I) hexafluorophosphate to 
afford a white solid in 68 % yield. FT-IR spectroscopy shows a strong 
absorption band at 821 cm-1; this is characteristic of non-coordinated 
hexafluorophosphate anions. The elemental analysis data are consistent with a 
formulation {Ag(C24H20N2)(PF6)}n and the ESI mass spectrum is dominated by 
peaks corresponding to [Ag2L2(PF6)]+ (m/z 1033), [AgL(CH3CN)]+ (m/z 484) and 
[AgL]+ (m/z 443). The 1H NMR spectra in d3-acetonitrile and d3-nitromethane 
revealed one set of peaks indicating the formation of a single, symmetrical 
solution species. The 1H NMR spectrum in d3-acetonitrile is presented in Figure 
5.17. The spectrum is similar to the room temperature spectra of {Ag(L1)(PF6)}∞ 
and {Ag(L2)(PF6)} ∞ in this solvent and the pyridyl protons occur at almost exactly 
the same chemical shifts. This indicates that a polymeric structure may have 
also formed with Ligand L5. On cooling the sample down to 243 K, a single, 
sharp set of resonances was still observed. 
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Figure 5.17. 1H NMR spectrum of the aromatic region of  
{Ag(C24H20N2)(PF6)}n (300 MHz, d3-acetontrile, 298 K). 
 
Small, colourless crystals were obtained by the slow diffusion of diethyl ether 
into an acetonitrile solution of the complex. Single crystal X-ray diffraction 
analysis revealed a 1:1 metal:ligand zigzag coordination polymer (Figure 
5.18).12 
  Polymer 4 (P4) 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 5.18. X-ray crystal structure of polmer 4.  
Hydrogen atoms are omitted for clarity. 
 
In P4, each silver(I) centre occupies a linear coordination environment (Npy-Ag-
Npy = 179.0(4)º and 175.2(3)º) and is bound to pyridyl binding units from two 
different ligands. These bridging ligands separate the metal centres by a 
distance of  19.1 Å and the Ag-Npy bond lengths (2.120(8)-2.142(8) Å) are 
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unremarkable and analogous to those found in P1, P2 and P3. Within the 
ligands, the phenyl rings are twisted with respect to one another (46º and 47º) 
and with respect to the pyridine rings (6º, 17º, 21º, 28º). The zigzag chains pack 
together into layers as shown in Figure 5.19. 
      (a) 
 
 
 
 
 
 
               (b) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19. Crystal packing diagram for polymer 4 showing the packing in     
(a) one layer and (b) multiple layers (view approximately orthogonal to (a)). 
Hydrogen atoms, anions and solvent molecules have been removed for clarity. 
 
The zigzag polymers pack together to form two dimensional layers (Figure 5.19 
(a)). Within the layers the cationic chains are linked together by π-π stacking 
interactions (centroid-plane distance= 3.4 - 3.7 Å). Figure 5.19 (b) shows that 
the polymer layers pack together in a three dimensional network to form open 
channels. These channels are occupied by acetonitrile solvent molecules and 
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the PF6- counter-ions. The acetonitrile molecules interact with the silver(I) ions 
through weak Ag···NMeCN contacts (3.3 Å). There are also a number of short 
F···H contacts between the counter-ions and the protons of the pyridine and 
phenyl rings (2.4-2.5 Å).  
 
5.3 Summary 
Four novel silver(I) supramolecular polymers have been described. Figure 5.20 
shows the one dimensional structures of polymers 1-4. All of the polymers 
exhibit a zigzag geometry. In P2, the silver(I) ions occupy a trigonal coordination 
environment due to the incorporation of an acetonitrile molecule into the 
coordination sphere, however, in P1, P3 and P4 the metal centres are linear. 
The conformations of the ligands are susceptible to change and while L2 adopts 
a syn-conformation in P3, ligands L1 and L5 adopt an anti-conformation in P1, 
P2 and P4. The reason that the ligands adopt different conformations remains 
unclear as the only difference between them is the central linker and this does 
not appear to be implicated in any bonding or stabilising interactions in any of 
the three polymers. 
  
P1 
 
 
P2 
 
 
P3 
 
 
P4 
 
 
 
 
 
 
 
Figure 5.20. 1D structures of polymers 1-4. 
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5.4 Conclusion 
In this chapter, the coordination chemistry of silver(I) hexafluorophosphate with 
ligands L1, L2 and L5 was investigated. The results reveal the formation of four 
new supramolecular arrays, {Ag(L1)(PF6)}∞, {Ag(L1)(CH3CN)(PF6)} ∞, 
{Ag(L2)(PF6)}∞ and {Ag(L5)(PF6)}∞. The X-ray crystal structures of these 
complexes reveal one dimensional zigzag polymeric chains linked into two 
dimensional networks by Ag···N contacts, Ag···π interactions, F···H contacts and 
π-π stacking. The structure of the {Ag(L1)(CH3CN)(PF6)}∞ array demonstrates 
the flexibility of the silver(I) centre by the incorporation of a solvent molecule 
into the coordination sphere.  
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5.5 Experimental 
5.5.1 General 
All solvents and reagents were purchased from Sigma-Aldrich and were used 
without further purification. 1H NMR spectra were recorded on AC300 and 
AV300 Brüker spectrometers and variable temperature experiments were 
performed by Dr Neil Spencer using an AV 400 Brüker spectrometer. NMR data 
were processed using standard Brüker software. Infrared spectra were recorded 
from KBr pellets on a Perkin Elmer Paragon 1000 FT-IR spectrometer. 
Electrospray Ionisation (ESI) spectra were recorded by Dr Peter Ashton on a 
Micromass LCT Time of flight mass spectrometer in positive ionization mode. 
Microanalyses data were obtained using a CE Instruments EA1110 elemental 
analyser.  
 
5.5.2 Synthesis of silver(I) polymers of L1 
Ligand L1 (14.9 mg, 0.046 mmol) was dissolved in chloroform (5 ml) and 
excluding light, a solution of silver(I) hexafluorophosphate (11.6 mg,            
0.046 mmol) in methanol (5 ml) was added. The reaction mixture was stirred for 
3 hours after which an off white solid had precipitated. The crude product was 
collected by vacuum filtration, washed with chloroform (5 ml) and diethyl ether 
(5 ml) and dried in vacuo over P4O10 (19.3 mg, 73 % yield).  
1H NMR (300 MHz, CD3CN, 298 K): δ 8.82 (2H, dd, J= 2.4, 0.9 Hz, H2), 8.52 
(2H, dd, J= 4.9, 1.5 Hz, H6), 7.99 (2H, ddd, J= 8.1, 2.4, 1.5 Hz, H4), 7.62 (4H, d, 
J= 8.5, H8/9), 7.43 (2H, ddd, J= 8.1, 4.9, 1.1 Hz, H5), 7.41 (4H, d, J= 8.5 Hz, 
H8/9), 4.09 (2H, s, H11). 
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Elemental analysis (%) calculated for {Ag(C23H18N2)(PF6)}: C: 48.0; H: 3.2;    
N: 4.9; Found: C: 48.0; H: 2.8; N: 5.0. 
IR (Neat): ν= 1603(w), 1582(w), 1478(m), 1437(w), 1400(w), 1191(w), 1135(w), 
1012(w), 825(s), 793(m), 763(m), 739(m), 700(m), 659(m), 621(m) cm-1. 
 
5.5.3 Synthesis of silver(I) polymer of L2 
Ligand L2 (15.0 mg, 0.046 mmol) was dissolved in chloroform (5 ml) and 
excluding light, a solution of silver(I) hexafluorophosphate (11.6 mg,           
0.046 mmol) in methanol (5 ml) was added. The reaction mixture was stirred for 
3 hours after which an off white solid had precipitated. The crude product was 
collected by vacuum filtration, washed with chloroform (5 ml) and diethyl ether 
(5 ml) and dried in vacuo over P4O10 (20.3 mg, 77 % yield).  
1H NMR (300 MHz, CD3CN, 298 K): δ 8.84 (2H, dd, J= 2.6, 0.7 Hz, H2), 8.54 
(2H, dd, J= 5.0, 1.7 Hz, H6), 8.01 (2H, ddd, J= 8.1, 2.6, 1.7 Hz, H4), 7.71 (4H, d, 
J= 8.8, H8/9), 7.43 (2H, ddd, J= 8.1, 5.0, 1.1 Hz, H5), 7.19 (4H, d, J= 8.8 Hz, 
H8/9). 
Mass Spectrum (E.S.I): m/z 1009.1 {Ag2L2 + PF6}+, 757.2 {AgL2}+, 472.1 {AgL 
+ CH3CN}+, 
Elemental analysis (%) calculated for {Ag(C22H16N2O)(PF6)}: C: 45.8; H: 2.8; 
N: 4.9; Found: C: 45.7; H: 2.7; N: 4.9. 
IR (Neat): ν= 1697(w), 1599(w), 1508(m), 1477(m), 1436(w), 1280(w), 1250(m), 
1177(m), 836(s), 805(s), 703(m), 641(w) cm-1. 
 
 
 
 188
Chapter 5 
5.5.4 Synthesis of silver(I) polymer of L5 
Ligand L5 (15.0 mg, 0.045 mmol) was dissolved in chloroform (5 ml) and 
excluding light, a solution of silver(I) hexafluorophosphate (11.3 mg,           
0.045 mmol) in methanol (5 ml) was added. The reaction mixture was stirred for 
3 hours after which an off white solid had precipitated. The crude product was 
collected by vacuum filtration, washed with chloroform (5 ml) and diethyl ether 
(5 ml) and dried in vacuo over P4O10 (18.0 mg, 68 % yield).  
1H NMR (300 MHz, CD3CN, 298 K): δ 8.83 (2H, dd, J= 2.4, 0.9 Hz H2), 8.53 
(2H, dd, J= 4.8, 1.8 Hz, H6), 8.00 (2H, ddd, J= 8.1, 2.4, 1.7 Hz, H4), 7.60 (4H, d, 
J= 8.5 Hz, H8/9), 7.43 (2H, ddd, J= 8.1, 4.8, 0.7 Hz, H5),  7.39 (4H, d, J= 8.5 Hz, 
H8/9), 3.03 (2H, s, H11). 
Mass Spectrum (E.S.I): m/z 1033.2 {Ag2L2 + PF6}+, 779.3 {AgL2}+, 484.1 {AgL + 
CH3CN}+, 443.1 {AgL}+. 
Elemental analysis (%) calculated for {Ag(C24H20N2)(PF6)}: C: 48.9; H: 3.4;   N: 
4.8; Found: C: 48.8; H: 3.2; N: 4.8. 
IR (Neat): ν= 1604(w), 1581(w), 1479(m), 1437(w), 1400(w), 1298(w), 1191(w), 
1011(m), 821(s), 799(s), 739(m), 700(s) cm-1. 
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Chapter 6 
A Novel Azo Ligand System 
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6.1 Introduction 
As discussed in chapter 4, the coordination chemistry of Hannon’s ligand L6 has 
been extensively studied.1 Ligand Lazo is an analogue of L6 in which the imine 
constituent has been replaced by an azo bond (Figure 6.1).2 The azo bond is 
less susceptible to hydrolysis than the imine bond and so Lazo complexes 
should be more robust than their L6 analogues. The coordination chemistry of 
Lazo has also been previously investigated.2,3 
 
   
(a) 
 
 
 
 
(b) 
 
 
 
 
Figure 6.1. Hannon’s (a) ligand L6 and (b) ligand Lazo. 
 
6.1.1 Research Aims 
In this chapter the effect of modification to the central spacer of Lazo is explored. 
A novel dinucleating ligand, L7, is presented and its coordination chemistry 
investigated (Figure 6.2). L7 is very similar to Hannon’s Lazo ligand except that 
the central methylene bridge has been replaced by a secondary amine.  
 
 
 
 
Figure 6.2. Ligand L7. 
 
It was anticipated that the amine bridge would not significantly affect the 
coordination chemistry and that the reaction of this ligand with four coordinate 
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metal ions would result in the formation of dinuclear [M2L2]2+ species analogous 
to those formed with Lazo and L6. 
 
6.2 Results and Discussion 
6.2.1 Ligand L7 
Ligand L7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6.1. Synthesis of Ligand L7. 
 
2-Nitrosopyridine is not commercially available and was synthesized from         
2-aminopyridine in the two step reaction outlined by Taylor et al..4 The          
4,4’-diaminodiphenylamine spacer was also prepared using a literature 
procedure.5 Ligand L7 was synthesized in 65 % yield by an acetic acid catalysed 
reaction between two equivalents of 2-nitrosopyridine and one equivalent of 
4,4’-diaminodiphenylamine. A mixture of the ligand and half-ligand precipitated 
from the reaction mixture as a red powder. The crude product was purified by 
preparative RP-HPLC using a gradient of 100 % water to 100 % methanol over 
40 minutes and the pure product was observed and collected at 38.10 minutes. 
Partial microanalytical data are consistent with the expected ligand formulation 
of {C22H17N7} and the ESI mass spectrum is dominated by two peaks 
corresponding to [L7 + H]+ (m/z 380) and [L7 + Na]+ (m/z 402). FT-IR 
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6.46.66.87.07.27.47.67.88.08.28.48.68.8
spectroscopy shows a broad band at 3425 cm-1 and a sharp one at 1409 cm-1 
corresponding to the amine stretch and azo components, respectively. The 1H 
NMR spectrum of the ligand has been assigned with the assistance of a 2D 
COSY and is shown in Figure 6.3.  
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Figure 6.3. 1H NMR spectrum of Ligand L7  
(300 MHz, d3-chloroform, 298 K). 
 
The resonances of the pyridine ring are readily identified from their distinctive 
splitting patterns. H3 appears as a doublet and is coupled to H4 with a coupling 
constant of ~8 Hz. The resonance corresponding to H5 is observed as a doublet 
of doublets and is coupled to both H4 and H6 with coupling constants of ~7 Hz 
and ~5 Hz, respectively. The coupling with H6 is smaller due to the presence of 
the adjacent electronegative nitrogen atom which also shifts the H6 signal 
downfield to 8.73 ppm. The two doublets at 7.33 ppm and 8.08 ppm show a 
distinct roofing effect and correspond to H8 and H9 (J ~9 Hz). The signal for the 
amine proton (H11) occurs as a singlet at 6.66 ppm.  
Recrystallisation of this ligand from chloroform afforded red crystals 
suitable for X-ray diffraction analysis. The X-ray crystal structure of L7 is shown 
in Figure 6.4.6 
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(b) 
 (a) (c)  
 
 
 
 
 
 
 
 
 
Figure 6.4. X-ray crystal structure of (a) Ligand L7  
(b) H-bonded network and (c) π-π stacking interactions.  
 
The free ligand adopts an anti-conformation with respect to the relative 
positions of the pyridyl nitrogen atoms (Figure 6.4 (a)). Therefore, the two 
pyridyl donors interact differently with their neighbours. The first forms N···H-N 
interactions with the central amine (H11) proton (Npy···H 2.3 Å; Npy···H-N angle 
153º) and the second with a pyridyl (H4) proton (Npy···H 2.4 Å; Npy···H-C angle 
169º). N···H-C interactions are also apparent between the azo nitrogen and the 
H9 protons of the phenyl rings (Nazo···H 2.7 Å; Nazo···H-C angle 149º). These 
inter-molecular interactions result in the formation of a large H-bonded network 
(Figure 6.4 (b)). Within this network, the ligand molecules are arranged into 
columns which are held together by face-to-face π-π stacking interactions 
(Figure 6.4 (c)). The inter-planar distance between the stacked phenyl rings is 
3.4 Å and the separation between the pyridyl rings is 3.3 - 3.5 Å.  
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In the following section the coordination chemistry of ligand L7 with silver(I), 
copper(I) and palladium(II) will be described. Each metal ion is expected to 
coordinate to a pyridylazo subunit from each ligand. Therefore, the reaction of 
each of these four coordinate metal ions with L7 is expected to result in the 
formation of a dinuclear [M2L2]2+ species. Two conformations of the dimeric 
species are possible: the helix and the box (cyclophane).2 
 
6.2.2 Silver(I) complex of L7 
Silver(I) acetate was added to a methanolic solution of ligand L7 and heated 
under reflux for 3 hours. Care was taken to exclude light from the reaction to 
prevent the reduction of the silver(I) starting material. On completion of the 
reaction, a red-brown solid was precipitated by the addition of methanolic 
ammonium hexafluorophosphate. The precipitate was isolated by vacuum 
filtration, washed with diethyl ether and dried in vacuo to give the pure product 
in 36 % yield. 
 Partial microanalytical data are consistent with a formula of 
{Ag(C22H17N7)(PF6)}n and infrared spectroscopy reveals bands at 850 cm-1 and 
558 cm-1 due to the non-coordinated hexafluorophosphate counter-ions. The 
ESI mass spectrum displays peaks with the correct m/z ratios and isotope 
distribution to correspond to [Ag2L2(PF6)]+ (m/z 1119), [AgL2]+ (m/z 867) and 
[Ag2L2]2+ (m/z 487). This indicates the presence of a monomeric and/or dimeric 
species in solution. The 1H NMR spectrum of this complex is shown in      
Figure 6.5.  
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Figure 6.5. 1H NMR spectrum of the silver(I) complex of L7  
(300 MHz, d3-acetonitrile, 298 K). 
  
 
The spectrum consists of seven aromatic signals. At room temperature, a single 
set of well defined signals is displayed. On cooling to 233 K all of the signals 
remain sharp, suggesting that there is either a single species in solution or that 
any fluxional processes are rapid on the NMR timescale.  
 Red crystals suitable for X-ray diffraction were grown over a four week 
period by the slow diffusion of diethyl ether into an acetonitrile solution of the 
complex. Intriguingly, the X-ray crystal structure does not show the expected 
dimeric [Ag2(C22H17N7)2(PF6)2] species but instead reveals an infinite polymeric 
chain {Ag(L7)(PF6)}∞  (Figure 6.6).7 
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(c) 
(b) 
(a)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6. Silver(I) complex of L7 (a) unit cell (b) polymeric chain structure 
(c) additional view of polymer exhibiting zigzag motif. 
Hydrogen atoms are omitted for clarity. 
 
The zigzag chain exhibits a 1:1 metal:ligand stoichiometry with the metal 
centres occupying a pseudo-tetrahedral, four-coordinate environment. Each 
silver(I) ion is bound to two separate ligands through Ag-Npy                
(2.33(3) - 2.36(2) Å) and Ag-Nazo (2.28(2) Å) bonds. The pyridylazo units are 
approximately coplanar (dihedral angles of 7.5º & 10.2º) and have Nazo-Ag-Npy 
bite angles of 67.1(9) - 67.8(9)º. The bridging ligands separate the silver(I) 
centres by a distance of 11.0 Å. In contrast to the free ligand which adopts an 
anti-conformation, a syn-conformation is seen in this complex as both pyridyl 
substituents are oriented in the same direction. The phenyl-phenyl (3.7º) and 
phenyl-pyridine rings (6.4º & 8.0º) are almost coplanar with respect to one 
another. The crystal packing of the polymer chains is shown in Figure 6.7. 
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   (a)  (b)  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7. Packing diagrams for {Ag(L7)(PF6)}∞ showing (a) double-stranded 
helices (b) a view down the helical axis. Hydrogen atoms, anions and solvent 
molecules have been removed for clarity. 
 
The packing diagram shows that the polymers pair up with one polymeric strand 
wrapping around the other to form a double-stranded helix. A racemic mixture is 
observed and the right- and left-handed helices are arranged into alternating 
rows (Figure 6.8).  
    (a)      (b)  
 
 
 
 
 
 
 
 
Figure 6.8. (a) Right- and (b) left-handed double helix of {Ag(L7)(PF6)}∞ 
Each polymer chain is shown in a different colour.  
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The helical pitch measures 21.3 Å in length and is defined as the distance 
between equivalent atoms when the double helix makes one complete turn 
about its axis. A hollow channel is formed along the helical axis with a Ag···Ag 
separation of 4.6 Å (no contact between the silver(I) ions). The driving force for 
the formation of these double-stranded helices seems to be a series of        
inter-polymer π-π stacking interactions between the phenyl and pyridine rings    
(centroid-plane distances of 3.3 – 3.9 Å). The counter-ions are located in the 
gaps between the helices. Each PF6- makes a weak F···Ag (3.2 Å) contact to a 
silver(I) ion and F···H contacts to an amine proton (F···H = 2.1 Å) and to the 
aromatic protons on six different ligands (F···H = 2.4 - 2.7 Å).  
 This result is very exciting because it represents a rare example of a 
supramolecular double-stranded helical polymer in which the polymer chains 
are held together through non-covalent interactions. Examples of 
supramolecular polymers formed from related pyridylimine ligands have already 
been discussed in chapter 5 (section 5.1.2), however, these single-stranded 
helical polymers are not intertwined. Numerous examples of other             
single-stranded helical polymers also exist8 but only a few double-stranded 
polymeric helices have been reported.9 An example of a silver(I)              
double-stranded polymer similar to the one discussed here was reported by 
Reger and co-workers in 2004 (Figure 6.9).10 
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Lx 
Ag(I)PF6 
 
 
 
Figure 6.9. Reger’s double-stranded helical polymer.10 
 
Reger used ligand Lx and silver(I) to construct the double-stranded helix shown 
in Figure 6.9. The double-stranded architecture is made up of two intertwined 
single-stranded helices. The polymer was formed by the simple mixing of the 
ligand and silver(I) starting material in a similar way to {Ag(L7)(PF6)}∞ and gives 
an analogous double-stranded helix.  
Another more sophisticated example is the double-stranded helical 
metallo-supramolecular polymer reported by Yashima et al. (Figure 6.10).11  
 
 
 
 
 
 
 Poly-(R)-Duplex (R)-Duplex  
 
 
 
 
 
 
 
Figure 6.10.  Yashima’s double-stranded metallo-supramolecular helical 
This double-strande ry metallo-polymer 
strands wrapped around each other in a helical fashion. The polymer is formed 
polymer with complementary strands.11 
d polymer consists of two complementa
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from two different bis-monodentate ligands which are modified with either an 
amidinium group or carboxylate group. This is in contrast to {Ag(L7)(PF6)}∞ 
which is synthesised from a single bis-bidentate ligand. As shown in Figure 
6.10, Yashima’s helix is held together by chiral amidinium-carboxylate salt 
bridges and the helicity is controlled by the use of either (R)- or (S)-phenylethyl 
groups. It is formed by first synthesising the (R)-duplex structure and then 
carrying out the polymerisation reaction to form the double helical polymer. 
Yashima’s system is more advanced than {Ag(L7)(PF6)}∞ because it does not 
form a racemic mixture but enables the helicity of the structures to be 
controlled.  
 
The coordination chemistry of copper(I) with ligand L7 has also been 
vestigated. 
oordination of L7 to copper(I) was achieved by the reaction of 
xafluorophosphate with one equivalent of L7 in 
 spectrum of this complex is shown in Figure 6.11. 
 
%
in
 
6.2.3 Copper(I) complex of L7 
C
tetrakis(acetonitrile)copper(I) he
methanol. The reactants were heated under reflux for six hours whilst 
maintaining a nitrogen atmosphere. The resultant solution was concentrated 
under reduced pressure and the purple product precipitated in 98 % yield by the 
addition of diethyl ether.  
Partial microanalytical data are consistent with a {Cu(C22H17N7)(PF6)}n 
formulation. The ESI mass
 202
 
100 442.0
443.0
 [Cu (L7)2]2+ 
Chapter 6 
 
 
 
 
     
Figure 6.11. The ESI mass spectrum of {Cu(C22H N )(PF6)}n. 
 
 
he most abundant peak appears at m/z 442 and corresponds to the dimeric 
species [Cu2L2] . A weak peak for the monomeric species [CuL2]  (m/z 821) is 
                   6
5
3
2 7
8
N
N
N
N
N
N
 
 
 
 
17 7
T
2+ +
also observed, however, this is probably formed by fragmentation during 
electrospray ionisation. Infrared spectroscopy reveals a strong peak 
corresponding to the non-coordinated PF6- counter-ions at 845 cm-1 and a broad 
band at 3429 cm-1 which is attributed to the central amine group. The 1H NMR 
spectrum of this complex was recorded in d3-acetonitrile and is presented in 
Figure 6.12. 
4
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Figure 6.12. 1H NMR spectrum of {Cu(C22H17N7)(PF6)}n 
(500 MHz, d3-acetonitrile, 298 K). 
The spectrum shows a single set of  
remain broa ure spectra 
 
 broad resonances. The NMR signals
d even on cooling down to 233 K. Broad room temperat
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were also obtained in d6-dmso, d4-methanol and d3-nitromethane solutions. The 
mass spectrum results showed that each copper centre has a monocationic 
charge, however, the observed broadening could be due to the formation of a 
trace quantity of a copper(II) species from the oxidation of the metal centre. 
Unfortunately, attempts to grow X-ray quality crystals of this complex 
proved unsuccessful. However, the structure of this complex is expected to be 
similar
 
 
 
The coordination vestigated with 
alladium(II). 
6.2.4 Palladium(II) complex of L   
The complex was prepared by stirring tetrakis(acetonitrile)palladium(II) 
 L7 under an argon atmosphere 
               
 
 to that of Hannon’s copper(I) complex formed from the analogous ligand 
Lazo. In solution, the Lazo complex exists as a mixture of two dimeric isomers: a 
helicate and a box (Figure 6.13).2,12  
 
 
 
 
 
 
 
Figure 6.13. Representation of helix and box  
conformations of [Cu2(Lazo)2]2+. 
 chemistry of ligand L7 has also been in
p
 
7
tetrafluoroborate with one equivalent of ligand
for 16 hours. The solvent was removed under vacuum and the crude material 
washed with methanol and diethyl ether to yield a dark blue solid in 78 % yield. 
The FT-IR spectrum exhibits strong peaks at 1084 cm-1 and at 
3438 cm-1; These are characteristic of non-coordinated tetrafluoroborate anions
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and secondary amines, respectively. The elemental analysis data are c nsist nt 
with an empirical formula of {Pd(C22H17N7)(BF4)2}n. This complex does not fly 
well in electrospray mass spectrometry which could be consistent with a 
polymeric solution structure. However, the positive ion ESI mass spectrum does 
shows weak peaks corresponding to [Pd2L2]2+ (m/z 485.0) and [PdL2 - H+]+   
(m/z 863.1). The charge of the mono-cationic peak implies that the central 
nitrogen can become deprotonated during electrospray ionization, thereby 
decreasing the overall charge of the cationic species. From previous studies it is 
also known that the palladium(II) ion can become reduced to palladium(I). While 
these results may indicate the presence of a dimeric and monomeric species, 
the observed peaks could be fragments of a higher mass polymeric species. 
The 1H NMR spectrum of this complex has been recorded in d3-acetonitrile, at 
298 K. At this temperature a broad set of signals are observed. To investigate 
this further, a variable temperature 1H NMR experiment has been performed in 
d3-acetonitrile. Spectra were recorded from the same NMR sample at 298 K, 
273 K and 233 K and are shown in Figure 6.14. 
o e
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 H6                         H4 H3      H8/9 H11                   H5       H8/9                                       298 K 
 
 
 
 
 273 K 
 
 
 
233 K 
7.27.47.67.88.08.28.48.68.89.09.2
 
 
 
 
Figure 6.14. 1H NMR spectra of the palladium(II) complex of L7  
at 298 K, 273 K and 233 K (400 MHz, d3-acetonitrile). 
 
At room temperature, the 1H NMR spectrum displays a broad set of signals. 
This broadening may arise from the presence of two or more, inter-changeable 
solution species or from the instability of the complex in solution. However, on 
cooling the sample down to 273 K, sharper signals were obtained and only a 
single set of resonances is seen. If multiple species had been present, cooling 
would normally slow down the inter-conversion of the species, resulting in an 
NMR spectrum with a set of signals for each species. Therefore, it is more 
probable that the ligands are in exchange with the d3-acetonitrile solvent 
molecules than with each other. However, a 1H NMR spectrum run in the      
non-coordinating, d3-nitromethane, gave a similar broad spectrum. Further 
cooling to 233 K resulted in the coalescence of the phenyl peaks.  
Numerous attempts were made to grow X-ray quality crystals of this 
complex. However, all attempts were unfortunately unsuccessful. Since it is 
unclear from the data obtained whether a discrete or polymeric species has 
been formed, the corresponding complex with the pyridyimine ligand L6 was 
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also prepared in hope that it might provide further insight. As discussed in 
section 6.1, ligand L6 is analogous to ligand L7.  
 
6.3 Palladium(II) complex of L6  
The synthesis of ligand L6 has already been described in chapter 4. The 
corresponding palladium(II) complex was formed by stirring a 1:1 ratio of L6 with 
tetrakis(acetonitrile)palladium(II) tetrafluoroborate under an argon atmosphere. 
After 16 hours, the solvent was removed under vacuum to yield an orange 
product. Attempts were made to purify this complex by washing with methanol, 
chloroform and diethyl ether. 
To investigate the solution behaviour of this complex, 1H NMR spectra 
were recorded in d3-acetonitrile and d3-nitromethane (Figure 6.15). 
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                     H7                          H9/10  H9/10                                                                                                       H12  
4.04.55.05.56.06.57.07.58.08.59.0
Figure 6.15. 1H NMR spectra of the palladium(II) complex of L6 in  
(a) d3-acetonitrile and (b) d3-nitromethane solution (400 MHz, 298 K). 
 
One main set of signals is observed in both spectra, however, numerous 
smaller resonances are also present. This indicates the presence of one major 
product and at least one minor product, possibly the box and helix 
 207
Chapter 6 
 
conformations that have already been discussed. Low temperature studies were 
carried out (Figure 6.16) and appear to show an increase in the ratio of the 
minor component(s) at low temperature. This would be consistent with a       
box-helix equilibrium in which the one species is enthalpically favoured and the 
other entropically favoured as is seen in cuprous box-helix equilibrium with this 
ligand.12 
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Figure 6.16. 500 MHz  1H NMR spectra of the palladium(II) complex of L6 in  
(a) d3-acetonitrile and (b) d3-nitromethane solution  
 
The ESI mass spectrometry results show the presence of a multitude of 
different solution species (Figure 6.17) indicating that the complex may be more 
complicated than a two species equilibrium or that it is not stable in solution. 
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  [PdL + MeCN]2+ 
 
 
 
 
 
Figure 6.17. ESI mass spectrum of the palladium(II) complex of L6. 
 
Unfortunately, attempts to grow X-ray quality crystals of this complex were also 
unsuccessful.  
 
 
 
 
 
 
 
 
 209
Chapter 6 
 
6.4 Conclusions 
In this chapter the synthesis and characterisation of a novel pyridylazo ligand 
(L7) has been discussed. The ligand is analogous to Hannon’s Lazo except that 
the spacer has been modified by exchanging the central methylene group for an 
amine substituent.  
L7 has been utilized in the synthesis of three novel metallo-complexes. 
Surprisingly, the solid state structure of the silver(I) complex of L7 does not 
reveal the dimeric species seen for Lazo but instead shows it to have a 
polymeric {Ag(C22H17N7)(PF6)}∞ architecture. These polymer chains have been 
shown to pack together to form double-stranded helices that are held together 
by π-π stacking interactions.  
With a M2L2 formulation, the copper(I) complex of L7 is analogous to the 
previously reported copper structures of Lazo and L6. 
The palladium(II) complex of L7 has a {Pd(C22H17N7)(BF4)2}n formulation, 
however it remains unclear whether the complex formed has a dimeric or 
polymeric structure. The palladium(II) complex of L6 was prepared in hope that 
it might provide further insight. Data obtained for this complex indicated that the 
palladium(II) complexes may contain a number or inter-converting species or 
that they are not stable in solution.  
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6.5 Experimental 
6.5.1 General 
All solvents and reagents were purchased from Sigma-Aldrich and were used 
without further purification. 1H NMR spectra were recorded on AC300 and    
DRX 500 MHz Brüker spectrometers and were processed using standard 
Brüker software. Variable temperature NMR experiments were performed by   
Dr Neil Spencer using a DRX 500 MHz Brüker spectrometer. Infrared spectra 
were recorded from KBr pellets on a Perkin Elmer Paragon 1000 FT-IR 
spectrometer. UV/Visible spectra were recorded using a Cary 5000 Varian 
spectrophotometer and quartz cuvettes. Electrospray Ionisation (ESI) spectra 
were recorded on a Micromass LCT Time of flight mass spectrometer in positive 
ionization mode. Microanalyses data were obtained using a CE Instruments 
EA1110 elemental analyser.  
 
6.5.2 Synthesis of Ligand L7 
6
5
4
3
2
7
8
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N
N
N
N
N
N
N
 
C22H17N7 
FW: 379.15 
2-Nitrosopyridine4 (0.150 g, 1.388 mmol), 4,4’-diaminodiphenylamine5 (0.138 g, 
0.694 mmol) and 2 drops of acetic acid were stirred together in dichloromethane 
(25 ml) for 48 hours. The red precipitate was filtered and washed with diethyl 
ether (8 ml). The crude product was purified by preparative RP-HPLC using a 
gradient of 100 % water to 100 % methanol over 40 minutes with a 10 minute 
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methanol wash. The product peak was observed and collected at 38.10 minutes 
(0.171 g, 65 % yield). 
1H NMR (300 MHz, CDCl3, 298 K): δ 8.73 (2H, d, J= 4.8 Hz, H6), 8.08 (4H, d,  
J= 8.8 Hz, H8/9), 7.91 (2H, td, J= 7.8, 1.6 Hz, H4), 7.83 (2H, d, J= 7.8 Hz, H3), 
7.38 (2H, dd, J= 7.8, 4.8 Hz,  H5), 7.33 (4H, d, J= 8.8 Hz, H8/9), 6.66 (1H, s, H11). 
13C NMR (400 MHz, CDCl3, 300 K): δ 163.2 C2/7/10, 149.5 C6, 147.4 C2/7/10, 145.3 
C2/7/10, 138.2 C4, 125.8 C8/9, 124.7 C5, 117.8 C8/9, 115.4 C3. 
Mass Spectrum (ESI): m/z 402.1 {Ligand + Na}+, 380.2 {Ligand + H}+. 
Elemental analysis (%) calculated for C22H17N7: C: 69.6; H: 4.5; N: 25.8; 
Found: C: 69.6; H: 3.9; N: 25.2.  
IR (KBr): ν= 3425(s), 1589(s), 1500(w), 1460(w), 1192(w), 1140(s), 829(w),  
788(w), 741(w), 668(w) cm-1.  
 
6.5.3 Synthesis of silver(I) complex of L7 
Ligand L7 (0.010 g, 0.026 mmol) was dissolved in methanol (5 ml) to form an 
orange solution. Light was excluded from the reaction vessel and silver(I) 
acetate (0.004 g, 0.026 mmol) was added. The solution was heated under reflux 
for 3 hours resulting in the formation of a red solution. A red/brown solid 
precipitated on addition of methanolic ammonium hexafluorophosphate. The 
precipitate was isolated by filtration, washed with diethyl ether (5 ml) and dried 
in vacuo (12 mg). 
1H NMR (300 MHz, CD3CN, 298 K): δ 8.71 (2H, d, J= 5.1 Hz, H6), 8.17 (2H, td, 
J= 7.7, 1.6 Hz, H4), 8.00-7.97 (3H, m, H3&11), 7.84 (4H, d, J= 8.9 Hz, H8/9), 7.65 
(2H, dd, J= 7.7, 5.1 Hz, H5), 7.14 (4H, d, J= 8.9 Hz, H8/9). 
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Mass Spectrum (ESI): m/z 1119.0 {Ag2L2 + PF6}+, 867.2 {AgL2}+, 487.0 
{Ag2L2}2+. 
Elemental analysis (%) calculated for [Ag(C22H17N7)](PF6)·(CH3CN)0.25:          
C: 42.1; H: 2.8; N: 15.8; Found: C: 42.5; H: 2.6; N: 15.4.  
IR (KBr): ν= 3417(s), 2360(w), 1617(s), 1589(m), 1541(m), 1501(m), 1396(m), 
1363(m), 1302(m), 1233(w), 1136(s), 850(s) cm-1. 
UV/Vis (CD3CN): λmax (nm) = 268, 444. 
 
6.5.4 Synthesis of copper(I) complex of L7 
Ligand L7 (0.015 g, 0.038 mmol) was dissolved in methanol (5 ml) and stirred 
under a nitrogen atmosphere. Tetrakis(acetonitrile)copper(I) 
hexafluorophosphate (0.015 g, 0.038 mmol) was added and the solution heated 
under reflux for 6 hours. The reaction mixture was allowed to cool and the 
volume of the filtrate was reduced under vacuum. Diethyl ether was added 
dropwise to precipitate the purple product. The crude product was washed with 
chloroform (3 ml) and diethyl ether (3 ml) and dried over P4O10 (21 mg, 94 % 
yield). 
1H NMR (500 MHz, CD3CN, 298 K): δ 8.51 (2H, bs), 8.29 (4H, bs), 8.18 (1H, 
bs), 7.87 (4H, bs), 7.74 (2H, bs), 7.12 (4H, bs). 
Mass Spectrum (ESI): m/z 1029.1 {Cu2L2 + PF6}+, 442.0 {Cu2L2}2+.   
Elemental analysis (%) calculated for [Cu(C22H17N7)](PF6)·(CH3O2)0.5: C: 44.2; 
H: 3.1; N: 16.1; Found: C: 44.5; H: 2.9; N: 15.4.  
IR (KBr): ν= 3429(br), 2919(w), 2360(w), 1582(s), 1529(w), 1500(w), 1443(w), 
1303(m), 1242(w), 1203(w), 1141(s), 845(s) cm-1. 
UV/Vis (CD3CN): λmax (nm) = 276, 486. 
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6.5.5 Synthesis of palladium(II) complex of L7 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.017 g, 0.038 mmol) was 
added to a degassed suspension of ligand L7 (0.015 g, 0.038 mmol) in 
acetonitrile (6 ml). The solution immediately turned dark blue and was stirred 
overnight under an argon atmosphere. The solvent was removed under vacuum 
and the crude material washed with methanol (5 ml) and diethyl ether (5 ml) to 
yield a dark blue solid (19 mg, 76 % yield). 
1H NMR (400 MHz, CD3CN, 273 K): δ 8.93 (2H, bs, H6), 8.42 (2H, t, J= 7.9 Hz, 
H4), 8.34 (2H, d, J= 7.9 Hz, H3), 8.27 (5H, d, J= 8.7 Hz, H8/9&11), 7.71-7.68 (2H, 
m, H5), 7.58 (4H, d, J= 8.7 Hz, H8/9). 
Mass Spectrum (ESI): m/z 863.1 {PdL2 - H+}+, 485.0 {Pd2L2}2+, 380.2 {L + H}+. 
Elemental analysis (%) calculated for [Pd(C22H17N7)][BF4]2: C: 40.1; H: 2.6;    
N: 14.9; Found: C: 39.5; H: 2.9; N: 13.6.  
IR (KBr): ν= 3438(br), 2360(m), 1582(s), 1530(m), 1494(m), 1462(w), 1305(s), 
1242(s), 1140(b), 1084(s), 833(w) cm-1. 
UV/Vis (MeCN): λmax (nm) = 296, 614. 
 
6.5.6 Synthesis of palladium(II) complex of L6 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.031 g, 0.07 mmol) was 
added to a degassed suspension of ligand L6 (0.026 g, 0.07 mmol) in 
acetonitrile (4 ml). The solution immediately turned yellow and was stirred 
overnight under an argon atmosphere. The solvent was removed under vacuum 
to yield an orange solid. The crude product was washed with chloroform and 
diethyl ether, dissolved in nitromethane, filtered and then the solvent removed 
again to yield the yellow product (18 mg, 39 % yield). 
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1H NMR (400MHz, CD3NO2, 298K): δ 8.94-8.92 (2H, m, H6), 8.60-8.58 (2H, m, 
H4), 8.49 (2H, s, H7), 8.40 (2H, d, J= 7.3 Hz, H3), 8.20-8.16 (2H, m, H5), 7.45 
(4H, d, J= 8.3 Hz, H9/10), 7.11 (4H, d, J= 8.3 Hz, H9/10), 3.98 (2H, s, H12). 
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As discussed in chapter 1, metallo-supramolecular chemistry is an attractive 
tool for the self-assembly of a range of different architectures. During this work 
to develop new metallo-supramolecular complexes, a number of novel organic 
ligands have been prepared.  
In chapter 2, the synthesis of four palladium(II) and two platinum(II) tetra-
stranded, dinuclear complexes has been described. To the best of our 
knowledge there are no other examples of similar tetra-stranded, dinuclear 
platinum(II) complexes reported in the literature. Biological investigations were 
carried out on four of the palladium(II) complexes. Gel electrophoresis and AFM 
experiments revealed that all four bind to DNA and promote localised changes 
in the DNA structure. Cytotoxicity experiments demonstrated that two of the 
cylinders showed good activity in a selection of cancer cell lines, while the other 
two were inactive. Preliminary results showed that the two active cylinders also 
proved to be non-mutagenic and non-genotoxic. The drawback of these 
complexes is that they are insoluble in water and only sparingly soluble in some 
water/solvent mixtures. Future work needs to focus on improving the aqueous 
solubility. Further biological testing also needs to be carried out to fully elucidate 
the mode of action of the cylinders. Due to time constraints the biological 
activities of the platinum(II) complexes were not studied and these also require 
investigation. 
In chapter 4, the synthesis and characterisation of two new dinuclear  
cis-platin type compounds was discussed. Gel electrophoresis and CD and LD 
studies show that both of the compounds bind to DNA disturbing the orientation 
and stacking of the nucleotide bases. Cytotoxicity testing revealed that the 
compounds were active against A2780 and T47D cell lines but were less active 
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than cis-platin. Future work could involve reactions of the compounds with 
model bases to find out whether they bind to the bases of DNA. It would also be 
interesting to exchange the chlorine atoms for other ligands such as             
2,2’-bipyridine and to investigate the biological activities of the resulting 
complexes.   
In chapter 5, the coordination chemistry of silver(I) was investigated and 
resulted in the formation of four metallo-supramolecular polymers which were 
characterised crystallographically. The crystal structures highlight the 
importance of the conformation of the ligand and of inter-molecular interactions 
for linking the polymers together into two and three dimensional networks.   
In chapter 6, a new pyridylazo ligand system was developed and the 
coordination chemistry of this ligand investigated. One of the complexes that 
was synthesised from this ligand was a silver(I) polymer. The solid state 
structure showed that the polymer chains pair up and intertwine to form a 
racemic mixture of double helices. This result is very interesting because it 
represents a rare example of a supramolecular double-stranded helical 
polymer, whereas Hannon’s previously reported analogous ligands had formed 
double-stranded dinuclear complexes. This demonstrates that small changes in 
the ligand can result in dramatic changes in the resulting complexes. Future 
work would be to investigate the coordination chemistry of this ligand with other 
metal ions. 
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